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Abstract 
This thesis presents investigations into aspects of oocyte-type 5S ribosomal RNA 
(5S rRNA) nuclear transport in Xenopus laevis oocytes. Oocyte-type 5S rRNA 
synthesis begins in the nucleus of early-stage oocytes before other ribosomal RNAs 
and proteins are available, and the RNA is subsequently stored in the cytoplasm in 
specific complexes with proteins as 42S and 7S ribonucleoprotein particles (RNPs). 
5S rRNA remains sequestered in the cytoplasm until it receives the signal to return to 
the nucleus to be incorporated into 60S ribosomal subunits; a process occurring in the 
nucleolus. Movement of 5S rRNA into the nucleus is concurrent with the maximal 
synthesis of the other ribosomal RNAs and ribosomal proteins at the later stages of 
oogenesis. At this time, 5S rRNA interacts with ribosomal protein L5 to fonn pre-
ribosomal 5S RNPs. By microinjecting in vitro-synthesised, labelled 5S rRNA and 5S 
RNPs into late-stage Xenopus oocytes, I have analysed the mechanism of 5S rRNA 
localisation to the nucleus. The results presented in this thesis provide evidence for a 
model for 5S rRNA nuclear import where the exchange of TFIIIA for L5 binding 
triggers the switch from cytoplasmic storage to its nuclear accumulation. It is likely 
that L5 provides a nuclear localisation signal which interacts with components of the 
nuclear transport machinery used by nuclear proteins, enabling the 5S RNP to be 
translocated into the nucleus through the channel provided by the nuclear pore 
complex. The process of 5S rRNA nuclear import requires physiological temperatures 
and metabolic energy, and involves interactions with nuclear pore complex 
glycoproteins. 
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Chapter One 
General Introduction 
1.1 The Nuclear Membrane as a Selective Barrier 
In eukaryotic cells the nuclear membrane forms a barrier between the genetic 
material in the nucleus and the site of expression of protein-coding genes in the 
cytoplasm. Transport of molecules and ions in both directions across this membrane 
is therefore an important process in regulating gene expression during the development 
and growth of a cell and in response to a changing environment. Proteins such as 
transcription factors, steroid hormone receptors, and enzymes need to move into the 
nucleus to interact with DNA during the process of RNA transcription, and histone 
proteins also have to undertake transport through the nuelear membrane to interact 
with DNA. RNA also undergoes nueleo-cytoplasmic transport: the RNA-protein 
complexes involved in processing messenger RNA are assembled in the cytoplasm and 
function in the nucleus, the processed mRNA must move out to the cytoplasm to be 
used as a template for protein synthesis, and transfer RNA and signal recognition 
partiele RNA (involved in protein translocation through the endoplasmic reticulum 
membrane) are exported from the nueleus after synthesis to their site of action in the 
cytoplasm. Finally, ribosomes, the machinery upon which proteins are manufactured, 
are assembled from a collection of proteins and RNAs and this involves coordinated 
movement of ribosomal components between these two cellular compartments. 
In spite of the central importance of the process of nuclear transport, the 
construction of a model for the transport process, integrating the molecular interactions 
and cellular components involved, has remained enigmatic. Most of the studies to 
date have focused on the mechanism of protein transport from cytoplasm to nucleus 
(for recent reviews see: Wagner et al., 1990; Garcia-Bustos et al., 1991; Silver, 1991; 
Stochaj & Silver, 1992), Proteins for which nuclear transport processes have been 
characterised include: steroid hormone receptors, such as the progesterone receptor 
(Guichon-Mantel et al., 1991); growth factors (reviewed in lans, 1994); histones 
(Breeuwer & Goldfarb, 1990); ribosomal proteins (Moreland et al., 1985); components 
of signalling pathways such as calmodulin (Pruschy et al., 1994) and the catalytic 
2 
subunit of protein kinase C (Harootunian et al., 1993); and viral proteins (Kemler et 
al., 1994; Schliephake & Rethwilm, 1994). Initially, it was presumed that the passage 
of viral proteins and nucleic acids into the nucleus for viral replication would occur 
exclusively when the nuclear membrane is absent during cell division, as is the case 
with many oncogenic viruses such as the murine leukaemia virus (Roe et al., 1993; 
Lewis & Emerman, 1994). However, there is now evidence that transport across the 
membrane is an important process in the infection of cells with some viruses, 
including simian virus 40 (SV40; Yamada & Kasamatsu, 1993), influenza virus 
(Martin & Helenius, 1991a,b) and human immunodeficiency virus type-I (HIV-I; 
Meyer & Malim, 1994; Stevenson, 1994). 
RNAs are most likely to exist within the cell exclusively in specific complexes 
with proteins as ribonucleoprotein particles (RNPs), which serve to stabilise the 
molecules and to regulate their function. The nucleo-cytoplasmic trafficking of RNPs 
has been the focus of much recent research. The mechanism of transport out of the 
nucleus has been investigated for tRNA (Zasloff et al., 1982; Tobian et al., 1985), 
pre-mRNA (Eckner et al., 1991; Dargemont & KUhn, 1992; Williams et al., 1994), 
signal recognition particle RNA (He et aI., 1994), uridine-rich small nuclear RNAs (U 
snRNAs; Hamm & Mattaj, 1990; Terns et al., 1993), 5S rRNA (Guddat et al., 1990), 
and ribosomal subunits (Bataille et al., 1990). Some of the U snRNAs also undergo 
transport across the nuclear membrane in the other direction, and this import process 
has been studied as well (Fischer & LUhrmann, 1990; Hamm et al., 1990; Michaud & 
Goldfarb, 1991, 1992). The process of nuclear transport must therefore accommodate 
a variety of molecules and complexes, and operate in both directions across the 
nuclear membrane. 
1.2 Movement of 5S rRNA Between the Nucleus and Cytoplasm 
Ribosome biogenesis requires movement across the nuclear membrane of four 
different RNA molecules (28S, 18S, 5.8S and 5S ribosomal RNAs [rRNAs]) and 
approximately eighty ribosomal proteins. In somatic cells, ribosomal proteins move 
from their site of synthesis in the cytoplasm to the nucleus, where they combine with 
ribosomal RNAs to form pre-ribosomal particles. This process occurs in the 
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nucleolus, the subnuclear compartment which is the site of ribosome synthesis 
(Hadjiolov, 1985). The 60S and 40S ribosomal subunits formed are then exported to 
the cytoplasm to take part in protein synthesis, with 18S rRNA in the 40S subunit and 
28S, 5.8S and 5S rRNA in the 60S subunit (Hadjiolov, 1985; Hill et al., 1990). In 
oocytes of the South African clawed frog, Xenopus laevis, the requirement for large 
numbers of ribosomes (approximately 1012 in a fully grown oocyte; Hausen & 
Riebe sell, 1991) for the burst of protein synthesis accompanying embryogenesis, 
results in additional steps to the process of ribosome production. 
In Xenopus oocytes there are two families of developmentally regulated 5S 
rRNA genes: oocyte-type and somatic-type (Wegnez et al., 1972; Ford & Southern, 
1973; reviewed in Wolffe & Brown, 1988). Oocyte-type 5S rRNA is transcribed in 
the developing oocyte from approximately 20000 copies of the gene per haploid 
genome, but its transcription is greatly reduced during embryogenesis and is blocked 
in somatic cells. Somatic-type 5S rRNA differs from oocyte-type at six nucleotides 
and is transcribed from approximately 400 gene copies per genome throughout the 
development of the frog, including in oocytes (Wormington & Brown, 1983). These 
two types of 5S rRNA have been found to follow different pathways in oocytes with 
respect to interaction with proteins in RNPs and intracellular localisation, with oocyte-
type 5S rRNA being specialised for storage, and somatic-type ready for the production 
of ribosomes in the mature oocyte (Allison et al., 1995). 
Oocyte-type 5S rRNA synthesis begins in early previtellogenic oocytes before 
other ribosomal components are available (Mairy & Denis, 1971). After synthesis in 
the nucleus, 5S rRNA moves to the cytoplasm for storage in two different RNPs: 
either in a 1:1 ratio with transcription factor IIIA (TFIIIA) as 7S RNPs (Honda & 
Roeder, 1980; Pelham & Brown, 1980); or with one of various tRNAs, a protein 
related to the elongation factor EF-la. and p43 (a protein related to TFIIIA) as 42S 
RNPs (Picard et al., 1980; Mattaj et al., 1983; 10ho et al., 1990). Although somatic-
type 5S rRNA is synthesised in oocytes, it does not appear to be stored long-term 
(Denis & Wegnez, 1977). Therefore, the six nucleotide difference between oocyte-
type and somatic-type 5S rRNAs appears to confer the storage property on oocyte-type 
when compared with somatic-type, as demonstrated by its preferential binding to 
TFIIIA in vivo (Allison et al., 1995). 
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At vitellogenesis, the developmental stage encompassing ribosome synthesis, 
18S, 5.8S and 28S rRNA synthesis occurs simultaneously from multiple repeats of the 
rDNA by RNA polymerase I and is concurrent with ribosome assembly in the 
amplified nucleoli (Mairy & Denis, 1971; Picard & Wegnez, 1979; Picard et al., 
1980). When ribosome synthesis is maximal, oocyte-type 5S rRNA is released from 
storage in the cytoplasm and moves into the nucleus to join other ribosomal 
components being assembled into pre-ribosomal particles in the nucleolus (Allison et 
al., 1991, and references therein). After release from 7S and 42S RNPs, 5S rRNA 
binds with ribosomal protein L5 to form 5S RNPs which are detectable in the 
cytoplasm (Allison et al., 1991). In ribosomes treated with EDTA, the 5S RNP is 
released intact (Blobel, 1971), demonstrating that the 5S rRNA/L5 interaction is stable 
through to its incorporation into functioning ribosomes. Therefore, it is likely that 5S 
rRNA is in the form of the stable pre-ribosomal 5S RNP as it moves into the nucleus. 
The fmal journey of 5S rRNA across the nuclear membrane is out of the nucleus in 
the form of the 60S ribosomal subunit, to become part of the functioning ribosome in 
the cytoplasm (reviewed in Ware & Khanna-Gupta, 1990). In somatic cells, the 
majority of newly synthesised 5S rRNA is not likely to enter the cytoplasm, but forms 
5S RNPs with L5 in the nucleus and is targeted directly to the nucleoli (Steitz et al., 
1988). However, a cytoplasmic pool of 5S rRNA has been reported in rat liver cells 
(Ogata et al., 1993), and somatic-type 5S rRNA microinjected into the oocyte 
cytoplasm is able to enter the nucleus (Allison et al., 1995), suggesting that somatic-
type 5S rRNA has the potential to re-enter the nucleus after a cytoplasmic excursion. 
In summary, the pathway to ribosome incorporation for Xenopus oocyte-type 5S 
rRNA involves various 5S rRNA-protein interactions and passage across the nuclear 
membrane in both directions during oocyte development. Therefore, this molecule 
provides an ideal system for the investigation of the process of RNA nucleo-
cytoplasmic transport and RNA-protein interactions involved. The pathway of 5S 
rRNA from storage in the cytoplasm to the nucleus for ribosome assembly is the focus 
of this thesis, with an investigation of the mechanism by which 5S rRNA is targeted 
to the nucleus. This chapter provides a review of the process of nuclear transport, 
which will be related to 5S rRNA transport throughout the rest of the thesis. 
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1.3 The Structure and Function of the Nuclear Pore Complex 
1.3.1 Basic structure and function 
The transport of molecules and ions in both directions across the nuclear 
membrane occurs exclusively through aqueous channels formed by nuclear pore 
complexes (NPCs; for recent reviews see: Akey, 1992; Forbes, 1992; Hurt, 1993; 
Pante & Aebi, 1993, 1994; Agutter & Prochnow, 1994; Hinshaw, 1994). NPCs are 
assemblies of multiple protein subunits that span the two layers of the nuclear 
envelope, forming a junction between the inner and outer membranes. These 
structures are composed of two rings, facing the cytoplasm and nucleoplasm 
respectively, between which is sandwiched a central spoke-like assembly containing 
the transporter through which nucleocytoplasmic trafficking takes place (Akey, 1989; 
1990; Hinshawet al., 1992). The complex has a large central channel, through which 
macromolecules up to a diameter of 26 nm can be transported in a facilitated manner 
(Feldherr et al., 1984). This central channel has been proposed to be in the form of 
an iris-like assembly which expands to provide a larger functional diameter and allows 
passage of macromolecules in an energy- and signal-dependent manner (Akey, 1990). 
The large NPC channel is surrounded by smaller peripheral channels that may serve to 
allow the passive diffusion of ions and molecules of less than 9 nm in diameter 
(Hinshaw et al., 1992), However, recent evidence suggests that movement of some 
ions through the nuclear pore complex may occur via a regulated process, and not by 
passive diffusion (Bustamante, 1992, 1994; Himpens et al., 1994a,b; Mazzanti et al., 
1994). 
Facilitated transport of proteins through the NPC has been separated into two 
steps (Newmeyer & Forbes, 1988; Richardson et al., 1988; Akey & Goldfarb, 1989). 
In the first step the protein binds at the nuclear pore complex in a mechanism which 
depends on a specific signal provided by the protein, and does not require metabolic 
energy. The second step requires metabolic energy and involves the translocation of 
the protein through the nuclear pore channel. These two steps of import have been 
shown to be dependent on factors present in the cytosol that must interact with both 
the molecule or particle being transported and the NPC (for recent reviews see~ 
Powers & Forbes, 1994; Simos & Hurt, 1995). The role of these factors in nuelear 
transport will be discussed further in Section 1.5. 
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Only approximately 15% of nuelear pore complex proteins have been identified 
(Starr & Hanover, 1992; Panre & Aebi, 1994). Some of these proteins have a role in 
the maintenance of NPC structure, while others are presumably involved in the 
regulation of facilitated nueleo-cytoplasmic transport. In the next section, the potential 
roles for some of the identified NPC proteins are discussed. 
1.3.2 Specific proteins of the NPC 
The majority of vertebrate NPC proteins examined to date are members of a 
family of glycoproteins that possess N-acetylglucosamine (GlcNAc) residues joined by 
O-glycosyllinkages to serine and threonine residues on the polypeptides (Davis & 
Blobel, 1987; Hanover et al., 1987; Starr & Hanover, 1990). These proteins, 
collectively termed nueleoporins, occupy peripheral sites on the NPC at both the 
cytoplasmic and nueleoplasmic faces, as determined by immunofluorescence and 
immunoelectron microscopy of nuelear envelopes with antibodies raised against 
nuclear membrane extracts (Davis & Blobel, 1986; Park et aI., 1987; Snow et al., 
1987). Some of these GlcNAc-bearing pore proteins possess a highly conserved 
repeated peptide motif of FXFG or GLFG (single letter code for amino acids, where X 
codes for any amino acid), which appears to be important for interaction with soluble 
components of the nuelear transport machinery (for reviews see: Fabre & Hurt, 1994; 
Rout & Wente, 1995). 
The essential role of peripheral nueleoporins in the functioning of the NPC in 
nueleo-cytoplasmic transport has been demonstrated by the construction of NPCs 
specifically lacking the GlcNAc-bearing proteins (Finlay & Forbes, 1990; Finlay et al., 
1991). These NPCs retained their structural integrity and diffusional channel, but 
were found to be defective for nuclear protein transport. Monoclonal antibodies raised 
against nUcleoporins and microinjected into Xenopus oocytes have been found to 
inhibit the facilitated nucleocytoplasmic transport of proteins and RNA, but do not 
affect passive diffusion through the NPC (Snow et al., 1987; Featherstone et al., 
1988). Recent studies have demonstrated that nucleoporins in this group interact with 
7 
factors involved in both docking of nuclear proteins at the nuclear pore complex 
(Kraemer et al., 1995; Moroianu et ai., 1995a,b; Paschal & Gerace, 1995; Radu et al., 
1995a,b), and in subsequent translocation through the nuclear pore complex (Dingwall 
et al., 1995; Hartmann & Gorlich, 1995; Yokoyama et al., 1995). One of the 
GlcNAc-bearing nucleoporins, p62, is symmetrically localised on both the cytoplasmic 
and nucleoplasmic sides of the NPC (Cordes et al., 1991), indicating that it could have 
a role both in nuclear import and export. This is corroborated by evidence of an 
interaction between p62 and mRNA which is being exported from the nucleus 
(Dargemont et al., 1995). 
Filamentous elements have been observed extending from both cytoplasmic and 
nuclear faces of the NPC (for review see Davis, 1995). These filaments give an 
asymmetric aspect to NPC structure, with short fibrils perpendicular to the nuclear 
membrane at the cytoplasmic face, and a complex fish net-like structure emanating 
from the nuclear side (Jarnaik & Aebi, 1991; Ris, 1991; Goldberg & Allen, 1992; 
1993). Nucleoporins have been isolated that may be constituents of these fibres; they 
include Nup358 (Wu et al., 1995a) and Nup214 (Kraemer et al., 1994) at the 
cytoplasmic side, and Nup153 (Sukegawa & Blobel, 1993) and Nup98 (Radu et al., 
1995b) facing the nucleoplasm. Interaction of the cytoplasmically disposed 
nucleoporins with factors involved in the docking stage of nuclear protein import 
suggest that the fibres are involved in the recognition of the transported protein at the 
NPC (Moroianu et al., 1995b; Radu et al., 1995b). The NPC fibres may also form a 
part of a complex series of tracks that link the cytoplasm and nucleus through the 
cytoskeleton and karyoskeleton, and which may provide the physical pathways for 
nucleo-cytoplasmic transport. Messenger RNA molecules have been observed 
attached to filamentous tracks in the nucleus (Huang et ai., 1994), and fibrils can be 
seen linking NPCs with nucleoli, providing possible paths for the nuclear transport of 
ribosomal components (Cordes et ai., 1993), Indeed, a nucleolar protein, Nopp140, 
has been visualised during transport attached to filamentous tracks emanating from the 
nucleolus (Meier & Blobel, 1992), 
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Infonnation on the biochemical make-up of the NPC is far from complete; 
however, functional studies using pores depleted of specific proteins as well as genetic 
studies in yeast, are yielding promising results in the detennination of the function of 
NPC proteins (for review see: Doye & Hurt, 1995). 
1.4 Nuclear Transport Signals 
1.4.1 Proteins 
Proteins which function in a cellular compartment other than the site of protein 
synthesis in the cytoplasm require a specific signal for appropriate targeting after (or 
during the process of) translation. Thus, the targeting of proteins to the endoplasmic 
reticulum and mitochondria, requires specific signals within the amino acid sequence 
of the molecules (Walter '& Lingappa, 1986). Facilitated nuclear transport of 
karyophilic proteins also requires specific signals called nuclear localisation signals 
(NLSs; for reviews see: Roberts, 1989; Silver & Goodson, 1989; Wagner et al., 1990; 
Silver, 1991; Garcia-Bustos et al., 1991a; Richter & Standiford, 1992; Stochaj & 
Silver, 1992). The NLS appears to be involved in the energy-independent binding 
step of transport through the NPC (Akey & Goldfarb, 1989; Newmeyer & Forbes, 
1988). NLSs have been characterised for yeast (Moreland et al., 1985; Nelson & 
Silver, 1989), mammalian (Shaulsky et al., 1990), amphibian (Robbins et al., 1991; 
Standiford & Richter, 1992), viral (Kalderon et al., 1984; Yeh et al., 1990) and plant 
(Varagona et al., 1992) proteins. The mere presence of an NLS on a molecule is 
sufficient to enable the NPC channel to open and allow its passage, even to the extent 
that 20-260 A gold particles coated with NLS-containing proteins are readily 
transported through the NPC (Dworetzky & Feldherr, 1988). 
NLSs have been investigated using three major techniques: deletion analysis, 
whereby portions of the amino acid sequence are deleted to assess their importance 
with regard to nuclear transport (Dingwall et al., 1982); mutational analysis resulting 
in amino acid substitution (Robbins et al., 1991; Standiford & Richter, 1992); and by 
gene fusion of the putative NLS to a non-nuclear protein (Moreland et al., 1985; 
Lanford et al., 1990; Yeh et al., 1990). A functional NLS is defined as the minimal 
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amino acid sequence both necessary and sufficient to induce nuclear localisation of a 
non-nuclear protein to which it is fused. Unlike the signals targeting proteins to the 
endoplasmic reticulum and mitochondria, NLSs are not proteolytic ally removed during 
the transport process. 
No consensus amino acid sequence for nuclear localisation has been determined, 
but there are common features between those identified to date. NLSs are typically 
short sequences (approximately 8 to 10 amino acids) that contain a high proportion of 
the positively charged amino acids lysine and arginine, with the frequent presence of a 
flanking proline or glycine residue. The most studied NLS is that of the SV 40 large T 
antigen, which has a NLS composed of the short stretch of basic amino acids: 
PKKKRKV (Kalderon et al., 1984; Lanford et al., 1984). Subsequently, more 
complex types of NLS have been identified that involve more than one sequence of 
amino acids. Nucleoplasmin, an abundant nuclear protein in Xenopus, has an NLS 
composed of two basic sequences separated by a spacer region of 10 amino acids 
(Dingwall et al., 1988; Robbins et al., 1991). Similar NLSs have been described for 
the Xenopus Nl protein (Kleinschmidt & Seiter, 1988) and the nucleolar protein N038 
(Schmidt-Zachmann et al., 1987). Other types of NLS are composed of several 
clusters of basic amino acids, as has been found for the progesterone receptor 
(Ylikomi et al., 1992) and the oncogene product p53 (Shaulsky et al., 1990). Not all 
protein NLSs that have been identified conform to the model involving short 
sequences of basic amino acids. In some proteins the amino acids that make up the 
NLS are dispersed throughout a large segment of the protein, such as the U 1 snRNP-
specific UIA protein (Kambach & Mattaj, 1992), the U2 snRNP-specific U2B" 
protein (Kambach & Mattaj, 1994) and Saccharomyces cerevisiae Gal4 protein (Silver 
et al., 1988). These residues may form a more compact NLS when the protein is in 
its folded conformation. Furthermore, the nuclear localisation of the pre-
mRNNmRNA binding protein hnRNP Al protein has been found to be dependent on 
a novel glycine-rich domain at its carboxyl terminus (Siomi & Dreyfuss, 1995). A 
summary of types of protein NLS is provided in Table 1.1. 
The positioning of the NLS in a protein is important for its function, presumably 
due to the necessity of exposing the signal for interaction with NLS binding proteins 
or receptors involved in nuclear transport. Nelson and Silver (1989) determined that 
Table 1.1 Types of protein nuclear localisation signal 
Nuclear localisation signal 
sequence of basic amino 
acids PKKKRKV 
two sequences of basic amino 
acids separated by a spacer 
region 
clusters of basic amino acids 
dispersed over a large region 
of basic 8m:ino acids 
glycine-rich domain at C-
terminus 
Example protein(s) 
SV 40 T antigen 
Xenopus nucleoplasmin 
Xenopus Nl protein 
Xenopus N038 
rabbit progesterone 
receptor 
human, mouse, rat and 
Xenopus p53 
Xenopus UIA protein 
Xenopus U2B" protein 
yeast Gal4 
human hnRNP Al protein 
Reference 
Kalderon et al., 1984 
Lanford et al., 1986 
DingWall et al., 1988 
Robbins et al., 1991 
Kleinschmidt & Seiter, 1988 
Schmidt-Zachmann et al., 1987 
Ylikomi et al., 1992 
Shaulsky et al., 1990 
Kambach & Mattaj, 1992 
Kambach & Mattaj, 1994 
Silver et al., 1988 
Siomi & Dreyfuss, 1995 
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the ability of the SV 40 T antigen NLS to function in nuclear transport partly depended 
on the (non-nuclear) protein to which it had been experimentally fused, while Roberts 
et al. (1987) found that the positioning of a NLS within the protein sequence of the 
non-nuclear protein pyruvate kinase affected its nuclear targeting ability. In addition, 
the efficiency of nuclear targeting of a NLS is greatly enhanced if multiple copies of 
the signal are present (Roberts et al., 1987; Dworetzky et al., 1988). Sequences 
flanking the NLS may also be important for the regulation of NLS function. The 
phosphorylation of sites adjacent to an NLS has been found to increase the efficiency 
of nuclear accumulation (Rihs & Peters, 1989; Ribs et al., 1991; Moll et al., 1991; 
Jans & Jans, 1994). Furthermore, cyclic AMP-dependent protein kinase has been 
implicated in the control of nuclear localisation (Gauthier-Rouviere et al., 1995), 
Regions adjacent to the NLS could potentially provide a mechanism for the control of 
sub-cellular localisation of a protein, perhaps during development. An example of a 
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developmentally regulated NLS, which functions in Xenopus oocytes but not in 
Xenopus somatic cells, has been found in the oncoprotein encoded by the adenovirus 5 
E1a gene (Standiford & Richter, 1992). It is possible that this mechanism usurped by 
the viral protein is operating for those Xenopus proteins that undergo a shift in nucleo-
cytoplasmic distribution during embryogenesis (Dreyer, 1989). 
1.4.2 RNAslRNPs 
In addition to NLSs for proteins that are transported across the nuclear 
membrane, there must also be signals that target RNAs into and out of the nucleus. 
All RNA molecules are likely to exist in specific associations with proteins as RNPs 
during functioning and transportation within the cell. Direct evidence for this comes 
from electron microscopic studies which have visualised export through the NPC of 
pre-mRNA bound with specific proteins (Mehlin et ai., 1992; 1995). The nuclear 
import and export signals on transported RNPs could therefore reside either in the 
amino acid sequence of the protein or proteins, in the nucleotide sequence of the 
RNA, or in a combination of both. In fact, examples of all these scenarios have been 
identified for different RNPs, and the requirements for nuclear transport of RNPs 
appear to be both complex and varied (Fischer & Ltihrmann, 1990; Hamm & Mattaj, 
1990; Fischer et ai., 1991; 1993; 1994a,b; 1995; Michaud & Goldfarb, 1992; Terns et 
ai., 1993; Jarmolowski et ai., 1994; reviewed in Izauralde & Mattaj, 1995). 
Studies on the requirements for RNA nuclear transport were fIrst undertaken for 
the nuclear export of tRNA (Zasloff et ai., 1982). The process of nuclear export of 
this small molecule was found to be carrier-mediated, and mutational analysis revealed 
that export required many regions of the nucleotide sequence (Tobian et ai., 1985). 
The mutations that had an effect on export were found to result in changes to stem-
loop structures on the tRNA molecule, indicating that maintenance of secondary 
structure is important for the interactions involved in nuclear transport. It is unknown 
whether these nucleotide sequences interact directly with the nuclear transport 
machinery, or provide a binding site (or sites) for a protein which is transported 
complexed with the RNA and acts to target the tRNA for export. Such a protein 
could be glyceraldehyde-3-phosphate dehydrogenase, whose binding has been related 
to tRNA export (Singh & Green, 1993), 
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The nuclear export of mRNA is also a process that requires cis-acting signals 
within the RNA structure. The m7GpppN (monomethylated) cap structure, a modified 
guanosine nucleotide which is added to the 5' end of the RNA during transcription by 
RNA polymerase IT, is involved in signalling nuclear export of the molecule (Hamm 
& Mattaj, 1990; Dargemont & KUhn, 1992; Jarmolowski et al., 1994). The possession 
of an altered cap structure results in reduced nuclear export capability for mRNA 
(Hamm & Mattaj, 1990), and the presence of an analogue of the cap inhibits the 
export of mRNA microinjected into oocytes (Dargemont & KUhn, 1992). Other 
elements of the mRN A structure also appear to be involved in signalling export. The 
3' end of histone mRNA (Eckner et al., 1991), specifically the 3' stem-loop region of 
this molecule (Williams et al., 1994), has been implicated in its export to the 
cytoplasm. 
The assembly of V snRNPs, which function in the processing of mRNAs, 
involves transport across the nuclear membrane in both directions and is therefore an 
interesting process in tenns of RNA nuclear transport signals (reviewed by: Izaurralde 
& Mattaj, 1992). The V snRNAs are transcribed in the nucleus and move into the 
cytoplasm where they fonn specific associations with proteins. Two different types of 
proteins are involved in these interactions: those common to all particles (the Sm 
proteins), and those specific to the individual V snRNP (i.e., VI, V2, V4, and V5 
snRNPs; Parry et al., 1989). The assembled RNPs then move back into the nucleus to 
perfonn their splicing function (reviewed by LUhnnann et al., 1990). V snRNAs 
therefore presumably require a signal for nuclear export, and the V snRNPs require a 
signal for nuclear import. Hamm and Mattaj (1990) detennined that, as with mRNA, 
the likely signal that targets VI snRNA from the nucleus is the monomethylguanosine 
cap. VI snRNA possessing a different capping nucleotide, produced experimentally 
by transcription with RNA polymerase TIl, was shown to be retained in the nucleus. 
A more recent study has demonstrated that the monomethylated cap alone does not act 
as the signal for nuclear export of VI snRNA; there is also a requirement for the 3' 
stem-loop structure (Neuman de Vegvar & Dahlberg, 1990; Terns et al., 1993). The 
study of Terns et al. (1993) also showed that efficient nuclear export of VI snRNA 
after synthesis involves sequences within the 5' terminal 124 nucleotides. 
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After export to the cytoplasm, the monomethylguanosine structure is converted 
to a trimethylguanosine cap (m3G; Liihnnann et al., 1990). This trimethylguanosine 
cap nucleotide is an essential requirement for Dl snRNA re-import into the nucleus in 
Xenopus oocytes, as cytoplasmically microinjected uncapped Dl snRNA, or Dl 
snRNA capped with the 'unnatural' ApppG cap, remained cytoplasmic (Fischer & 
Liihnnann, 1990). By constructing mutants of Dl snRNA, Hamm et al. (1990) were 
able to determine that the binding site for 8m proteins on the RNA molecule, in 
addition to the trimethylguanosine cap, are essential for nuclear import. Thus, the 
signal that targets Dl snRNPs for nuclear import is a combination of both the RNA 
structure and a component of the bound protein. D2 snRNP import to the nucleus 
also appears to have a requirement for the trimethylguanosine cap, since D2 snRNA 
synthesised without this capping nucleotide and microinjected into the oocyte 
cytoplasm, is excluded from the nucleus (Fischer et al., 1991). The presence of an 
excess of a 2,2,7mGpppG dinucleotide analogue of the cap structure also inhibits the 
nuclear import of Dl and D2 snRNAs, presumably by competing for a factor to which 
this import signal binds (Fischer et al., 1991; Michaud & Goldfarb, 1992). However, 
the nuclear import of D4 and D5 snRNPs has a less stringent requirement for the 
trimethylguanosine cap (Fischer et al., 1991). 
In somatic cells from mouse, monkey and Xenopus, it has been found that, 
although the trimethylguanosine cap accelerates the nuclear import of Dl snRNPs, it is 
not an essential requirement for nuclear targeting, with the 8m domain alone 
potentially providing sufficient signal (Fischer et al., 1994b). An earlier study also 
demonstrated that the 8m core domain contains a transport signal that is independent 
of the trimethylguanosine cap (Fischer et al., 1993). The D1 snRNP may therefore be 
an example of a developmentally regulated NL8, with different factors involved in the 
import process in Xenopus oocytes and in somatic cells (Marshall say & Liihrmann, 
1994). 
Finally, in Xenopus oocytes the nuclear export of 58 rRNA, the molecule which 
is the focus of this thesis, is dependent on binding to either the protein TFIIIA (as 78 
RNPs) or ribosomal protein L5 (as 58 RNPs), since 58 rRNA mutants that are 
incapable of binding these proteins are retained in the oocyte nucleus after synthesis 
(Guddat et al., 1991), It is therefore possible that the NL8 targeting the export of 58 
rRNA resides on one of these proteins. Although there is evidence of a requirement 
for specific protein associations during export, the proteins involved in 58 rRNA 
nuclear import have not been investigated. Therefore, the role of ribosomal protein 
L5 in the nuclear import of 58 rRNA is examined in this thesis. 
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1.5 Nuclear Localisation Signal Receptors and Other Trans"Acting 
Factors in Nuclear Transport 
1.5.1 Saturability of nuclear transport 
The presence of NL8s on karyophilic molecules implies the existence of 
receptors to which these signals bind in the pathways for nuclear transport. 
Investigation of factors involved in recognition and targeting of karyophilic proteins 
for nuclear import has led to the discovery of proteins in the cytosol, as well as those 
associated with the NPC, that are essential to both the binding and translocation steps 
of transport through the pore channel (reviewed in Powers & Forbes, 1994). 
However, it is likely that a large number of nuclear transport factors remain to be 
discovered, which could act specifically in the import and export of specific classes of 
proteins and RNPs. 
Indirect evidence for the involvement of specific binding factors, or receptors, in 
nuclear transport has been provided by studies showing that nuclear transport is a 
saturable process. For example. the rate of nuclear import of a radio-labelled 
synthetic karyophilic protein, P(lys)-B8A (bovine serum albumin [B8A] conjugated 
with multiple copies of the minimal 8V40 T antigen NL8), is reduced in the presence 
of 'excess' unlabelled P(lys)-B8A (Michaud & Goldfarb, 1991). Likewise, the nuclear 
export of tRNA (Zasloff et ai, 1983) and ribosomal subunits (Batai1l6 et al., 1990) has 
been shown to involve a cellular component (or components) present in limiting 
amounts. Further studies have been able to demonstrate the utilisation of common 
components of the nuclear transport machinery between different karyophiles (nuclear 
molecules or complexes), by testing import of tagged molecules in the presence of 
another karyophile 'in excess' (Michaud & Goldfarb, 1991,1992; Dargemont & Kuhn, 
1992; Iannolowski et al., 1994). In this way, karyophiles can be grouped into 
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different classes, depending on their requirements for a limiting factor, which may 
prove to be an NLS receptor. It is conceivable that these groupings of molecules to 
be transported may enable the co-ordination and regulation of nuclear transport on the 
basis of the availability of NLS receptors at any given time during the growth and 
development of a cell, and in response to a changing environment. 
Biochemical approaches have subsequently been used in the identification of 
factors essential for NLS recognition and nuclear transport. Firstly, NLS-binding 
proteins have been isolated on the basis of peptide cross-linking, affinity 
chromatography, or ligand blotting using identified NLSs. Proteins able to bind the 
SV40 T antigen NLS have been identified in rat liver cells (Adam et al., 1989; Benditt 
et al., 1989), yeast (Lee & MtSlese, 1989), human tissue culture cells (Li & Thomas, 
1989), and plants (Hicks et al., 1995; Hicks & Raikhel, 1995). It was initially 
assumed that NLS-binding proteins would reside predominantly at the nuclear 
envelope, however the NLS-binding proteins identified were found to be localised in 
the nucleoplasm and cytoplasm, as well as at the nuclear envelope (Benditt et al., 
1989), and therefore could not be classed exclusively as components of the NPC. 
Furthermore, these studies have been unable to determine whether the isolated NLS-
binding proteins have an actual role in the process of nuclear transport. 
1.5.2 Characterisation of factors involved in the two steps of nuclear 
protein import 
Recently, new biochemical techniques have been used to isolate specific factors 
associated with steps in nuclear protein import. These involve the use of cell-free 
systems, which enable the testing of isolated fractions of cytosol for the presence (or 
absence) of a factor required for nuclear transport. One such system utilises Xenopus 
egg extracts in the formation of transport-competent nuclei isolated from rat liver, or 
constructed de novo around added DNA (Newmeyer & Forbes, 1990; Newmeyer et 
at., 1986b). Another system involves the use of cultured mammalian cells which have 
been permeabilised by treatment with digitonin, which selectively perforates the 
plasma membrane while leaving the nuclear membrane intact and transport-competent 
(Adam et al., 1990). Using either of these systems, the nuclear import of proteins has 
been shown to be dependent on factors present in the cytosol, with the binding and 
translocation steps of nuclear import dependent on components of two different 
cytosolic fractions which contain specific transport factors (Adam et al., 1990; 
Newmeyer & Forbes, 1990; Moore & Blobel, 1992). 
1.5.2.1 NLS binding and docking at the NPC 
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One fraction of cytosol used in the in vitro transport systems, termed fraction A 
(Moore & Blobel, 1992), or NIF1 (Newmeyer & Forbes, 1990), was found to be 
required for the docking of a karyophilic protein at the NPC, but was not sufficient for 
translocation through the NPC channel. The factors responsible for this activity have 
subsequently been isolated and have been found to be highly conserved between 
species (as described below, and reviewed by: Simos & Hurt, 1995). In addition, it 
has been determined that there are separate factors involved in NLS binding and 
docking at the nuclear pore complex, resulting in a further division of the 'first' step 
of nuclear protein import into interaction between the NLS and its receptor, followed 
by association of the complex with proteins of the nuclear pore. 
The first direct evidence for the involvement of NLS-binding proteins in nuclear 
transport came from the study of Adam and Gerace (1991). They isolated two 
polypeptides from bovine erythrocytes, based on their ability to bind the SV40 T 
antigen NLS, which were able to stimulate nuclear transport in vitro. Proteins 
analogous to this heterodimeric 54/56 kD nuclear transport receptor have subsequently 
been isolated from Xenopus eggs (importin-a., or importin-60, G5r1ich et al., 1994, 
1995a,b), rat liver (karyopherin-a., Radu et al., 1995a), human cultured cells 
(karyopherin-a., or Rch1, Moroianu et al., 1995a,b; hSRP1a., Weis et al., 1995), 
mouse cultured cells (m-importin, Imamoto et al., 1995b), and yeast (karyopherin-a. or 
Kap6Op, Enenkel et al., 1995). In addition, a protein isolated from goat uterus, p55, 
appears to act as the NLS-binding protein for the estrogen receptor (Nirmala & 
Thampan, 1995 a,b). Importin-a. (G5rlich et al., 1995b) and hSRP1a. (Weis et al., 
1995) have been found to bind bipartite NLSs as well as the simple type of the SV40 
T antigen, suggesting that these receptors may recognise a variety of transport signals. 
Although these receptors bind NLSs prior to nuclear import, they do not appear 
to act alone to target karyophilic proteins to the nuclear pore, but require at least one 
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other factor. A factor with this associated activity, p97, was first isolated from bovine 
erythrocytes (Adam & Adam, 1994; Chi et al., 1995). Other proteins required for 
docking at the nuclear pore have been isolated from other species, and found to 
directly interact with nuclear pore complex glycoproteins (Kraemer et al., 1995; 
Moroianu et al., 1995a,b; Paschal & Gerace, 1995; Radu et al., 1995a,b). These 
proteins are Xenopus importin-~ (or importin 90; Gerlich et al., 1995a,b), rat 
karyopherin-~ (Radu et al., 1995a,b), human karyopherin-~ (Moroianu et al., 1995a,b), 
and yeast karyopherin-~, or Kap95p (Enenkel et al., 1995). It appears that the 
proteins responsible for NLS binding and subsequent docking at the NPC form a 
complex after binding of the karyophile, termed the nuclear pore targeting complex by 
one group (Imamoto et al., 1995a,c). This complex includes the importin a/~ (or 
similar) heterodimer, the protein being imported, and possibly other, as yet 
unidentified, factors. In the first stage of nuclear targeting, the protein binds the NLS 
receptor (importin-a type), after which the docking protein binds (importin-~ type) 
and the complex associates with the nuclear pore (Gerlich et al., 1995b, Imamoto et 
al., 1995c). The complex then appears to be translocated through the NPC channel 
(with the aid of factors described below), and importin-a bound with the transported 
protein dissociates from importin-~ as it enters the nucleoplasm (Gerlich et al., 
1995b). 
1.5.2.2 Translocation 
The second step in nuclear protein import, translocation through the nuclear pore 
complex channel, has been found to be dependent on a second cytosolic fraction 
(Newmeyer & Forbes, 1990; Moore & Blobel, 1992). A factor responsible for this 
activity was isolated from Xenopus oocytes and was found to be a single protein of 25 
kD, identified as the GTP-binding protein Ran, a protein with a sequence related to 
the Ras family (Moore & Blobel, 1993; 1994a). Ran (Ras-related nuclear protein) is 
an abundant nuclear protein that has been implicated in many nuclear functions via its 
activity as a GTPase in combination with the guanine nucleotide exchange factor 
RCC1, and potentially other Ran binding proteins (reviewed in Dasso, 1993; Goldfarb, 
1994). The putative active GTP-bound form of Ran is essential for the nuclear import 
and export of proteins in digitonin permeabilised cells (Melchior et al., 1993; 
Moroianu & BIobel, 1995). Nuclear protein import in yeast is dependent on GTP 
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hydrolysis, and the Ran activating protein Rna1p (Corbett et al., 1995; Schlenstedt et 
al., 1995). 
The translocation activity of nuclear protein import is dependent on the presence 
of another factor, which acts in conjunction with Ran. This protein, p10 (also called 
pp15 and Ran interacting protein [Ranip]), has been identified in Xenopus (Moore & 
Blobel, 1994b) and has a human homologue, N1F2 (Paschal & Gerace, 1995), 
although it is not clear as to the role of this protein. Both Ran (Dingwall et al., 1995; 
Hartmann & Gorlich, 1995; Yokoyama et al., 1995) and Ranip (Paschal & Gerace, 
1995) have been found to interact directly with nucleoporins, indicating that they may 
be bound at the NPC during their role in translocation. 
The final factor found to date to be associated with protein import is the heat 
shock protein hsp70, and its cytosolic counterpart hsc70 (Shi & Thomas, 1992; 
Imamoto et al., 1992; Okuno et al., 1993; Yang & DeFranco, 1994). Hsc70 is co-
localised with karyophilic proteins during their transport (Okuno et a!., 1993), and 
antibodies against hsc70 inhibit the nuclear import of karyophilic proteins (Imamoto et 
al., 1992). The role of hsc70 in nuclear transport is unclear, but there is evidence of 
an affinity for NLSs (Imamoto et al., 1992). In addition, hsc70 has been found to 
shuttle between cytoplasmic and nuclear compartments, potentially carrying 
karyophilic cargoes with it (Mandell & Feldherr, 1990). Hsc70 is also able to 
associate with the guanine nucleotide exchange factor RCC1, in a complex of proteins 
that includes Ran (Saitoh & Dasso, 1995), providing a potential link between 
hsp70/hsc70 and the Ran-mediated step of protein transport. 
As summarised in Table 1.2, there have been at least five different soluble 
factors isolated that are required for nuclear protein import: importin-a/karyopherin-
a/NLS-receptor, importin-~/karyopherin-~/97 kD accessory protein, Ran/TC4, Ranip, 
and hsp/hsc70. These proteins form part of the sequence of events starting with the 
NLS and resulting in nuclear translocation of the NLS-bearing molecule. It is likely 
that the requirements for some of these factors vary between different karyophiles, and 
this may contribute to the regulation of the transport process. Indeed, the 
requirements for hsp70 have been found to differ between the glucocorticoid receptors 
from two different cell types (Yang & DeFranco, 1994). 
Table 1.2 Factors involved in nuclear protein import 
Import step 
Binding to NLS 
Docking at the 
nuclear pore 
Translocation 
Unknown 
Factor 
bovine 54/56 kD receptor 
Xenopus importin-a (60 kD) 
mouse importin 
rat karyopherin-a 
human SRPla 
human karyopherin-a (Rchl) 
yeast karyopherin-a (Srplp, Kap6Op) 
bovine 97 kD 'accessory' protein 
Xenopus importin-~ (90 kD) 
rat karyopherin-~ 
human karyopherin-~ 
yeastkaryopherin-~ OKap95p) 
Xenopus Ran 
Xenopus Ran interacting protein 
(pl0, ppl5) 
human NTF2 (Ran interacting protein) 
human hsp70/hsc70 
rat hsc70 
1.5.3 Trans-acting factors in RNP nuclear transport 
Reference 
Adam & Gerace, 1991 
Gorlich et al., 1994; 1995a,b 
Imamoto et al., 1995b 
Radu et al., 1995a,b 
Weis et al., 1995 
Moroianu et al., 1995a,b; 
Gorlich et al., 1995a 
Enenkel et al., 1995 
Adam & Adam, 1994; 
Chi et al., 1995 
Gt)riich et at., 1994; 1995a,b 
Radu et al., 1995a,b 
Moroianu et al., 1995a,b 
Enenkel et al., 1995 
Moore & Blobel, 1993; 1994a 
Moore & Blobel, 1994b 
Paschal & Gerace, 1995 
Shi & Thomas, 1992; 
Okuno et al., 1993; 
Yang & DeFranco, 1994 
Imamoto et al., 1992 
19 
To date, the studies on factors associated with nueleo-cytoplasmic trafficking 
have largely focused on the import of proteins into the nueleus. Are there specific 
factors associated with the nueleo-cytoplasmic trafficking of RNPs? Transport 
competition studies have demonstrated that there are separate pathways for the 
transport of karyophilic proteins and some of the U snRNAs (Fischer et al., 1991; 
Michaud & Goldfarb, 1991, 1992; van Zee et al., 1993), and it is likely that different 
factors are involved in mediating the transport of molecules with such differing 
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nuclear targeting signals. The nuclear import of the various V snRNPs has been 
found to occur by three distinct targeting pathways (Michaud & Goldfarb, 1992), and 
the nuclear export of RNAs is mediated by class-specific components (Jarmolowski et 
al., 1994), thus indicating the presence of many factors governing these processes. 
Comparisons of various classes of karyophiles, utilising competition studies, will be 
further discussed in Chapter Four. 
Nuclear import of VI and V2 snRNPs in digitonin-penneabilised cells is 
dependent on the addition of an exogenous cytosolic extract, demonstrating the 
presence of factors in the cytoplasm that promote snRNP transport (Marshallsay & 
Liihrmann, 1994). As reported for the cytosolic fraction involved in the NLS-binding 
and targeting component of the protein import pathway (Adam et al., 1990; Newmeyer 
& Forbes, 1990; Adam & Gerace, 1991; Moore & Blobel, 1992), the nuclear transport 
activity of the cytosol was sensitive to the sulphydryl alkylating agent N-
ethylmalemide. Furthennore, these factors were found to mediate the differential 
requirement for the m3G-cap in oocytes and somatic cells, as the addition of a 
cytosolic extract from Xenopus oocytes conferred cap-dependence on the nuclear 
transport process, whereas factors from somatic cell cytosol resulted in cap-
independent nuclear import (Marshall say & Ltihrmann, 1994). This provides evidence 
for the involvement of cytosolic factors in the developmental regulation of nucleo-
cytoplasmic trafficking. 
RanlTC4 has also been implicated in RNA nuclear export through studies of the 
associated protein RCC1 (Moore & Blobel, 1994a). Nuclear export of mRNA has 
been found to be defective in mammalian cells expressing a mutant fonn of the 
mammalian RCC1, and its yeast homologue PRP20/SRM1/MTR1 (Amberg et al., 
1993; Dasso, 1993; Kadowaki et al., 1993), while V3 small nucleolar RNA (snoRNA) 
intranuclear transport and VI snRNA export is inhibited in mammalian cultured cells 
depleted of RCC1 (Cheng et al., 1995). Furthennore, the nuclear export of pre-
mRNA is blocked in yeast cells expressing Ran that binds, but does not hydrolyse 
GTP (Schlenstedt et al., 1995). It is therefore likely that the nucleo-cytoplasmic 
trafficking of proteins and RNAslRNPs utilise common components within the 
cytoplasm and nucleoplasm. 
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1.6 Shuttling Proteins 
Although most proteins and RNPs appear to move across the nuclear membrane 
unidirectionally, some proteins apparently shuttle constitutively across the nuclear 
membrane in both directions, potentially ferrying protein or RNP cargoes (reviewed in 
Laskey & Dingwall, 1993). Such shuttling proteins include: two hsp70-re1ated 
Xenopus proteins (Mandell & Feldherr, 1990); the nucleolar proteins N038, nucleolin 
(Borer et al., 1989) and Nopp140 (Meier & Blobel, 1992); the yeast RNA-binding 
protein Np13 (Flach et al., 1994); the progesterone receptor (Guiochon-Mantel et al., 
1991); the hnRNA packaging protein Al (Piiiol-Roma & Dreyfuss, 1992); the HIV-I 
Rev protein (Meyer & Malim, 1994), and the Ul snRNP-specific protein UIA 
(Kambach & Mattaj, 1992). These studies have mostly utilised inter-species 
heterokaryons, whereby cells of two different species are fused creating a cell with 
two morphologically distinct nuclei. The protein under study is only expressed in one 
cell type due to the transfection of the expression vector. Therefore, after fusion of the 
cells the movement of the protein into the nucleus of the other cell type can be 
observed using fluorescently-Iabelled antibodies. 
Many of the identified shuttling proteins bind RNA, and this suggests that they 
may play an important role in RNA transport (Pinol-Roma & Dreyfuss, 1992; Flach et 
al., 1994). In the case of the UIA protein, its shuttling is dependent on the 
distribution of U snRNA, to which it binds (Kambach & Mattaj, 1992). In addition, 
the nucleolar shuttling proteins may have a role in the nucleo-cytoplasmic transport of 
ribosomal components (Borer et al., 1989; Meier & Blobel, 1992). The amino 
tenninus of nucleolin specifically recognises SV 40 T antigen-type NLSs (Xue et al., 
1993), the type of signal likely to target ribosomal proteins to the nucleus (Moreland 
et al., 1985; Underwood & Fried, 1990; Schaap et al., 1991). N038 is also capable of 
binding the SV 40 T antigen and HIV -1 Rev NLSs but not the bipartite nucleoplasmin 
NLS, suggesting that the NLS receptors on these shuttling proteins may be capable of 
discriminating between different classes of NLS (Szebeni et al., 1995), 
An interesting feature of shuttling proteins is the signals that specify import and 
export, and their ability to be regulated depending on the binding of the karyophile. 
There is some debate as to whether the transport of shuttling proteins is a facilitated 
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process in both directions across the nuclear membrane (Guiochon-Mantel et al., 
1994), or whether import is facilitated, and export proceeds via diffusion out of the 
NPC (Guiochon-Mantel et al., 1991; Laskey & Dingwall, 1993; Schmidt-Zachmann et 
al., 1993). In the latter case, the nuclear export of the protein could be regulated by 
binding within the nucleus, a process called nuclear retention (Cohen & Paine, 1992; 
Paine, 1993; Laskey & Dingwall, 1993; Schmidt-Zachmann et al., 1993; Vancurova et 
al., 1993; 1994). In this process, the interaction of the shuttling protein with 
molecules in the nucleus would retain it in this cellular compartment, only allowing its 
diffusion out of the nucleus on release from this bound state. In this way, a model 
can be described whereby the shuttling protein binds to a specific karyophile in the 
cytoplasm, is transported to the nucleus in an A TP-and NLS-dependent manner and, 
once in the nucleus, is retained until the transported karyophile, which may become 
bound to non..;.diffusible elements, becomes disengaged. 
Contrasting with the notion of passive export of proteins from the nucleus is the 
evidence that the nuclear export of the progesterone receptor, a shuttling protein, 
requires the presence of the NLS which also targets import (Guiochon-Mantel et aI., 
1994). Furthermore, sequences from two proteins have been recently isolated that 
act as nuclear export signals when fused to heterologous proteins (reviewed in Gerace, 
1995). The sequence LALKLAGLDI provides the nuclear export signal for protein 
kinase inhibitor (Wen et al., 1995), while a similar sequence (LPPLERLTL) signals 
nuclear export for the HIV-l Rev protein (Fischer et al., 1995). Factors have been 
isolated that are capable of interaction with the Rev nuclear export signal in human 
cells (Bogerd et al., 1995) and yeast (Stutz et al., 1995). These factors may have a 
role in a more general pathway of nuclear export, as there is evidence that HIV-l 
Rev-induced mRNA export proceeds via interaction with factors in common with the 
nuclear export of 5S rRNA and Ul snRNA (Fischer et al., 1995). 
1.7 SS rRNA Nuclear Transport and the Scope of This Thesis 
The aim of the research described in this thesis was to investigate the 
mechanism whereby 5S rRNA is imported into the nucleus after storage in the 
cytoplasm in Xenopus oocytes. This thesis is divided into three sections of 
23 
experimental work focusing on different areas of the nuclear import process: the RNP 
status of 58 rRNA during transport; the role of the nuclear pore complex; and the 
involvement of cytoplasmic factors, utilising a comparative investigation with other 
karyophilic molecules. 
Chapter Two addresses the mechanism whereby 58 rRNA passes through the 
nuclear membrane, and investigates whether this occurs via a passive or facilitated 
process through the nuclear pore complex. General inhibitors of facilitated NPC 
transport were used to assess their effect on the nuclear import of radiolabelled 58 
rRNA microinjected into the cytoplasm of Xenopus oocytes. Chapter Three addresses 
the role of ribosomal protein L5 in the nuclear import of 58 rRNA. The nuclear 
import characteristics of in vitro-generated radiolabelled L5/58 rRNA complexes (58 
RNPs) are compared with the characteristics of labelled 58 rRNA described in Chapter 
Two. Evidence is presented for 58 rRNA being bound in the 58 RNP during the 
nuclear import process, and the implications for the function of ribosomal protein L5 
in signalling release from cytoplasmic storage and subsequent nuclear import are 
discussed. Finally, Chapter Four provides a comparison of the pathway of nuclear 
transport of 58 RNPs with a nuclear protein and two small nuclear RNAs (one 
nucleoplasmic and the other nucleolar), to determine whether common saturable 
components exist between the different karyophiles. The results of these studies give 
an indication of the nature of the 58 RNP NL8 and give further evidence of a role for 
ribosomal protein L5 in the targeting of 58 rRNA for nuclear import. 
Chapter Two 
5S rRNA Nuclear Import: A Passive or Facilitated 
Process Through the Nuclear Pore Complex? 
2.1 Introduction 
As described in· Chapter One, oocyte-type 5S rRNA moves between the 
cytoplasmic and nuclear compartments of Xenopus oocytes during development. In 
the study outlined in this chapter, the mechanism of 5S rRNA nuclear import after 
storage in the cytoplasm has been investigated. Part of the work described in this 
chapter has been published (Allison et al., 1993; refer to Appendix) 
2.1.1 Facilitated versus passive transport 
Transport of ions and molecules across the nuclear membrane takes place 
exclusively through the nuclear pore complex (NPC). Movement through the NPC 
channel has been categorised in two ways: passive diffusion, if the molecule is below 
the 40 kD exclusion limit for transport through the resting NPC (Peters, 1984); and 
active transport that requires A TP and involves an expansion of the pore channel to 
allow access of larger molecules (Akey, 1990; 1992; Forbes, 1992; Hurt, 1993; Pante 
& Aebi, 1993; 1994; Agutter & Prochnow, 1994; Hinshaw, 1994; Davis, 1995). 
Recently, a re-evaluation of these te1lllS has taken place and the defmition of all ATP-
requiring nuclear transport as being 'active transport' has been proposed to be too 
simplistic (Cohen & Paine, 1992; Paine, 1992; 1993; Vancurova et al., 1993; Davis. 
1995). Therefore. a third category of transport through the NPC, facilitated diffusion. 
must be considered. 
Simple passive diffusion through the NPC is a process that is restricted by the 
sieve-like nature of the nuclear envelope to molecules of less than 90-100 A in 
diameter. The process involves movement down the chemical gradient f01llled across 
the nuclear membrane and through the aqueous phase of the cell. Therefore, passive 
diffusion does not include binding to 'static' components such as the cytoskeleton and 
membranes, nor does it involve interaction with receptors that target the molecule for 
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nuclear transport. Simple passive diffusion is a relatively slow process, with less 
potential for regulation than processes involving receptor-ligand interactions, and does 
not require ATP. Nuclear transport through the process of passive diffusion can result 
in net nuclear (or cytoplasmic, in the case of nuclear export) accumulation, if there are 
retention sites for the molecule in that cellular compartment. In this way, karyophiles 
could 'drift' into the nucleus and remain there by binding to macromolecules or non-
diffusible factors, thus maintaining the direction of the chemical gradient in the 
soluble phase. It appears that few molecules of physiological importance are likely to 
undertake nucleo-cytoplasmic transport by simple passive diffusion a1,one. Even some 
that fall within the size limit for passive diffusion through the NPC channel (assuming 
that there is no binding of other proteins), such as histone HI (Breeuwer & Goldfarb, 
1990) and SV40 Vp3 (Dean & Kasamatsu, 1994), are imported via a facilitated 
process. However, the free catalytic subunit of cAMP-dependent protein kinase 
microinjected into cultured cells does undergo nuclear transport in both directions by 
simple diffusion (Harootunian et ai., 1993). 
Active transport has an essential requirement, either directly or indirectly, for 
metabolic energy in the form of A TP, while facilitated diffusion mayor may not 
require ATP. The feature differentiating active transport from facilitated diffusion is 
that active transport must occur against the chemical activity gradient, while facilitated 
diffusion proceeds down the gradient (Cohen and Paine, 1992). Chemical activity 
gradients are formed by molecules in the solution within the cell; that is, the gradient 
does not include, for example, those molecules bound to non-diffusible elements such 
as the cytoskeleton. In reality, it is difficult to determine the chemical activity 
gradient of a molecule in vivo, as the proportion of the cytoplasmic and nuclear pools 
of the molecule that are bound or soluble are difficult to determine experimentally. 
Recently, Vancurova et al. (1993) devised a method for determination of the chemical 
activity gradient, and involvement of nuclear retention, in the nuclear uptake of 
nucleoplasmin, an abundant protein in Xenopus nuclei. Using oil-isolated Xenopus 
oocyte nuclei paired with either a bolus of cytoplasm or a latex bead loaded with 
fluorescently-Iabelled nucleoplasmin, they established that nucleoplasmin reached 
equilibrium between the bead and nucleus in an A TP-dependent manner, whereas 
actual concentration within the nucleus required a factor present in the bolus of 
cytoplasm. In addition, puncturing the nuclear membrane, thereby releasing the NPC 
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restriction for transport, did not alter the kinetics of nucleoplasmin uptake, suggesting 
that transport does not normally occur against the chemical activity gradient and that 
the protein accumulates in the nucleus by binding to a non-diffusible element. 
Therefore, nucleoplasmin import can be explained by facilitated diffusion, followed by 
binding within the nucleus. 
Concentration of karyophiles within the nucleus could be explained entirely by 
facilitated diffusion and intranuclear binding, without a requirement for a motor-like 
transporter to move the molecule (or complex) through the NPC channel. It has been 
suggested that the role of proteins such as Ran, a small GTPase that has been 
implicated in the process of nuclear transport (refer to Chapter One, section 1.5.2.2; 
Kadowaki et al., 1993; Melchior et al., 1993; Moore & Blobel, 1993; 1994; Bischoff 
et al., 1995a,b; Moroianu & Blobel, 1995), may be to target molecules to specific 
intranuclear binding sites, rather than for translocation through the NPC channel 
(Cheng et al., 1995; Davis; 1995; Tanakoff & Schneiter, 1995). It is plausible that 
nuclear accumulation of proteins and RNAs is largely attributable to the presence of 
retention sites in the nucleus (Schmidt-Zachmann et al., 1993; Vancumva et al., 1993; 
1994; Boelens et al., 1995; Paine et al., 1995), especially for those proteins involved 
in DNA and RNA binding (LaCasse & Lefebvre, 1995). Furthermore, the nuclear 
export of some shuttling proteins occurs via a diffusional pathway, with the 
nuclear:cytoplasmic distribution of the protein being regulated by a combination of 
facilitated import and nuclear retention site availability, as is the case for the nucleolar 
protein nucleolin (Schmidt-Zachmann et al., 1993). 
5S rRNA is 41 kD in size (121 nucleotides) and therefore falls within the limit 
for unrestricted diffusion through the resting NPC. Therefore, it is possible that the 
mechanism of transport of this molecule could be via either of the three mechanisms 
outlined above. However, a 3' truncated 5S rRNA molecule of 98 nucleotides in 
length is excluded from the nucleus after cytoplasmic microinjection into Xenopus 
oocytes, suggesting that the full length 5S rRNA does not move into the nucleus by 
simple diffusion (Allison et al., 1991; 1993). To distinguish between the possible 
transport mechanisms, treatments that inhibit facilitated transport through the NPC 
were used in the present study to assess their effect on 5S rRNA nuclear transport. 
27 
2.1.2 Temperature dependence and ATP requirement 
Several criteria have been used in other studies to establish whether the nucleo-
cytoplasmic transport of proteins and RNAs occurs via an active or passive 
mechanism. Firstly, the facilitated transport of molecules across the nuclear 
. membrane is inhibited at 0 to 4°C, while passive diffusion can occur at approximately 
90% of the normal rate (Breeuwer & Goldfarb, 1990; Kambach & Mattaj, 1992). 
Reduction in nuclear transport at low temperatures is due to a general reduction in the 
rate of enzyme-mediated processes in chilled cells. It is therefore possible to lower 
the temperature of incubation for the cells under treatment and observe a reduction in 
active nuclear transport, while the process of passive diffusion is unaffected. In this 
way, chilling has been shown to inhibit the nuclear import of all karyopbilic proteins 
studied (for reviews see: Roberts, 1989; Wagner et al., 1990), as well as the export of 
U snRNAs (Jarmolowski et al., 1994), tRNA (Zasloff, 1983), signal recognition 
particle RNA (He et al.,1994), mRNA (Dargemont & KUhn, 1992), the RNA 
components of Ro RNPs, Y RNAs (Simons et al., 1994), and ribosomal subunits 
(Bataille et al., 1990). 
Another means of determining whether the mechanism of passage of a 
macromolecule through the nuclear membrane is energy-dependent is to test whether 
the process continues after depletion of ATP. ATP-hydrolysing enzymes have been 
used in a cell-free system (Newmeyer et aI., 1986a,b), as well as in Xenopus oocytes 
(Bataille et al., 1990), to reduce ATP levels and to distinguish between facilitated 
transport and passive diffusion of protein and ribonucleoprotein particles through the 
nuclear membrane. ATP has been found to be an absolute requirement for the nuclear 
transport of RNAs and RNPs such as influenza virus RNPs (Kemler et al., 1994), 
mRNA (Dargemont & KUhn, 1992), and ribosomal subunits (Battaille et al., 1990). 
Even though the requirement for ATP in the above transport processes is well 
established, its exact role is unclear. A TP has been found to be required for the 
translocation step of passage through the NPC, but not the binding at the nuclear 
envelope (Newmeyer & Forbes, 1988; Richardson et al., 1988). Therefore, it may be 
important in the activation of the machinery which enlarges the pore diameter to allow 
entry of the molecule, or propels the karyophile through the channel. A nucleoside 
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triphosphatase has been extracted from isolated rat liver nuclear envelopes which 
appears to have a role in the nuclear export of pre-mRNA (Agutter et aI., 1979; Bernd 
et al., 1982; SchrOder et al., 1986a,c). Translocation through the NPC channel may 
involve ATP hydrolysis by this enzyme. The activity of this nucleoside triphosphatase 
is thought to be regulated by phosphorylation and dephosphorylation via protein 
kinases (Schroder et al., 1986b; 1988). It has been proposed that the nuclear envelope 
nucleoside triphosphatase is in the form of myosin molecules, which could be integral 
to the NPC structure, providing an ATP-dependent contractile mechanism for the 
propulsion of molecules through the channel (Berrios & Fisher, 1986; Berrios, 1992). 
In addition, A TP has been proposed to be required for motor-driven transport of 
proteins and RNPs along cytoskeletal or nucleoskeletal tracks to the NPC (Rosbash & 
Singer, 1993). However, recent studies suggest that it is GTP hydrolysis, mediated by 
the small GTPase Ran and its accessory proteins, and not A TP hydrolysis that is 
required for translocation of molecules through the nuclear pore complex (Kadowaki 
et al., 1993; Melchior et al., 1993; Bischoff et al., 1995a,b; Cheng et al., 1995; 
Moroianu & Blobel, 1995; Schlenstedt et al., 1995). The role of ATP in nuclear 
transport may be in the mediation of the operation of this GTPase via ATP-utilising 
activating proteins. 
Alternatively, ATP may be required at the earlier steps in the pathway for 
nuclear transport. The activation of nuclear localisation signals may require A TP for 
the phosphorylation of sites on the molecule adjacent to the signal. Phosphorylation 
has been implicated in the functioning of NLSs of the SV40 large T antigen (Ribs & 
Peters, 1989; Ribs et al., 1991; lans & lans, 1994), nucleoplasmin (Vancurova et al., 
1995) and the serum response factor, a ubiquitous nuclear transcription factor 
(Gauthier-Rouviere, 1995). ATP may also be required in the promotion of interactions 
with factors which promote nuclear targeting such as a NLS receptor or nuclear pore 
targeting complex (Adam & Adam, 1994; Powers & Forbes, 1994; Gorlich et al., 
1995a,b; Imamoto et al., 1995a,b,c). 
Another possible role of A TP in nuclear transport, which is not necessarily 
mutually exclusive with the mechanisms proposed above, is its involvement in 
changing the conformational state of the transported molecule. This could be 
important in the maintenance of the nuclear targeting signal in an exposed state to 
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enable interaction with the nuclear transport machinery, or in the transformation of the 
molecule into an elongated form, thereby allowing passage through the NPC channel. 
Electron microscopic analysis of different Chironomus ribonucleoprotein particles has 
determined that there is a change from globular to more linear form as the particles 
approach the NPC (Mehlin et al., 1992; 1995). There is also evidence of a role for a 
. nuclear envelope-associated RNA helicase, which unwinds sections of double stranded 
RNA, in the nuclear export of mRNA (SchrOder et al., 1990). In addition, heat shock 
proteins, which act as molecular chaperones for transport into mitochondria by altering 
the conformation of the protein in an A TP-dependent manner, are also involved in 
nuclear transport (Imamoto et al., 1992; Shi & Thomas, 1992; Okuno et al., 1993; 
Yang & DeFranco, 1994). 
2.1.3 Wbeat germ agglutinin 
Wheat germ agglutinin (WGA) is a plant lectin, or carbohydrate-binding protein 
that specifically binds N-acetylglucosamine (GlcNAc) residues (Hanover et al., 1987; 
Holt et al., 1987; Yoneda et ai., 1987). As described in Chapter One, the NPC 
contains a number of glycoproteins which are essential to its structure, with respect to 
the nuclear membrane, and function in nuclear transport. Several of these so-called 
nucleoporins have been isolated by antibodies directed against NPCs, and have been 
characterised as having GlcNAc residues joined by unusual O-linkages to their 
polypeptide backbone, at approximately 10 moles of GlcNAc per mole of protein 
(Holt et al., 1987). WGA has a high affmity for clusters of GlcNAc residues and 
hence binds these proteins. 
Fluorescently-Iabelled WGA binds to the nuclear envelope at the nuclear pore 
complex, giving a characteristic punctate staining pattern on the nuclear envelope 
(Finlay et al., 1987; Yoneda et al., 1987). Higher resolution images have been 
obtained using electron microscopy of isolated nuclear membranes labelled with gold-
conjugated WGA (Akey and Goldfarb, 1989; Wilken et al., 1993; Pante & Aebi., 
1994), or WGA conjugated to the electron-dense ferritin molecule (Finlay et al., 1987; 
Allen, 1990). From these images it has been determined that WGA binds to the 
central 'transporter' region of the NPC (Akey and Goldfarb, 1989) and at greater than 
15 molecules per pore (Finlay et al., 1987). In addition, Allen (1990) visualised 
ferritin-labelled WGA binding to fibrous material at both cytoplasmic and 
nucleoplasmic pore margins in nuclei of cultured mammalian cells. 
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Treatment of cells with WGA has been found to inhibit the nuclear import of 
karyophilic proteins including nucleoplasmin in an in vitro system (Finlay et al., 1987) 
and in cultured cells (Yoneda et aI., 1987); synthetic peptide containing the SV40 
large T antigen nuclear localisation sequence in cultured cells (Wolff et al., 1988); and 
a group of labelled proteins microinjected into Xenopus oocytes (Dabauvalle et al., 
1988). Treatment with WGA prevents the efflux of RNPs from rat nuclei (Baglia and 
Maul, 1983); as well as export of small nuclear RNA precursors (Neuman de Vegvar 
and Dahlberg, 1990), mRNA (Dargemont and KUhn, 1992), signal recognition particle 
RNA (He et al., 1994), and ribosomal subunits (Bataille et al., 1990) in Xenopus 
oocytes. The nuclear import of the UI-U6 snRNAs in Xenopus oocytes is also 
sensitive to WGA (Fischer et al., 1991; Michaud and Goldfarb, 1992). WGA-induced 
transport inhibition has been shown to be specific to facilitated transport and not 
simply a function of blocking or constraining the NPC channel, as the passive 
diffusion of small fluorescently-Iabelled dextran molecules through the NPC continues 
at a normal rate with this treatment (Finlay et al., 1987; Yoneda et al., 1987; 
Dabauvalle et al., 1988; Wolff et al., 1988). As mentioned in Chapter One (section 
1.3.2), antibodies raised against the WGA-binding nucleoporins (Davis & Blobel, 
1986; Snow et al., 1987) also have an effect on nucleo-cytoplasmic transport, 
presumably by binding and thereby inactivating the nucleoporins (Featherstone et al., 
1988; Akey & Goldfarb, 1989; Finlay et al., 1991; Michaud & Goldfarb, 1992; 
Yamada & Kasamatsu, 1993; Kemler et al., 1994). 
The in vitro construction of NPCs which are depleted of WGA-binding 
nucleoporins has provided further evidence of a role for these proteins in nucleo-
cytoplasmic transport (Finlay & Forbes, 1990; see also Chapter One). In this study, 
nuclei were constructed in a nuclear assembly extract devoid of WGA-binding 
proteins. These biochemically altered NPCs were functional for diffusion, but not for 
the binding of nuclear localisation signals, or subsequent facilitated transport. 
Previous studies had determined that WGA inhibits the A TP-dependent translocation 
step of NPC transport, but not the initial binding step (Newmeyer & Forbes, 1988). 
Therefore, the inhibition of binding in biochemically altered NPCs may be due to an 
indirect structural perturbation in the NPCs created without these proteins (Finlay & 
Forbes, 1990). However, nuclear localisation signal-dependent binding of 
nucleoplasmin at the NPC has been visualised at WGA-reactive fibrils that radiate 
from the pore to the cytoplasm (Richardson et al., 1988; Allen, 1990), thus 
corroborating the concept of WGA-binding proteins being involved in this initial 
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interaction (see also Rout & Wente, 1994). Furthermore, factors involved in the 
docking of karyophiles at the NPC, as well as the subsequent translocation step of 
import, have been found to directly interact with nucleoporins that are able to bind 
WGA (Kraemer et al., 1995; Moroianu et al., 1995a,b; Paschal & Gerace, 1995; Radu 
et al., 1995a,b; Yokoyama et al., 1995). 
Facilitated nuclear transport is not necessarily inhibited by chilling, A TP 
depletion and WGA. For example, the nuclear import of the Ca2+ -binding protein 
calmodulin in tissue culture cells has been found to be inhibited by chilling and wheat 
germ agglutinin treatment but not by ATP depletion, demonstrating that calmodulin 
nuclear import proceeds via facilitated diffusion (Pruschy et al., 1994). Thus, ATP 
may not be an essential component in all mediated pathways of nuclear transport, as 
facilitated diffusion can proceed in its absence (see Section 2.1.1). In summary, 
chilling, ATP depletion and WGA treatments are able to differentiate passive diffusion 
from facilitated NPC-mediated transport and, in some cases, may also be capable of 
distinguishing between facilitated diffusion and active transport. 
2.1.4 Assays used in the present study 
Microinjection of labelled molecules into Xenopus oocytes has been used 
extensively in studies of RNA/RNP nuclear transport processes (DeRobertis et al., 
1982; Bataille et al., 1990; Guddat et al., 1990; Allison et al., 1991; Fischer et al., 
1991; 1993; Michaud & Goldfarb, 1991; 1992; Dargemont & Kuhn, 1992; Terns et 
al., 1993; Jarmolowski et al., 1994; He et al., 1995; Pokrywka & Goldfarb, 1995). 
Oocytes are readily obtained by surgical removal from adult females and, at 
approximately 1.2 mm in diameter (for late-stage oocytes), they are large enough to be 
easily manipulated and microinjected. In addition, the nucleus can be manually 
separated from the cell, allowing a simple determination of nuclear transport by 
measurement of the cytoplasmic and nuclear pools of the molecule(s) under study. In 
this investigation, the use of in vitro-generated, radiolabelled 5S rRNA enabled the 
quantification of 5S rRNA import under various treatments that inhibit facilitated 
transport through the nuclear pore complex. 
2.2 Materials and Methods 
Unless otherwise stated, general reagents used in these studies were obtained 
from BDH (Poole, England) and electrophoresis reagents were obtained from 
Boehringer Mannheim (N.Z. Ltd., Auckland, New Zealand). All chemicals were of 
Analytical or Molecular Biology Grade. 
2.2.1 In vitro synthesis of 3zP_5S rRNA 
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The oocyte-type 5S rRNA gene template, pXlo-wt (Romaniuk et al., 1987), was 
provided by Dr PJ. Romaniuk (University of Victoria, Victoria, British Columbia, 
Canada). Internally-labelled oocyte-type 3zP_5S rRNA was synthesised in vitro from 
pXlo-wt linearised with Dra I (Boehringer Mannheim). Transcription reactions were 
performed using 50 U T7 RNA polymerase (Epicentre Technologies: Intermed 
Scientific Ltd., Auckland, New Zealand) and 100 pCi [a_32P]GTP (3000 Cilmmole; 
Amersham Australia Pty. Ltd or DuPont NEN: Life Technologies Ltd., Auckland, 
New Zealand) in a 20 pI reaction containing transcription buffer (Epicentre), 10 mM 
dithiothreitol, 40 U RNasin (Prom ega: Pacific Diagnostics Pty. Ltd., Auckland, New 
Zealand), 200 pM ATP, CTP and UTP, 40 pM GTP and 1 pg DNA template. The 
mixture was incubated for 1 h at 37°C followed by treatment with 1 U RNase-free 
DNase I (Boehringer Mannheim) for 15 min at 37°C. After incubation, 130 pI UB 
Blue (175 mM NaCI, 5 mM Tris, pH 7.4,5 mM EDTA, 0.5% sodium dodecylsulphate 
[SDS], 0.05% methylene blue, 7 M urea) and 1 pg glycogen (Boehringer Mannheim) 
were added. The samples were purified by extraction with an equal volume of 1: 1 
phenol:chloroform (24:1 chloroform:isoamyl alcohol), followed by extraction with an 
equal volume of chloroform, and precipitated with 2 vol ethanol for 30 min on ice. 
The RNA was collected by centrifugation at 10 000 x g for 20 min at room 
temperature, and the pellet washed with 300 pI 70% ethanol. The dried pellet was 
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resuspended in TE (10 mM Tris-HCI, pH 7.6, 1 mM EDTA) and stored at -80°C. 
The RNA was quantified using DNA Quik STRIPs (Eastman Chemical Co., New 
Haven, CT, USA), according to the manufacturer's instructions. The typical yield was 
2 pg per reaction. 
2.2.2 Surgical removal of oocytes and preparation for microinjection 
Xenopus laevis (Xenopus I, Ann Arbor, MI, USA) were reared on a diet of 
cockroaches and salmon pellets. Adult females were anaesthetised by immersion in 
ice-water for 30 min followed by placement on ice for a further 30 min. A 1 cm 
incision was made in the skin of the lower abdomen (on one side above the leg) 
followed by an incision through the muscle layer to expose the ovarian tissue. A lobe 
of ovary was removed with sterile scissors and placed in TNE solution (0.15 M NaCI, 
0.05 M Tris-HCI, pH 8.0, 1 mM EDTA). The incision was sutured with 4/0 coated 
Vicryl dissolvable sutures (Ethicon, UK), with 2-3 stitches in the muscle layer and the 
same number in the skin. The frog was then maintained on ice for 10 min prior to 
placing in ice water. When the animal had started movement, it was placed back into 
its tank, maintained with running water at 18°C. All procedures in the surgical 
removal of oocytes from the frogs had been approved by the University of Canterbury 
Animal Ethics Committee. 
After rinsing the tissue three times with TNE to remove blood, EDTA was 
removed by rinsing in phosphate buffered saline (PBS; 68 mM NaCI, 1.3 mM KCI, 
4.0 mM NazHP04' 0.7 mM KHZP04). The oocytes were then separated by treatment 
in 1 mg/ml collagenase (Type I, Sigma Chemical Co., St Louis. MO, USA; made up 
in 0.1 M sodium phosphate, pH 7.4) for 30 min with constant end-over-end rotation. 
The separated oocytes were next washed twice with PBS and twice with 0-R2 
medium (82.5 mM NaCI, 2.5 mM KCl, 1.0 mM CaClz• 1.0 mM MgClz, 1.0 mM 
NazHP04• 5.0 mM HEPES [N-2-hydroxyethyl-piperazine-N'-2-ethanesulphonic acid]. 
3.8 mM NaOH), and stored in 0-R2 at 18°C in culture dishes. The 0-R2 was 
changed daily and any unhealthy oocytes (those with uneven pigmentation giving a 
mottled appearance) were removed. 
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2.2.3 Microinjection 
Microinjection needles were drawn from 1 mm OD glass capillary tubes (Clark 
Electromedical, England) using a Narishige (Japan) micropipette puller (model PW -6), 
and the tip was broken to produce a needle diameter of approximately 20 pm. 
Microinjections were performed using a PV830 Pneumatic PicoPump (World Precision 
Instruments Inc., New Haven, cr, USA.) and micromanipulator (model M3301). The 
samples to be injected were loaded under vacuum and delivered under nitrogen gas 
pressure of approximately 35 psi (varied according to the solution being injected). 
Calibration of the injection amount was performed by measuring the diameter of the 
drop ejected and calculating its volume. The volume delivered was adjusted by 
varying the time (in msec) the pressure was activated. 
Stage V to VI oocytes were selected based on the classification of Dumont 
(1972). Stage V oocytes were defined as 1000 to 1200 pm in diameter with a 
pigmented animal hemisphere. Stage VI oocytes were defined as 1200 to 1300 pm in 
diameter with a distinct unpigmented equatorial band. To stabilise oocytes during the 
microinjection process they were placed in culture dishes to which 900 pm nylon 
mesh had been attached. Twenty to 50 nl of sample was injected into the oocyte 
cytoplasm at the equatorial region of the vegetal hemisphere, with the oocyte just 
covered with O-R2 medium. To ensure the simultaneous initiation of nuclear transport 
for all treatments, dishes of oocytes were placed on ice until all microinjections were 
completed before placing at 18°C to begin the assay. 
2.2.4 Nuclear dissections and RNA extraction 
For 32P_5S rRNA nuclear transport assays, nuclei were manually dissected in ice 
cold 1 % trichloroacetic acid with watchmaker's forceps. The nucleus was extruded 
from the oocyte after making a single tear at the animal pole with one pair of forceps 
and applying pressure from the vegetal hemisphere with another pair of forceps. 
Nuclei were manually cleared of any adhering cytoplasmic material with the forceps, 
and the enucleated cytoplasm and clean isolated nucleus were transferred to separate 
microfuge tubes on ice. Total RNA was extracted from five pooled nuclear and 
cytoplasmic fractions per sample. 
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RNA was extracted from nuclear and cytoplasmic oocyte fractions using a 
potassium acetate method modified from Peppel and Baglioni (1990). To enhance the 
efficiency of the extraction of RNA from the nuclear fractions, the total amount of 
RNA was increased by the addition of two uninjected 'carrier' oocytes. The samples 
were homogenised in Solution 1 (2% SDS, 200 mM Tris-HCI, pH 7.5, ImM EDTA) 
by pipetting in and out of a Gilson pipette tip and mixed for 5 s using a Vortex mixer 
at high speed. 150 pI of ice-cold Solution 2 (42.9 g potassium acetate and 11.2 ml 
glacial acetic acid in 100 ml) was added and the samples mixed for 10 s using a 
Vortex mixer, at low speed to prevent shearing the chromosomal DNA that could 
subsequently contaminate the RNA. The samples were then placed on ice for 2 min 
to precipitate the DNA and proteins, and these were removed by centrifugation at 
10 000 x g for 5 min at room temperature. The RNA samples were further purified 
by extracting the clear supernatant twice with 300 pI of chloroform:isoamyl alcohol 
(24:1) and precipitated with 650 pI of isopropanol at -20°C overnight. The RNA was 
collected by centrifugation at 10 000 x g for 25 min at room temperature and the 
\ 
pellet washed with 1 ml of 70% ethanol. The RNA pellet was air dried for 5-10 min 
and dissolved in 10 pI formamide-dye loading buffer (95% deionised formamide, 
0.05% xylene cyanol, 0.05% bromophenol blue) for polyacrylamide gel 
electrophoresis. 
2.2.5 Gel electrophoresis and autoradiography 
RNA samples were run on 8% polyacrylamide gels containing 8 M urea in TBE 
(89 mM Tris, 89 mM boric acid, 2.7 mM EDTA). The samples were heated at 100°C 
for 3 min to ensure denaturation, and placed immediately on ice prior to loading on 
the gel. Electrophoresis was carried out in TBE at 600 V (constant voltage) for a 20 
cm long gel of 0.75 mm in thickness (Protean IIxi; BioRad Pty Ltd, Auckland, New 
Zealand) for approximately 1 h, until the xylene cyanol and bromophenol blue dye 
bands were 5 cm and 10-11 cm from the origin, respectively. After electrophoresis, 
gels were dried at 80°C for 2 h under vacuum, and exposed to X-ray film (Hyperfilm, 
Amersham) between intensifying screens (Kodak X-omatic Regular) at -80°C for 1-7 
days. The intensity of bands on autoradiographs was determined by densitometry 
using a Zeineh analytical hand-held scanning densitometer and Biomed Image 
Analysis Software (Advanced American Biotechnology, Fullerton, CA, USA). 
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2.2.6 ATP depletion, WGA and chilling assays 
For ATP depletion assays, oocytes were preinjected with 50 nl of 1 U/pl apyrase 
(grade VITI; Sigma Chemical Co.) in PBS to give an intracellular concentration of 100 
U/ml. Mter 30 min incubation at 18°C, oocytes were injected with 32P-labelled 5S 
rRNA at 0.02 pmole per oocyte. Mter an additional incubation for 6 h at 18°C, the 
assay for nuclear import was performed as described above. To verify the loss of 
cellular ATP. oocyte ATP levels were measured using a CLS ATP Bioluminescence 
Kit (Boehringer Mannheim). Single oocytes were homogenised in boiling 20 mM 
HEPES. pH 7.5, and incubated for 5 min at 100°C. Samples were then diluted 1:500 
in ddH20. A 500 pI sample was added to an equal volume of luciferase extract 
immediately prior to measurement of luminescence using an SAl A TP photometer 
(model 2000). For each sample, the mean was taken from four consecutive integrating 
counts of 60 s. 
Wheat germ agglutinin (WGA; Sigma Chemical Co.) was dissolved in PBS at 
concentrations ranging from 0.25 to 1 mg/ml. WGA (50 nl) or PBS (as a control) was 
cytoplasmically injected into oocytes. Mter incubation at 18°C for 3 h, oocytes were 
injected with 32P-Iabelled 5S rRNA, incubated for a further 18 to 26 h, and analysed 
for nuclear import as described above. As a control for the specificity of the WGA 
treatment, 50 nl of 1 mg/ml WGA mixed with 500 mM N-acetylglucosamine (Sigma 
Chemical Co.) was cytoplasmically injected into oocytes prior to the injection of 32p_ 
5S rRNA. 
For the chilling assays, oocytes were injected with 32P_5S rRNA and incubated 
for 6 h on ice (with the ice container placed at 4°C) or at 18°C, or for 6 h on ice 
followed by 16 h at 18°C and 18 h at 18°C as a control. Mter incubation, nuclei 
were manually dissected and the assay for nuclear import performed as described 
above. 
2.2.7 FITC-dextran controls 
As a control to demonstrate that chilling and WGA treatments were not affecting 
the process of passive diffusion through the nuclear pore, fluorescein isothiocyanate 
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(FITC)-labelled dextrans were injected into the oocyte cytoplasm immediately prior to 
incubation on ice or 3 h after microinjection of WGA. Oocytes were injected with 50 
nl of 100 mg/ml FITC-dextran of 10 kD and 150 kD in size (Sigma Chemical Co.). 
After an 18 h incubation, nuclei were manually dissected in nucleus isolation buffer 
(25 mM Tris-HC1, pH 8.0, 10% glycerol, 5 mM MgCI2, 2 mM dithiothreitol). The 
. isolated nuclei were placed in the depression of a microscope slide in nucleus isolation 
buffer, and viewed under the fluorescence microscope to enable detection of FITC-
dextran that had diffused into the nucleus. 
2.3 Results 
2.3.1 32P.5S rRNA microinjected into the oocyte cytoplasm accumulates in the 
nucleus over time 
To establish the kinetics of import of microinjected oocyte-type 5S rRNA in my 
hands, I performed the assay for nuclear import over time. As had been previously 
demonstrated for HeLa cell 5S rRNA (DeRobertis et al., 1982) and for oocyte-type 5S 
rRNA (Allison et al., 1991), 32p_5S rRNA injected into the cytoplasm of Xenopus 
oocytes was imported into the nucleus (Fig. 2.1). Nuclear accumulation reached 
steady-state levels after 8 to 10 hours at approximately 10% nuclear. The results 
shown in Fig. 2.1 (and figures showing subsequent nuclear transport assays) are from 
a batch of oocytes from a single frog. 
2.3.2 Wheat germ agglutinin 
To establish whether the nuclear import of 32P_5S rRNA occurs via a facilitated 
or passive mechanism through the nuclear pore complex, treatments that inhibit 
facilitated transport were used. The first criterion for facilitated transport that was 
tested was sensitivity to treatment with WGA. Cytoplasmic microinjection of WGA 
(at an intracellular concentration of 0.1 mg/ml) three hours prior to 32p_5S rRNA 
injection significantly inhibited 32p_5S rRNA nuclear import (Fig. 2.2 A, cf. lanes 2 
and 4). This effect was reversed by co-injection of N-acetylglucosamine (lane 6), 
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Figure 2.1: The nuclear accumulation of microinjected oocyte-type 32p-5S rRNA. 
In vitro-synthesised 32p-5S rRNA was microinjected into the oocyte cytoplasm to a concentration of 
approximately 0.02 pmoles per oocyte. After incubation at 18°C for the time intervals indicated, the 
oocytes were manually dissected and RNA extracted from five pooled nuclear and cytoplasmic fractions. 
The samples were subjected to electrophoresis on denaturing 8% polyacrylamide gels containing 8 M urea, 
followed by autoradiography. The percentage of radioactivity in the nucleus was quantified by densitometry 
of the autoradiographs. Each point represents the mean from three replicate samples of five oocytes. The 
bars indicate the standard error of the means. 
Figure 2.2: The effect of WGA on the nuclear import of 5S rRNA. 
(A) OocyteS were preinjected with WGA at a cellular concentration of 0.1 mg/ml (lanes 3 and 4), or 
with WGA (0.1 mglml) and 50 mM N-acetylglucosamine (WGA + GlcNAc; lanes 5 and 6). PBS was 
injected as a conttol (lanes 1 and 2). After incubation for 3 h at 18°C, 32p-labelled 5S rRNA was 
injected into the cytoplasm and the oocyteS were incubated for a further 18 h. The analysis for nuclear 
import was then performed as described in the legend to Fig. 2.1. 
C, cytoplasmic fractions; N, nuclear fractions. 
(8) Dose-dependent inhibition of 5S rRNA nuclear import. OocyteS were preinjected with 50 nl of 
WGA at various concentrations. The fmal intracellular concentration ofWGA is denoted on the x axis. 
After 3 h incubation, 32p-5S rRNA was injected and nuclear import assayed after 18 h as described 
in the legend to Fig. 2.1. The percentage of radioactivity in the nucleus was quantified by 
densitometry of the autoradiographs. Import in the presence of WGA is expressed as a percentage of 
the import of 32p-5S rRNA in conttol oocytes preinjected with PBS only (% Conttol). 
(C) [over page] The effect of WGA on the passive diffusion of a small dextran into the oocyte 
nucleus. FITC-labelled dextran of 10 000 MW was cytoplasmically injected into oocytes that bad been 
preinjected with PBS as a conttol, or WGA (at 0.1 mglml). Nuclei were manually dissected after 
18 h incubation and the presence of the fluorescent label was detected by fluorescence microscopy. 
Nuclei from both treatments are shown with a combination of bright-field and fluorescence lighting 
to show the outline of the nucleus, as well as with florescence only. 
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which competes with the NPC proteins for binding to WGA. The extent of nuclear 
transport inhibition was dependent on the concentration of WGA injected, with an 
86% reduction in nuclear accumulation at a cellular concentration of 1 mg/ml WGA 
(Fig. 2.2 B). 
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To establish that the treatment with WGA only affected facilitated transport, and 
was not acting by the occlusion of the NPC, WGA-treated oocytes were 
cytoplasmically injected with a fluorescein isothiocyanate (FITC)-labelled dextran of 
10 kD in size (within the 30-40 kD size limit for passive diffusion through the nuclear 
pore complex). FITC-dextran was present in isolated nuclei from oocytes injected 
with either WGA or PBS only (Fig. 2.2 C), indicating that the process of passive 
diffusion was not affected. FITC-dextran of 150 kD, larger than the size limit for 
pas sive diffusion through the NPC, remained excluded from the nucleus with both 
treatments (data not shown). These results demonstrate that the nuclear membrane 
retains its·characteristics as a sieve-like barrier during the assay and that the 10 kD 
FITC-dextran was not simply binding at the outside of the nuclear membrane without 
moving into the nucleus proper. This control has not previously been reported for 
Xenopus oocytes, and thus these results augment those obtained in cultured somatic 
cells (Dabauvalle et al., 1988; Finlay & Forbes, 1990). 
2.3.3 Chilling 
An additional criterion for mediated transport is its inhibition in chilled cells. 
The nuclear import of cytoplasmically microinjected 32.P_5S rRNA was inhibited by the 
incubation of oocytes on ice, at 0-4°C (Fig 2.3 A, cf. lanes 2 and 4). 32.P_5S rRNA 
nuclear transport competence was restored when the oocytes were subsequently 
incubated at 18°C (cf. lanes 6 and 8), suggesting that chilling blocked RNA nuclear 
import by inhibiting the activity of specific components of the transport machinery, 
rather than by preventing import by way of non-specific cellular damage. These 
results indicated that 5S rRNA import proceeds via a facilitated process, which is 
inhibited when enzyme and receptor binding activity is reduced. 
To establish that the chilling treatment was only affecting a facilitated process, 
the FITC-labelled dextrans were cytoplasmically injected into oocytes. Chilling 
Figure 2.3: The effect of chilling on the nuclear import of 55 rRNA. 
(A) 32p-55 rRNA was cytoplasmically injected into oocytes. The oocytes were incubated at either 
18°C for 6 h (lanes 1 and 2), 0 to 4°C for 6 h (lanes 3 and 4), 18°C for 18 h (lanes 5 and 6), or 0 
to 4°C for 6 h followed by 18°C for 12 h (lanes 7 and 8). After incubation, oocytes were manually 
fractionated into cytoplasmic (C) and nuclear (N) compartments, and the analysis for nuclear import 
performed as described in the legend to Fig. 2.1. 
(B) [over page] The effect of chilling on the passive diffusion of a small dextran into the nucleus. 
Oocytes were cytoplasmically injected with FlTC-labelled dextran of 10 000 MW. After incubation 
at 0 to 4°C for 8 h, nuclei were manually dissected and viewed under the fluorescence microscope. 
The nucleus in this example is shown both with a combination of bright-field and fluorescence lighting, 
as well as fluorescence only. 
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treatment did not affect the passive diffusion of the 10 kD into the nucleus (Fig 2.3 
B), and the 150 kD dextran remained excluded from the nucleus (data not shown). 
2.3.4 ATP depletion 
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The final criterion used to establish the passive or facilitated nature of 5S rRNA 
nuclear import was sensitivity to A 1P depletion. Active transport through the NPC 
has an absolute requirement for A 1P, and facilitated diffusion may have an A 1P 
requirement. Microinjection of the A 1P-hydrolysing enzyme apyrase (to an 
intracellular concentration of 100 Vlml) reduced the cellular concentration of A1P 
from 1-2 mM to 20 pM within 30 minutes, and ATP levels remained low for 24 hours 
after injection (Fig 2.4 A). As shown in Fig. 2.4 B, depletion of oocyte A 1P levels 
by prior injection of apyrase had a significant inhibitory effect on the nuclear transport 
of cytoplasmically injected 32P_5S rRNA (cf. lanes 2 and 4). The autoradiograph was 
deliberately over-exposed to demonstrate the absence of detectable levels of 32P_5S 
rRNA in the nuclear fraction of ATP-depleted oocytes. The results of this experiment 
demonstrate that the nuclear import of 5S rRNA occurs via an A1P-requiring process. 
2.4 Discllssion 
The results presented here demonstrate that the transport of oocyte-type 5S 
rRNA from cytoplasm to nucleus in Xenopus oocytes occurs via a facilitated 
mechanism through the nuclear pore complex. This process is temperature-dependent, 
requires A1P, and is inhibited by binding of WGA to nuclear pore complex proteins. 
In its sensitivity to these treatments, the nuclear import of 5S rRNA is similar to other 
small RNAs that undergo transport into the nucleus (Fischer et al., 1991; Michaud & 
Goldfarb, 1992). 
2.4.1 The nuclear accumUlation of 5S rRNA 
5S rRNA microinjected into the cytoplasm accumulates in the nucleus over time. 
Between 8 and 10 hours after microinjection, the rate of accumulation begins to 
diminish, resulting in a steady level of approximately 10% nuclear. This level of net 
Figure 2.4: The effect of AlP depletion on the nuclear import of 5S rRNA. 
(A) The effect of microinjected AlP-depleting enzymes on oocyte AlP levels. Oocytes were 
cytoplasmically injected with apyrase (to a cellular concentration of 100 Vlml). After incubation at 
18°C for the times indicated, oocytes were individually homogenised and processed for AlP 
quantification using the luciferase enzyme system (see Section 2.2). Bars indicate the standard error 
of the means from four sample replicates. 
(8) Oocytes were injected with apyrase to a cellular concentration of 100 Vlml (-AlP; lanes 3 and 
4), or PBS as a control (+ AlP; lanes 1 and 2). After incubation for 30 minutes at 18°C, 32p-5S rRNA 
was injected into the cytoplasm, and the oocytes were incubated for a further 6 h at 18°C. The 
analysis for nuclear import was then performed as described in Fig. 2.1. C, cytoplasmic fractions; N, 
nuclear fractions. 
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nuclear accumulation is half that previously reported for oocyte-type 5S rRNA injected 
into the cytoplasm of Xenopus oocytes (Allison et al., 1991), probably reflecting the 
variability in the rate of nuclear import between batches of oocytes due to differences 
in age and developmental stage. This effect is also demonstrated in the results of 
nuclear import assays presented in this thesis, where net nuclear import of 5S rRNA 
after 24 hours varied between 8 and 16% (cf. Figs 2.1, 4.1, 4.2, and 4.3 B). 
The extent of 5S rRNA import is low compared with other karyophiles. For 
example, HeLa U2 snRNA and Xenopus Ul snRNA were found to be approximately 
60% nuclear 8 hours after injection into the oocyte cytoplasm (Michaud & Goldfarb, 
1991; 1992), and the protein nucleoplasmin was found to be rapidly imported into 
oocyte nuclei reaching approximately 16% nuclear only one hour after its cytoplasmic 
injection (Michaud & Goldfarb, 1992). The low amount of 5S rRNA nuclear 
accumulation with respect to other karyophiles is likely to represent the complex 
developmental regulation of its sub-cellular localisation (described in Chapter One). 
Nuclear proteins are imported into the nucleus after their translation, to take part in 
activities such as transcription, and the U snRNAs are imported to their nuclear site of 
function after their assembly into U snRNPs in the cytoplasm. In contrast, the 
movement of oocyte-type 5S rRNA into the nucleus represents the formation of a 
steady-state between the import of 5S rRNA for ribosome assembly and its storage as 
part of storage RNPs or 80S ribosomes in the cytoplasm. Therefore, nuclear 
accumulation of 5S rRNA is regulated by the amount bound in import-competent 
RNPs (probably 5S RNPs) at any given time. The levelling of the rate of 5S rRNA 
nuclear accumulation may also be due in part to the saturation of some component (or 
components) at some stage of the 5S rRNA nuclear transport pathway. 
2.4.2 The effect of chilling, ATP depletion and WGA on 58 rRNA nuclear 
import 
In its response to the treatments used in this study, 5S rRNA nuclear import is 
similar to the import and export of other small RNAs (see Section 2.1), as well as the 
nuclear export of 5S rRNA (Jarmolowski et al., 1994) and 5S rRNA-containing RNPs 
(Featherstone et al., 1988; BattailIe et al., 1990). It appears that most nuclear 
molecules, including proteins that fall within the passive diffusion limit for NPC 
transport (Breeuwer & Goldfarb, 1990; Dean & Kasamatsu, 1994), as well as some 
ions (Mazzanti et al., 1994), move across the nuclear membrane by a facilitated, 
nuclear pore-associated process that can be inhibited by chilling, A TP-depletion and 
WGA. 
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The amount of WGA required to inhibit 5S rRNA nuclear import is comparable 
to the concentration of WGA shown to inhibit the nuclear import of U6 snRNA, but 
20 times less than the concentration required to inhibit U1 snRNA and U5 snRNA to 
the same degree (Fischer et al., 1991; Michaud & Goldfarb, 1992). This lower WGA 
concentration is also sufficient to significantly inhibit the nuclear import of karyophilic 
proteins (Daubauvalle et al., 1988; Kambach & Mattaj, 1992). As the actual 
mechanism of action of WGA is yet to be determined, the reason for this differential 
inhibition is unknown. It is possible that the action of WGA is not specific for 
nuclear pore activity, as there may be further sites for WGA binding within the 
cytoplasm which could indirectly affect nuclear transport; however, recent studies do 
not support this model. For example, Sterne-Marr et al. (1992) determined that the 
depletion of cytosolic WGA-binding proteins had no effect on nuclear protein import, 
demonstrating that WGA inhibition of transport was due to interaction with a 
component of the nuclear transport machinery. 
The inhibitory effect of WGA on nuclear transport is likely to be due its 
interference with the binding of nuclear transport factors to the NPC. WGA-reactive 
nucleoporins have been found to interact with both the component of the nuclear pore 
targeting complex involved with docking at the nuclear pore (Moroianu et al., 
1995a,b; Paschal & Gerace, 1995; Radu et al., 1995a,b), and with Ran, which is 
involved in later steps of the nuclear transport process (Yokoyama et al., 1995). 
Therefore, WGA-inhibition of 5S rRNA nuclear import could be due to the failure of 
a 5S rRNA-containing nuclear pore targeting complex to interact with the NPC during 
its docking or at a subsequent step involved with translocation. 
Chilling and A TP-depletion treatments have an effect on a variety of processes 
within the oocyte that could potentially have an impact on 5S rRNA nuclear transport. 
One possibility would be that the formation of transport-competent 5S rRNA-
containing RNPs is inhibited by chilling. However, this is unlikely since 5S rRNA-
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protein interactions such as the assembly of microinjected 5S rRNA into 7S RNPs can 
still occur at 0 to 4°C (Allison et al., 1993), The inhibition of 5S rRNA nuclear 
import at reduced temperatures may be the result of either a reduced interaction with 
factors such as a nuclear localisation signal receptor or a nuclear pore targeting 
complex (Imamoto et ai., 1995 a,b,c), or in the reduction of activity of a motor 
involved in translocation through the cytoplasm or at the nuclear pore. Likewise, the 
ATP requirement for 5S rRNA nuclear import may be prior to or during transit 
through the nuclear pore complex. A 1P could even be utilised subsequent to passage 
through the nuclear membrane, in the targeting of 5S rRNA to the nucleolus, or other 
intranuclear retention sites. ATP has been found to be a requirement for the 
intranuclear movement of a nucleolar protein N038 (Wu et ai., 1995b); however, other 
studies suggest that it is GTP hydrolysis that is required for nucleolar localisation 
(Finch et ai., 1993; Cheng et ai., 1995). 
2.4.3 Facilitated transport of 5S r RNA 
Inhibition of 5S rRNA nuclear import by chilling, A1P depletion and WGA 
eliminated the mechanism of passive diffusion as a possible mechanism for 5S rRNA 
import, but were unable to definitively distinguish between the possibilities of 
facilitated diffusion and active transport. Therefore, for the purposes of this study, I 
will refer to active transport and facilitated diffusion under the general term 
'facilitated transport', meaning a transport process involving some kind of receptor-
ligand interactions and a requirement for either physiological temperatures and/or 
ATP. For the purposes of this study the important feature of the transport process is 
not whether it occurs via facilitated diffusion or active transport, but that it is 
facilitated and receptor-mediated rather than passive. Intuitively, it would appear to 
be advantageous to utilise a facilitated process, which is more readily regulated and 
faster than passive diffusion alone (Paine, 1993), This would be especially important 
in the import of a ribosomal component, which may need to be coordinated with the 
import of ribosomal proteins. The import of oocyte-type 5S rRNA in Xenopus 
oocytes has been found to occur at the stage of development when ribosomal proteins 
are also being imported, and the other ribosomal RNAs are being synthesised (Allison 
et al., 1991, and references therein). Furthermore, it is likely that 5S rRNA is 
imported into the nucleus specifically bound with protein as an RNP, which would 
result in a complex too large to pass through the resting pore channel, thereby 
necessitating a facilitated process. 
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An important feature of 5S rRNA nuclear import that is not directly addressed in 
the experiments described in this Chapter, is the implications of RNA-protein 
interactions on the sub-cellular localisation of 5S rRNA. These interactions may serve 
to maintain 5S rRNA in the correct cellular compartment for the particular 
developmental stage of the oocyte by masking or exposing putative nuclear transport 
signals, and/or signalling retention in the cytoplasm or nucleus. Signals provided by 
bound proteins are likely to account for both retention in the cytoplasm for storage 
and subsequent nuclear accumulation at a later developmental stage. 5S rRNA binds 
with ribosomal protein L5 in a 5S RNP complex as a precursor to ribosome assembly 
(Steitz et al., 1988), and it is probable that 5S rRNA moves into the nucleus in this 
form. 5S rRNA is imported into the nucleus by either active transport or facilitated 
diffusion, and accumulates in the nucleus by means of specific binding in the nucleus 
to non-soluble elements such as at the nucleolus. 5S rRNA has been shown to 
accumulate at the nucleolus by the binding of biotin-labelled antisense 
oligonucleotides to oocyte sections (RaSka et al., 1995), and by immunogold labelling 
(Raska et al., 1990) and fluorescence microscopy (Steitz et al., 1988) using human 
autoantibodies to 5S RNPs. Binding of 5S rRNA (as 5S rRNA-containing RNPs) to 
non-diffusible elements within the nucleus could result in the import process 
proceeding down the chemical activity gradient, and therefore by facilitated diffusion 
rather than active transport, especially as it is likely that 5S rRNA is stored on the 
cytoplasmic side of the nuclear membrane as 7S RNPs but is imported into the 
nucleus as 5S RNPs. 
In Chapter Three and Four, further evidence is provided for the involvement of 
L5 in signalling release of 5S rRNA from cytoplasmic storage, for subsequent nuclear 
import, and the potential role for 5S rRNA-binding proteins in providing nuclear 
targeting and retention signals is discussed. 
Chapter Three 
A Role for Ribosomal Protein L5 
in 5S rRNA Nuclear Transport 
3.1 Introduction 
3.1.1 The importance of RNA-protein interactions 
Most, if not all, RNAs are likely to exist within cells in specific complexes with 
proteins termed ribonucleoprotein particles (RNPs). These interactions serve to 
stabilise the RNAs, maintain the molecules in a functional conformation, and target 
them to different cellular locales (reviewed in Wickens & Dahlberg, 1987; Dreyfuss et 
ai., 1988), Formation of RNJls is important in such essential processes as the 
production of mature message RNA (Liihrmann et ai., 1990), as well as signal 
recognition particle-mediated protein transport to the endoplasmic reticulum (Walter & 
Lingappa, 1986), and in the production of the protein biosynthesis machines; 
ribosomes (Hill et ai., 1990). The interaction between RNA and protein allows for a 
great variety of structural conformations in these complexes, resulting in the masking 
and exposing of signals for specific sub-cellular localisation and creation of sites for 
molecular interaction that enable different functional activities to take place. 
3.1.2 Nuclear transport of RNPs 
Transport of RNPs in both directions across the nuclear membrane requires the 
presence of signals that designate the complexes for movement through the nuclear 
pore complex (see Section 1.5), These signals may reside in the nucleotide sequence 
or conformation of the RNA, the amino acid sequence or structure of the bound 
protein, or in a combination of elements of both RNA and protein. Many proteins 
have been shown to be associated with RNA nuclear transport, some of which had 
been previously characterised as part of a stable RNP, and others which may have 
more transient interactions with the RNA. Table 3.1 gives a summary of the studies 
to date on proteins proposed to be involved in RNP nuclear transport. This table does 
not include proteins of the nuclear pore complex that have been found to directly 
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Table 3.1 Proteins involved in RNP nuclear transport 
RNA Protein(s) involved Direction of transport Reference 
in transport 
mRNA (general) hnRNP Al export Pinal-Roma & Dreyfuss, 1992 
CBP80 & CBPZO Dargemont & KUhn, 1992 
UsnRNAs CBP80 & CBPZO export Izaurralde et al., 1995 
tRNA glyceraldehyde-3- export Singh & Green, 1993 
phosphate 
dehydrogenase 
5S rRNA TFIIIA export Guddat et al., 1991 
L5? 
mV-l mRNA Rev export Fischer et al., 1994 
Histone mRNA 3'-end processing export Eckner et al., 1991 
activity 
SRPRNA SRP9/SRPI4 export He et al., 1994 
YRNAs La, Ro6O, R052 export Simons et al., 1994 
Ul, U2, U4 and Sm proteins import Fischer et al., 1993; 1994 
U5 snRNAs 
interact with RNPs in transit. or the factors involved in the general transport 
process(such as Ran/I'C4 and importin), but rather focuses on the more specific 
interactions of proteins that form part of stable RNPs. 
Evidence for the role of particular proteins in RNP transport comes from studies 
that demonstrate the inhibition of the transport process in the absence of protein 
binding. For example. two tRNA mutants that are unable to bind glyceraldehyde-3-
phosphate dehydrogenase are not exported from the nucleus (Singh & Green. 1993); 
signal recognition particle RNA (SRP RNA) that does not bind the proteins SRP9 and 
SRP14 is retained in the nucleus (He et al., 1994); the Ul. U2, U4 and U5 snRNAs 
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must be capable of binding Sm proteins to be competent for nuclear import (Fischer et 
al., 1993; 1994b); and the nuclear export of 5S rRNA in oocytes is inhibited in 
mutants that cannot bind TFIIIA or L5 (Guddat et al., 1990). However, it has also 
been proposed that studies using mutant RNAs are not purely testing the role of the 
specific protein in their transport, as the mutations could result in the generation of 
artifactual sites enabling the RNA to bind to nuclear retention factors (Boelens et al., 
1995). 
The only proteins for which there is direct evidence of an essential role in RNP 
transport are HIV-1 Rev protein (Fischer et al., 1994) and the cap binding protein 
CBP20 (Izaurralde et al., 1995). The presence of purified recombinant Rev protein 
was found to be essential for the export of mRNA containing the Rev recognition site 
(the Rev-responsive element) from Xenopus oocyte nuclei (Fischer et al., 1994). 
Evidence for a role for CBP20 in transport was provided by the inhibition of U 
snRNA export from Xenopus oocyte nuclei by antibodies raised against recombinant 
CBP20 (Izaurralde et al., 1995). The actual role of the identified protein components 
in RNP nuclear transport is unclear. They may provide nuclear transport signals 
(either for export or import), or alter the conformation of the RNA or bound protein to 
activate a masked signal. These proteins may also release theRNP from retention in 
either the nuclear or cytoplasmic compartments, allowing the RNP to enter the nuclear 
transport pathway. 
3.1.3 5S rRNA-protein interactions and nuclear transport 
5S rRNA-protein interactions serve to regulate the activity and subcellular 
localisation of oocyte-type 5S rRNA throughout oogenesis (Guddat et al., 1990; 
Allison et al., 1991; 1993; 1995). Therefore, investigation into the nuclear transport 
of 5S rRNA in oocytes needs to take into account a variety of interactions, that 
depend on both the temporal and spatial availability of different binding proteins. As 
is the case for other RNPs, it is possible that the signals for either import or export of 
5S rRNA are due to its interaction with different proteins. 5S rRNA-binding proteins 
could enable either cytoplasmic or nuclear accumulation by supplying functional 
nucleocytoplasmic transport signals, by the 'deactivation' of the transport signal due to 
concealment within the 5S rRNA-protein complex, or by the creation of a retention 
site for binding to static components, thereby preventing entry of 58 rRNA into the 
nuclear transport pathway. 
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Binding of either TFIIIA or ribosomal protein L5 has been proposed to be a 
requirement for nuclear export of newly synthesised 58 rRNA in Xenopus oocytes 
(Guddat et al., 1990), as described above. TFIIIA and L5 bind to a mutually 
exclusive, common binding site on 58 rRNA (Huber & Wool, 1986); therefore, the 
mutant 58 rRNA molecule may be inhibited in its nuclear export capability due to its 
failure to interact with only one of these proteins. It appears likely that TFillA is 
bound to 58 rRNA during its export out of the nucleus, as this transcription factor is 
involved with 58 rRNA both at its synthesis in the nucleus and during subsequent 
storage as a stable 78 RNP in the cytoplasm. However, 78 RNPs appear to be 
transported across the nuclear membrane in the direction of export only, as an 
immunohistochemical study detected these particles exclusively in the cytoplasm 
(Mattaj et al., 1983), and a mutant of oocyte-type 58 rRNA which binds TFIIIA with 
greatly reduced affinity is still imported into the nucleus (Allison et al., 1993). These 
observations suggest that, in addition to its role in 58 rRNA transcription, TFIIIA 
binding is required for 58 rRNA export and storage in the cytoplasm, but does not 
play a role in nuclear import at the onset of ribosome biogenesis. 
After storage in the cytoplasm as 78 RNPs, 58 rRNA moves back into the 
nucleus for ribosome assembly. Given the apparent nuclear exclusion of 78 RNPs, the 
trigger for nuclear import must involve the release of TFIIIA from 58 rRNA, probably 
by the binding of another protein or proteins. The best candidate for this role is 
ribosomal protein L5, with which 58 rRNA forms 58 RNPs prior to ribosome 
assembly (8teitz et al., 1988; Allison et al., 1991; 1993). Maximal synthesis of L5 
coincides with the synthesis of other ribosomal proteins and ribosome assembly in 
stage ill oocytes (Wormington, 1989), whereas TFIIIA concentration is highest prior 
to stage III, with levels subsequently decreasing (Dixon & Ford, 1982; Ginsberg et al., 
1984). Note that the protein components of 428 storage RNPs are no longer 
detectable in vitellogenic oocytes (Dixon & Ford, 1982), therefore 58 rRNA does not 
bind in these complexes at the later stages in oogenesis when some 78 RNPs are still 
present. The differential synthesis of TFIIIA and L5 during oocyte development 
results in the storage of 58 rRNA as 78 RNPs earlier in development, and the 
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subsequent out-competing of the very stable TFillA interaction by L5 to coincide with 
58 rRNA nuclear import for ribosome assembly (Allison et al., 1991). Thus, the shift 
is made from 58 rRNA storage in the cytoplasm to incorporation with other ribosomal 
RNAs and proteins into the ribosome. 
58 rRNA and L5 occur in equimolar ratios in ribosomes where they remain 
tightly bound as 58 RNPs that can be released intact from dissociated ribosomal 
subunits (Blobel, 1971). Therefore, it would seem advantageous if the nuclear import 
of these two essential ribosomal components occured simultaneously at the onset of 
ribosome biogenesis, rather than the molecules being imported by two separate 
pathways. However, the nuclear import of the Ul snRNA-binding protein U1A, 
which is essential to the assembly of active U1 snRNPs, is imported independently of 
U1 snRNA via a facilitated process through the nuclear pore complex (Kambach & 
Mattaj, 1992). UIA appears to shuttle between nucleus and cytoplasm, with the 
number of U1A binding sites (on U1 snRNA) on either side of the nuclear membrane 
resulting in the establishment of an eqUilibrium between the two compartments. The 
U1 snRNA-specific 70K protein (Romac et al., 1994) and the U2 snRNP-specific B" 
protein (Kambach & Mattaj, 1994) also enter the nucleus independently and associate 
with the RNAs in the nucleus. It is possible that a similar mechanism could be 
operating with 58 rRNA in oocytes to establish the nucleo-cytoplasmic distribution of 
ribosomal protein L5. In this scenario, 58 rRNA and L5 could move into the nucleus 
independently, with the amount of 58 rRNA, and therefore the number of L5 binding 
sites, on either side of the nuclear membrane limiting the nuclear accumulation of L5. 
In oocytes, a cytoplasmic pool of 58 RNPs is known to exist (Allison et al., 1991), 
demonstrating the presence of a potential cytoplasmic retention mechanism for L5. 
However, this mechanism is unable to explain what provides the stimulus for the 
nuclear mobilisation of 58 rRNA, which otherwise could be attributed to L5 binding 
prior to import. 
3.1.4 The study outlined in this chapter 
In Chapter Two, evidence was presented that the nuclear import of oocyte-type 
58 rRNA occurs via a facilitated, nuclear pore-associated process. The study outlined 
in this chapter investigated the nuclear transport of 58 RNPs, by microinjection of in 
55 
vitro~synthesised radiolabelled 5S RNPs into oocytes. These results demonstrate that 
pre-assembled 5S RNPs are stable in the oocyte and are imported into the nucleus via 
a facilitated, nuclear pore-associated process that can be inhibited by cytoplasmic ATP 
depletion, chilling, and wheat germ agglutinin. In addition, the nuclear import of 
microinjected oocyte~type 5S RNPs proceeded at a faster rate and to a greater extent 
than oocyte 5S rRNA alone, indicating that L5 binding may indeed be a prerequisite 
for 5S rRNA nuclear import. 
Materials and Methods 
3.2.1 In vitro synthesis of 35S·5S RNPs 
Xenopus oocyte-type 5S RNPs, labelled with 35S-methionine, were synthesised 
from the L5 cDNA clone pSP6-L5b (Wormington, 1989; a kind gift from Dr W.M. 
Wormington, University of Virginia, Charlottesville, Virginia, USA). A rabbit 
reticulocyte lysate coupled transcription-translation system for templates with SP6 
promoters (Promega, Madison, WI, USA) was programmed with 1 }lg circular pSP6-
L5b and 1 }lg of in vitro-transcribed Xenopus oocyte-type 5S rRNA (synthesised as 
described in Section 4.2) in the presence of 40 }lCi L-e5S]-methionine (1 000 
Ci/mmole, in vivo cell labelling grade; Amersham Australia Ltd. or DuPont NEN: Life 
Technologies Ltd., Auckland, New Zealand). The reaction mixture was set up 
according to the manufacturer's instructions and incubated for 2 h at 30°C. The 35S_ 
5S RNP mixture was stored at -80°C without further purification. Prior to loading 
into the microinjection needle, the 35S_5S RNP mixture was centrifuged through a 0.22 
pm filter (Ultrafree, Millipore, Bedford, MA, USA) to remove particulate matter and 
aggregates that tended to cause blockages in the needle. 
The added 5S rRNA was judged to be in approximately 10 to 20 fold excess of 
the rabbit 5S rRNA in the lysate, as determined by agarose gel electrophoresis and 
ethidium bromide staining (at 1 mg/ml) of RNA extracted from the reticulocyte lysate, 
compared with known amounts of purified 5S rRNA. Xenopus 5S rRNA added in 
excess would be likely to compete the rabbit 5S rRNA for binding to newly-
synthesised L5, thereby producing a population of oocyte-type 5S RNPs. To test for 
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the binding of Xenopus oocyte-type 5S rRNA during the translation process, 32p_5S 
rRNA (synthesised as described in Section 2.2.1) was added to the translation reaction 
in the place of unlabelled oocyte-type 5S rRNA. The presence of a band of 32P_5S 
rRNA in the same position as 35S_L5 in a gel shift assay was determined as described 
below. 
3.2.2 Microinjection and analysis of nuclear transport 
Oocytes were removed from adult Xenopus laevis and prepared for 
microinjection as described in Section 2.2.2. Stage V-VI oocytes were injected with 
50 nl of 35S-5S RNP solution and incubated at ISoC in O-R2 containing 1 pg/ml 
cycloheximide (Sigma) to inhibit the synthesis of 3sS-labelled proteins in the oocytes 
from unincorporated 3SS-methionine remaining in the lysate solution. Cycloheximide 
does not interfere with protein import in oocytes (Kambach & Mattaj, 1992). Nuclei 
were dissected in ice-cold isolation medium (S3 mM KCI, 17 mM NaCI, 10 mM Tris-
HCI, pH 7.4), and nuclear and cytoplasmic fractions were collected in microfuge tubes 
on ice (10 cytoplasms and nuclei per sample). Samples were prepared for protein 
electrophoresis by homogenisation in 250 pI isolation medium using a Gilson pipette 
tip, and the cellular debris was removed by centrifugation twice at 10 000 x g for 5 
min at 4°C, with the cleared supernatant removed to a fresh tube after each spin. The 
proteins were precipitated with 5 volumes of acetone (1250 pl) at -20°C overnight 
and collected by centrifugation at 10 000 x g for 15 min. The dried pellets were 
dissolved in 60 pl of sample buffer (2% SDS, 100 mM dithiothreitol, 60 mM Tris-
HCI, pH 6.S, 0.01 % bromophenol blue) by vigorous shaking for 1 to 2 h at room 
temperature. 
The protein samples in loading buffer were denatured by boiling for 10 min, and 
placed on ice before loading on a discontinuous 12% polyacrylamide/0.1 % SDS gel 
(Laemmli, 1970), of 20 cm in length and 0.75 mm thickness. After electrophoresis 
for 3 to 4 h at 200 V, the gel was fixed in 25% isopropanol:lO% acetic acid:3% 
glycerol for 30 min with constant agitation, followed by soaking in Amplify 
(Amersham) for 25 min. The gel was air dried overnight on a plastic gel drying 
frame with cellophane cover (Tut's Tomb, Idea Scientific Co., Minneapolis, MN, 
USA), then exposed to Hyperfilm-MP (Amersham) at -SO°C. The intensity of bands 
on the fluorographs was measured using a Zeineh analytical hand-held scanning 
densitometer and Biomed Image Analysis software (Advanced American 
Biotechnology). 
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In the experiments to compare the nuclear import of microinjected 32p_58 rRNA 
and 358_58 RNPs, the nuclear import of 32p_58 rRNA was assayed as described in 
8ection 2.2. A TP depletion and wheat germ agglutinin (WGA) treatments were also 
performed as described in 8ection 2.2. 50 n1 of 358-58 RNP solution was injected into 
the cytoplasm of each oocyte after preinjection of apyrase (grade VII, 8igma) or WGA 
(8igma). 
3.2.3 Electrophoretic mobility shift assay for SS RNPs 
To test for the binding of in vitro-synthesised ribosomal protein L5 to 58 rRNA, 
an electrophoretic mobility shift assay was performed, as described in Wormington 
(1989). 8amples from the translation reaction were loaded onto an 8% polyacrylamide 
gel and electrophoresed in TBE at room temperature for 4 h at 100 V. After 
electrophoresis, the gel was fIXed in 25% isopropanol:10% acetic acid for 30 min, and 
dried at 80DC for 2 h under vacuum, followed by autoradiography. Note that with the 
exception of the assay for 358_58 RNP stability after injection into oocytes, these RNP 
gels were not treated for fluorography. 
To verify the binding of Xenopus oocyte-type 32p_58 rRNA to in vitro-
synthesised 358_58 RNPs, two films were placed over the fixed and dried gel, 
according to the method of Pippin et al. (1994), and exposed at -80DC. This enabled 
the visualisation of the RNA-protein interaction by the presence of 32p_58 rRNA in the 
same position as 358_58 RNPs. 
For the analysis of 358_58 RNP stability within oocytes, 50 n1 of the 358_58 RNP 
mixture was cytoplasmically injected into oocytes. After overnight incubation, 10 
oocytes were pooled, and homogenised in 30 }II RNP homogenisation buffer (20 mM 
Tris, pH 7.6, 100 mM KCI, 1.5 mM MgCI2, 2 mM dithiothreitol, 0.1 mM 
phenylmethylsulphonyl fluoride, 10 U/ml RNasin [Promega]) using a Gilson pipette 
tip. Cellular debris (yolk: and pigment) was separated from the samples by 
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centrifugation at 10 000 x g for 10 min at 4°C, and the cleared supernatant was 
removed to a new tube. Glycerol-dye loading buffer (20 ruM EDTA, 5% glycerol, 
0.025% bromophenol blue, 0.025% xylene cyanol) was added to the samples prior to 
loading on the denaturing gel. 3zP_5S rRNA was run on the gel as a marker. The gel 
was divided into 3Zp and 35S portions to enable separate processing of the gels to 
. account for the different signal strengths between the two isotopes. The 3zP-containing 
gel portion was dried directly and the 35S-portion flxed for 25 min in 25% 
isopropanol: 10% acetic acid, and soaked in Amplify for a further 25 min prior to 
drying. The gel sections was exposed separately to Hyperfilm-MP at -80°C. 
3.3 Results 
3.3.1 In vitro synthesis and. characterisation of lSS-labeUed Xenopus oocyte-type 
5S rRNA-containirig 5S RNPs 
5S RNPs, with the ribosomal protein L5 component labelled with 35S_ 
methionine, were synthesised in vitro in a rabbit reticulocyte lysate-based coupled 
transcription/translation system. Initially, my aim was to produce 35S-L5 to use in 
nuclear transport assays. However, non-denaturing gel electrophoresis of the post-
translation reaction mixture revealed that most of the L5 produced was bound with 
rabbit 5S rRNA to produce 5S RNPs, as demonstrated by the slower migrating band 
indicated in Figure 3.1 A (lane 3) and 3.1 C (lane 2). This contrasts with the results 
of the study by Wormington (1989), where the in vitro translation of L5 in a wheat 
germ extract system resulted in only a small proportion (less than 25%) of the newly-
translated L5 being bound as 5S RNPs. The rabbit 5S rRNA had the potential to 
interfere with an accurate comparison between the nuclear import of the 5S RNPs and 
oocyte-type 5S rRNA injected alone. Somatic-type and oocyte-type 5S rRNAs from 
Xenopus display differential associations with 5S rRNA binding proteins (Allison et 
al., 1995), and mammalian 5S rRNA has been found to be more similar to Xenopus 
somatic-type 5S rRNA than oocyte-type (Ford & Southern, 1973). Therefore, it was 
important to either remove the rabbit 5S rRNA after translation, or provide excess 
oocyte-type 5S rRNA in the translation reaction mixture for the newly translated 35S_ 
L5 to bind to produce Xenopus oocyte-type 5S RNPs. Attempts to remove the rabbit 
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5S rRNA after translation by incubation with micrococcal nuclease (using the methods 
of Darby & Joho, 1992) were not successful, as the L5 was lost during this treatment 
(data not shown). This is probably due to the inherent instability or insolubility of L5 
when not complexed with 5S rRNA (Huber & Wool, 1986; Yeh & Lee, 1995). An 
alternative method was therefore used, to result in the production of oocyte-type 5S 
RNPs. 
In vitro transcribed Xenopus oocyte-type 5S rRNA was added to the translation 
reaction mixture programmed with pSP6-L5b, in 10 to 20 fold excess of the rabbit 5S 
rRNA. The added 5S rRNA should presumably out-compete the rabbit 5S rRNA in 
the extract for binding to the newly translated L5, producing a population of oocyte-
type 5S RNPs. While this study was in progress, a similar technique was published 
for the in vitro analysis of the binding of yeast ribosomal protein Ll to 5S rRNA (Yeh 
& Lee, 1995). To test whether the added oocyte-type 5S rRNA was binding to the 
newly transcribed L5, 32P-Iabelled 5S rRNA was added to a translation reaction. A 
sample of the reaction mixture was run on a non-denaturing gel, with unbound 32p_5S 
rRNA and 35S_5S RNPs synthesised in the absence of 32P_5S rRNA as size markers. 
The fixed and dried gel was overlaid with two X-ray ftlms, according to the method 
of Pippin et ai. (1994). 35S has a lower energy emission than 32p, and therefore the 35S 
signal will only expose the bottom film, while 32p can expose both ftlms. Thus, the 
presence of 32p_5S rRNA at the same position as the 35S-5S RNPs on the ftlm 
indicated the binding of added oocyte-type 5S rRNA to nascent L5. 
As shown in Figure 3.1 A and B, 32P_5S rRNA was detected in the translation 
reaction in the upper ftlm at the same position as the 35S-5S RNP band was detected 
in the lower ftlm (cf. lanes 2, 3, and 4). This both verifies the binding of added 5S 
rRNA to newly synthesised L5, and unambiguously identifies the shifted band as the 
location of the 5S RNPs. In vitro-generated 35S-5S RNPs microinjected in the oocyte 
cytoplasm remain stably bound as 5S RNPs in the oocyte after 18 hours of incubation 
as shown in Figure 3.1 C (cf. lanes 2 and 3-5), producing a band migrating more 
slowly than uninjected 5S rRNA (lane 1) and uninjected 35S_L5 (lane 2). The 5S RNP 
band corresponds in mobility to the L5/5S rRNA complex formed by cytoplasmically 
microinjected 32p_5S rRNA, as characterised in Allison et ai. (1995). Note that the 
slower migrating band in the lane containing 32P-5S rRNA (lane 1) only is not an 
Figure 3.1: Characterisation of in vitro-synthesised 3SS_sS RNPs. 
(A) and (B) Verification of binding of SS rRNA to 3SS-labelled ribosomal protein Ls in vitro. 3:!p_ 
labelled oocyte-type SS rRNA (lane 2), no SS rRNA (lane 3), or unlabelled SS rRNA (lane 4) was 
added to the 3sS_Ls translation reaction mixture. After non-denaturing gel electrophoresis, the gel was 
overlaid with two X-ray films. 3:!P-SS rRNA alone was run in lane 1 as a marker. The locations of 
unbound SS rRNA, unbound Ls, and SS rRNA complexed with Ls (SS RNP) are indicated. (A) 
Lower ftlm, exposed by both 3SS and 3:!p, (B) Upper film, exposed only by 3:!p, 
(C) Stability of 'SS-sS RNPs after microinjection into the cytoplasm of Xenopus oocytes. 35S-SS 
RNPs were cytoplasmically injected into oocytes. After 18 b, the oocytes were homogenised and 
electrophoresed on an 8% polyacrylamide gel. Lane 1, 3:!p_sS rRNA marker; lane 2, uninjected 35S-SS 
RNPfsS-Ls marker produced in vitro without the addition of Xenopus oocyte-type SS rRNA; lanes 3 
to 5, homogenates of 3SS-sS RNP-injected oocytes. 
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RNA-protein complex, but probably represents an artifact of the transcription process, 
where some of the 5S rRNA formed may be of a slightly different conformation or 
length. This band has been found to be reproducibly present on this type of gel (see 
also Allison et al., 1995 and this thesis, Fig. 4.4 B). The higher molecular weight 
bands in lane 2 of Fig. 3.1 A, B and C probably correspond to non-specific complexes 
. formed by interaction of 32p_5S rRNA or 35S_L5 with proteins of the reticulocyte 
lysate and the oocyte respectively. 
3.3.2 Comparison of the nuclear import kinetics of microinjected 35S_SS RNPs 
with 32P_5S rRNA 
Having established a technique for generating stable 35S-5S RNPs, I was then 
able to proceed to the analysis of their nuclear transport characteristics after 
microinjection into the oocyte cytoplasm. To assess whether the rate and extent of 
nuclear accumulation differ between 5S rRNA microinjected alone and the pre-
assembled 5S RNPs, 32P_5S rRNA and 35S-5S RNP import with time was assessed in 
parallel. If there is a prerequisite of L5 binding to 5S rRNA for nuclear import to 
take place, then the import of the pre-assembled 5S RNPs should proceed at a faster 
initial rate than 5S rRNA injected alone, as there will be a lag time for the assembly 
of 5S rRNA into transport-competent 5S RNPs. As shown in Fig. 3.2 A, 5S RNPs 
were found to accumulate in the nucleus at a greater rate than 5S rRNA. The [mal 
net extent of import was also found to be greater for 35S_5S RNPs, with a level of 
25% nuclear accumulation after 24 hours compared with approximately 8% for 32P_5S 
rRNA after this time. The same batch of oocytes was used for the nuclear transport 
assays for both 32p_5S rRNA and 35S-5S RNPs. 
As the 35S_5S RNPs microinjected in these assays for nuclear transport were not 
purified from the translation reaction mixture, it is possible that the rabbit reticulocyte 
lysate could be supplying factors that enhance nuclear transport (as suggested in 
Garcia-Bustos et al., 1991b). This could bias the results in favour of the nuclear 
accumulation of 35S_5S RNPs, when compared with 32p_5S rRNA injected unbound. 
Therefore, the effect of the reticulocyte lysate on the nuclear transport of 
microinjected 32P_5S rRNA was investigated. As shown in Fig. 3.2 B, the nuclear 
import of 32p_5S rRNA mixed with the rabbit reticulocyte lysate proceeded at the same 
Figure 3.2: Nuclear accumulation of cytoplasmically microinjected 3lp_5S rRNA 
and 35S_5S RNPs with time. 
(A) Quantitation of nuclear accumulation after microinjection into the cytoplasm. 3lp_5S rRNA or 
'SS-5S RNPs (in rabbit reticulocyte lysate) were microinjected into the oocyte cytoplasm. At various 
time points as indicated. oocytes were manually dissected. RNA or protein was extracted from 5 or 
10 pooled nuclear and cytoplasmic fractions, respectively, and separated by denaturing gel 
elecU'Ophoresis, followed by autoradiography elp·5S rRNA) or fluorography ("S-5S RNPs). The 
percentage of radioactivity in the nucleus was quantified by densitometry. The bars indicate the 
standard error of the means from three sample replicates. 
(B) 3lp_5S rRNA import is not affected by factors in the rabbit reticulocyte lysate. 3lp_5S rRNA was 
cytoplasmically microinjected into oocytes in a mixture either without (- RRL) or with (+ RRL) rabbit 
reticulocyte lysate. After 18 h incubation, nuclei were manually dissected and RNA was extracted 
from 5 pooled nuclear (N) and cytoplasmic (C) fractions. The samples were then separated by 
polyacrylamide gel elecU'Ophoresis as described above. 
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rate and to the same extent as 32P_5S rRNA injected without (cf. lanes 2 and 4). This 
figure shows an example of nuclear import after 24 hours. The same results were 
obtained when this analysis was perfonned at earlier time points (data not shown). 
Therefore, the rabbit reticulocyte lysate has no discernible effect on the nuclear 
transport process in these assays, and thus the enhanced rate of import must be due to 
the properties of the 5S RNP complex. 
3.3.3 The effect of chilling on the nuclear import of 3SS~5S RNPs 
As described in Chapter Two, chilling has been used as a criterion to establish 
whether nuclear transport of a molecule occurs via a facilitated or passive process. I 
have demonstrated that the nuclear import of microinjected 32P_5S rRNA is reversibly 
inhibited by incubation at 0-4°C (Section 2.3.3). The effect of this treatment was 
tested on the nuclear import of microinjected 35S_5S RNPs to see whether 5S RNP 
import also proceeds via this mechanism. As shown in Fig 3.3, the nuclear import of 
35S_5S RNPs was inhibited when the oocytes were incubated on ice at 0-4°C (cf. lanes 
2 and 4). This effect was reversible by subsequent incubation at 18°C (lane 6), 
indicating that the chilling blocked RNP import by inhibiting the activity of specific 
components of the nuclear transport machinery, rather than preventing import by way 
of non-specific cellular damage. Note that the sample in lanes 4 and 6 was incubated 
for a longer time at 18°C (16 hours, after 6 hours chilled) than that shown in lanes 1 
and 2 (6 hours); therefore, the greater amount of 35S-5S RNPs detectable in the 
nuclear fraction is not the result of an enhancement in nuclear accumulation, but 
reflects the nonnal kinetics of 5S RNP import (as shown in Fig. 3.2). The results of 
this chilling study provide additional evidence for the binding of 5S rRNA and L5 
during the import process, rather than an alternative and independent pathway for the 
nuclear accumulation of L5. 
3.3.4 The effect of oocyte ATP depletion on the nuclear import of 35S·5S RNPs 
For a further characterisation of the nuclear import mechanism of microinjected 
35S_5S RNPs, the ATP-dependence of the process was tested. In the absence of ATP, 
energy-dependent facilitated nuclear transport is inhibited (Newmeyer & Forbes, 1988; 
Richardson et al., 1988). Cytoplasmic ATP levels were depleted by microinjection of 
Figure 3.3: The effect of chilling on the nuclear import of 5S RNPs. 
Oocytes were injected with 35S_5S RNPs and incubated at 18°C for 6 h (lanes 1 and 2), 04°C for 
6 h (lanes 3 and 4), or 04°C for 6 h, then 18°C for 16 h (lanes 5 and 6). Nuclei were manually 
dissected and proteins were extracted by acetone precipitation from 10 pooled nuclear (N) and 
cytoplasmic (C) fractions. Samples were separated by 12% SOS-polyacrylamide gel electrophoresis, 
and the gel processed for fluorography. 
Figure 3.4: The effect of cellular ATP depletion on the nuclear import of 5S RNPs. 
Oocytes were preinjected with phosphate buffered saline as a control (+ A TP) or with the A TP 
hydrolysing enzyme apyrase (- ATP), prior to cytoplasmic microinjection of 35S_5S RNPs. After 
incubation at 18°C for 7.5 h, the assay for nuclear import was performed as descnDed in the legend 
to Fig. 3.3. C, cytoplasmic fractions; N, nuclear fractions. 
Figure 3.5: The effect of WGA on the nuclear import of SS RNPs. 
Oocytes were preinjected with phosphate buffered saline as a control (- WGA), WGA to a final 
cellular concentration of 2 mg/ml (+ WGA), or 2 mglml WGA and SO mM N-acetylglucosamine 
(WGA + GlcNAc), prior to cytoplasmic microinjection of "S-5S RNPs. After incubation at 18°C for 
18 h, the assay for nuclear import was performed as described in the legend to Fig. 3.3. C, 
cytoplasmic fractions; N, nuclear fractions. 
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the ATP hydrolysing enzyme apyrase (to a cellular concentration of 100 D/ml) as 
described in Section 2.3.4, which results in the rapid reduction of cellular ATP to 
'background' levels. After this treatment, microinjected 35S_5S RNPs were retained in 
the cytoplasm, as shown in Figure 3.4. Thus, as demonstrated for microinjected 5S 
rRNA, the process of 5S RNP import is ATP-dependent. 
3.3.5 The effect of wheat germ agglutinin on the nuclear import of 35S_5S 
RNPs 
The final treatment used to verify that a facilitated mechanism is used in the 
nuclear import of 5S RNPs was the lectin wheat germ agglutinin (WGA). WGA 
inhibits facilitated nuclear transport by binding to N-acetylglucosamine residues on 
integral nuclear pore complex proteins, as described in Section 2.1.3. I have 
determined that the nuclear import of 5S rRNA microinjected alone is inhibited by 
pre-injection of WGA, with the amount of inhibition proportional to the concentration 
of WGA injected (Section 2.3.2). Likewise, the nuclear import of 35S_5S RNPs was 
reduced in the presence of WGA (Fig. 3.5, cf. lanes 2 and 4). Co-injection of free N-
acetylglucosamine, which binds to the WGA thereby reducing its binding to the 
nuclear pore proteins, reversed the inhibitory effect of the lectin (lane 6). The process 
of nuclear accumulation of 35S_5S RNPs was less sensitive to WGA inhibition than 
3ZP-5S rRNA injected unbound, as a 20-fold higher concentration of WGA than that 
used with 32p_5S rRNA was required for approximately the same degree of nuclear 
transport inhibition (cf. Fig. 2.2). 
3.4 Discussion 
In this study I have developed a technique for the in vitro synthesis of oocyte-
type 5S rRNA-containing 35S-labelled 5S RNPs, which can be used for microinjection 
assays in Xenopus oocytes. These 5S RNPs remain stable in the oocyte environment, 
and accumulate in the nucleus via a facilitated mechanism through the nuclear pore 
complex, which is inhibited by chilling, cytoplasmic A TP depletion, and WGA. This 
technique provides a useful method for the direct analysis of RNP nuclear transport 
without relying on the assembly of the complex after microinjection of the naked 
RNA or protein. 
3.4.1 Protein binding and the compartmentalisation of 5S rRNA 
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Movement of 5S rRNA within oocytes is dependent on protein binding. 5S 
rRNA appears to exit the nucleus bound with TFIllA as 7S RNPs (Guddat et al., 
1990), and is retained in this complex in the cytoplasm awaiting a signal for nuclear 
import during ribosome biogenesis (Allison et al., 1991). TFIIIA must possess a 
nuclear localisation signal (NLS) to enable the protein to enter the nucleus, where it 
functions as a transcription factor. Therefore, the question remains as to why TFIIIA 
bound as 7S RNPs with 5S rRNA is apparently unable to undergo nuclear import. 
There are two main possibilities that account for 7S RNP retention in the cytoplasm: 
either the nuclear targeting sequence is somehow masked or inactivated by the 
conformational change brought about by binding of 5S rRNA; or 7S RNPs bind to 
non-diffusible factors, such as the cytoskeleton, that prevent their entry into the 
nuclear transport pathway. However, isolated 7S RNPs are competent for nuclear 
import in some situations, as they are capable of accumulation into isolated Xenopus 
somatic cell nuclei in an in vitro transport assay (Allison, 1989), indicating that the 
binding of 5S rRNA may not affect the nuclear targeting signaL There is also 
evidence that 7S RNPs do not bind to elements of the cytoskeleton (M. North, pers. 
comm.). Therefore, another mechanism could be the concealment of the NLS within 
the complex formed by the dimerisation of 7S RNPs, as proposed in Callaci et al. 
(1990), This is likely to result in the inability of the NLS to associate with the 
nuclear transport machinery, as it must remain in an exposed position to be active 
(Roberts et al., 1987), Masking of the NLS in 7S RNPs would ensure that 5S rRNA 
remains in storage in the cytoplasm, awaiting the signal for nuclear import and 
subsequent ribosome assembly. The results of this study provide evidence that the 
stimulus for 5S rRNA nuclear import may be due to the exchange of TFIIIA binding 
for ribosomal protein L5. 
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3.4.2 Comparison of SS rRNA and 5S RNP nuclear import 
The nuclear import of pre-assembled 58 RNPs microinjected into the oocyte 
cytoplasm proceeded at a faster rate and to a three-fold greater extent than 58 rRNA 
microinjected alone, suggesting that L5 binding is the fIrst step in nuclear targeting. 
This result correlates with a previous study where the nuclear import of 
cytoplasmically injected oocyte-type and somatic-type 58 rRNAs was compared 
(Allison et al., 1995). 80matic-type 58 rRNA had the same import profile as 58 
RNPs, reflecting the fact that somatic-type 58 rRNA preferentially binds L5 in vivo, 
whereas oocyte-type preferentially binds TFIIIA (Allison et al., 1995). The difference 
in the rate and extent of nuclear import between 58 rRNA injected alone and 58 RNPs 
could be due to the fact that the majority of injected 58 rRNA binds with TFIIIA and 
is retained in the cytoplasm, whereas the pre-assembled 58 RNPs are competent to 
enter the pathway of nuclear import. Therefore, the nuclear import of 58 rRNA 
injected alone is restricted by its limited ability to bind L5. The fact that the nuclear 
accumulation of 58 rRNA does not reach the levels of the pre-assembled 58 RNP 
after 24 hours, probably reflects the great capacity for this RNA to form storage 78 
RNPs in preference over binding to L5. 
Alternative interpretations can also be made for why there is greater nuclear 
accumulation of 58 RNPs when compared with 58 rRNA. It is possible that L5 is 
capable of nuclear import independent of binding to 58 rRNA, as must be the case in 
mammalian somatic cells where there is no significant cytoplasmic pool of 58 rRNA 
to which L5 could bind (8teitz et al., 1988). In this case, 58 RNP formation occurs in 
the nucleoplasm, followed by targeting to the nucleolus. The L5 component of the 
microinjected 58 RNPs could therefore enter the nucleus by a different, more efficient 
pathway of nuclear import. However, this is not likely to be the case in these assays, 
as the microinjected 58 RNPs were found to remain intact within the oocyte. 
Another explanation for the differential import proflles of 58 rRNA and 58 
RNPs is that the nuclear accumulation of labelled 58 rRNA may reflect both the 
import of the RNA as 58 RNPs and its subsequent export bound to TFIlIA, in the 
same time frame that labelled L5 (either bound with 58 rRNA or not) is retained in 
the nucleus. It has been proposed that excess 58 rRNA in the nucleus may be 
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targeted to the cytoplasm of mammalian somatic cells for degradation bound to a 
TFllIA-like protein (Lagaye et al., 1988). Similarly, 5S rRNA present in the oocyte 
nucleus in excess of requirements for ribosome assembly may be exported for storage. 
Furthermore, the study of Allison et al. (1993) found that cytoplasmically injected 
labelled 5S rRNA does appear in 7S RNPs in the nucleus, indicating that imported 5S 
rRNA may form 7 S RNPs. In this scenario, L5 would be retained in the nucleus even 
if the 5S rRNA with which it has been imported dissociates from it. Nuclear retention 
of L5 could occur by binding to elements such as ribosomal proteins, rRNAs or other 
components of the nucleolus, as appears to be the case for U3 snoRNA (Terns et al., 
1995). L5 could also be held in the nucleus by the lack of a positively acting nuclear 
export signal on the molecule. This model could account for part of the differential 
accumulation of 5S rRNA and 5S RNPs, but it is likely that this phenomenon can be 
largely explained at the initial steps of the nuclear import process, with oocyte-type 5S 
rRNA nuclear accumulation controlled by its preferential binding to TFIIIA. 
3.4.3 Facilitated transport of 58 RNPs 
As previously demonstrated for 32p_5S rRNA (see Chapter Two), 35S-labelled 5S 
RNP import is inhibited by cytoplasmic A TP depletion, chilling, and WGA. This 
supplies evidence that L5/5S RNP import occurs via a facilitated process through the 
nuclear pore complex. A requirement for metabolic energy has also been reported for 
the nuclear transport of other RNPs; such as, nuclear import of the U snRNPs 
(Michaud & Goldfarb, 1992; Fischer et al., 1991) and the export of ribosomal subunits 
(Bataille et al., 1990). 
The concentration of WGA required to maximally inhibit 35S_5S RNP import 
was approximately 20-fold higher than that which was previously demonstrated to 
inhibit 32p_5S rRNA import to the same extent (Chapter Two). This type of 
differential inhibition of import with WGA has been previously observed in 
comparisons between karyophiles (Fischer et al., 1991; Michaud & Goldfarb, 1992; 
1993; Marshallsay & LOhrmann, 1994); however, the mechanism operating has yet to 
be elucidated. This differential sensitivity may appear contradictory to the proposal 
that 5S rRNA moves into the nucleus bound with L5 as 5S RNPs, as the WGA 
sensitivity of the import process should be the same whether it is the RNA or the 
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protein that is tagged during the assay. An explanation for the different concentrations 
of WGA required to inhibit nuclear import of 58 rRNA and 58 RNPs could be the 
presence of WGA-binding factors in the reticulocyte lysate component of the 358_58 
RNP mixture. A pool of proteins that possess O-linked N-acetylglucosamine residues 
that are not associated with the NPC has been identified (Holt & Hart, 1986; Hart et 
al., 1989). Therefore, these factors in the lysate could titrate out the WGA and make 
less available for binding at the oocyte nuclear pore complex; hence the requirement 
for a higher concentration to overcome this effect. It is also possible that a small 
proportion of L5 is dissociating from the microinjected 58 RNPs and entering the 
nucleus via a different, less WGA-sensitive pathway than 58 rRNN58 RNPs. As 
previously discussed, L5 must have a mechanism of moving into the nucleus 
independent of binding to 58 rRNA in somatic cells. However, I think: that this is 
unlikely to explain the situation in the assays described here, as in vitro-synthesised 
58 RNPs remain stable after injection into oocytes. 
3.4.4 Summary 
8pecific interactions of RNA molecules with proteins in RNPs play a vital role 
in the regulation of the nucleo-cytoplasmic distribution of RNA, including the nuclear 
transport of 58 rRNA in Xenopus oocytes. Binding to L5 appears to be a prerequisite 
for nuclear accumulation of 58 rRNA after its storage in the cytoplasm; thus, the 
ability of L5 to exchange for TFIllA binding on the 58 rRNA molecule regulates in 
part the process of nuclear import. The results of this study further emphasise the 
specialised nature of oocyte-type 58 rRNA and the importance of its differential 
interaction with the proteins TFIIIA and L5 during oogenesis. 
Chapter Four details further investigation into the role of L5 in 58 rRNA nuclear 
accumulation, and discusses whether L5 provides an active nuclear targeting signal for 
58 rRNA. 
Chapter Four 
Comparison of the 5S rRNA Nuclear Transport 
Pathway with that of Other Molecules 
4.1 Introduction 
Nucleo-cytoplasmic transport of molecules and complexes can be described as 
occurring by different transport pathways, depending on their interaction with 
intermediates in the nuclear transport process. In this fmal part of my study on 58 
rRNA nuclear import in Xenopus oocytes, a comparison has been made between the 
import pathway for this molecule and that of other molecules that undergo transport to 
the nucleus. 
4.1.1 The saturability of nuclear transport processes 
The facilitated nuclear import and export of proteins and RNAslRNPs involves 
interactions with factors that are present in limiting amounts within the cytoplasm and 
nucleus (reviewed by Powers & Forbes, 1994~ Adam, 1995~ 8imos & Hurt, 1995), as 
well as the proteins of the nuclear pore complex (NPC; reviewed by Forbes, 1992; 
Pante & Aebi, 1993; 1994; Fabre & Hurt, 1994; Hinshaw, 1994; Rout & Wente, 
1994). Therefore, the process of nucleocytoplasmic transport is saturable when the 
sites for molecular interaction on these nuclear transport factors are exhausted. This 
saturation effect is demonstrated by the reduction in the rate of transport of the 
molecule concurrent with an increase in its cellular concentration. By this criterion, a 
saturable transport process has been demonstrated in Xenopus oocytes for the nuclear 
export of tRNA (Zasloff, 1983),408 and 608 ribosomal subunits (Khanna-Gupta & 
Ware, 1989; Bataille et al., 1990), mRNA (Dargemont & Kuhn, 1992), Ul snRNA 
(Jarmolowski et ai., 1994), and signal recognition particle RNA (He et aI., 1994), as 
well as for the nuclear import of karyophilic proteins (Goldfarb et al., 1986). 
Further analysis of mediated nuclear transport of proteins and RNAsJRNPs has 
identified the components of the transported molecule/complex responsible for the 
rate-limiting interactions. The association of the nuclear localisation signal (NL8) 
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with components of the nuclear transport machinery appears to be a limiting element 
in protein nuclear transport, as the presence of the prototypical NLS of the SV 40 T 
antigen inhibits the nuclear import of labelled nuclear proteins (Michaud & Goldfarb, 
1991; 1992; 1993). In addition, the rate of nuclear import of Ul, U2, U4 and U5 
snRNPs in Xenopus oocytes has been found to be reduced in the presence of the free 
trimethylguanosine cap dinucleotide (m3GpppG), demonstrating that this process is 
saturable due to the interaction of the 5' cap structure of the RNA with factors 
involved in nuclear import (Fischer et al., 1991; Michaud & Goldfarb, 1992). The 
nuclear export of mRNA and Ul, U2 and U5 snRNAs is also dependent on the 
structure at the 5' end of the molecule, as the transport process is inhibited by excess 
monomethylguanosine cap (Dargemont & Kuhn, 1992; Iarmolowski et al., 1994). 
The specific factors or receptors responsible for the limiting steps in nuclear 
transport are yet to be identified; however, many candidate molecules have recently 
been isolated (summarised in Section 1.5; and by Powers & Forbes, 1994; Simos & 
Hurt, 1995). The saturable component of the protein import pathway is likely to be 
part of the nuclear pore targeting complex, with which the protein must bind prior to 
its association with the NPC (lmamoto et al., 1995a,b,c). A lack of available NLS 
receptors (of the importin-a/karyopherin-a-type; Adam & Gerace, 1991; Enenkel et 
al., 1995; Gorlich et al., 1994; 1995a,b; Imamoto et al., 1995b; Moroianu et al., 
1995a,b; Radu et al., 1995a,b; Weis et al., 1995) would prevent the karyophilic 
protein docking at the nuclear pore and prevent its subsequent interaction with the 
NPC and nuclear import. 
The monomethylguanosine cap-dependence of Ul, U2 and U5 snRNA nuclear 
export is probably mediated via the cap binding proteins CBP20 and CBP80 
(Izaurralde et al., 1995), and the trimethylguanosine cap requirement for UI, U2, U4 
and U5 snRNA/RNP nuclear import in Xenopus oocytes is probably communicated 
through the binding of a protein analogous to CBP20 and CBP80. A soluble oocyte 
cytosolic factor, which could be a cap binding protein, has been found to be required 
for the trimethylguanosine cap-dependent import of Ul and U2 snRNPs (Marshallsay 
& Luhrmann, 1994). CBP80 has been found to directly interact with the human NLS-
receptor hSRPla (Weis et al., 1995), providing evidence that cap-binding proteins 
also require a receptor analogous to those required for protein import. However, this 
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NLS-receptor may be the product of a different member of the SRPI gene family than 
that involved in the pathway of import or export taken by 'typical' karyophilic 
proteins (Adam, 1995; Weis et al., 1995). 
4.1.2 Comparisons of nuclear transport pathways for different molecules 
The analysis of limiting components of nuclear transport pathways has been 
extended to provide a comparison between the mechanism of transport of different 
types of karyophiles. Inhibition of the nuclear transport of a labelled molecule in the 
presence of an excess of another unlabelled karyophile demonstrates the utilisation of 
at least one common nuclear transport intermediate. Microinjection assays of this type 
in Xenopus oocytes have resulted in the grouping of nuclear proteins and the snRNAs 
into three classes of nuclear import pathway (Fischer et al., 1991; Michaud & 
Goldfarb, .1991, 1992), and have determined that the nuclear export of RNAs occurs 
via different pathways (Jarinolowski et al., 1994). A summary of the nuclear transport 
competition studies to date is provided in Table 4.1. 
Synthetic proteins containing the SV40 large T antigen NLS have been used as 
prototypical karyophilic proteins in comparative studies of nuclear import (Michaud & 
Goldfarb, 1991; 1992; 1993; van Zee et al., 1993; Gulizia et al., 1994). The presence 
of the T antigen NLS inhibits the nuclear import of Xenopus nucleoplasmin and a 
group of labelled Xenopus nuclear proteins (Michaud & Goldfarb, 1992; 1993), as 
well as the preintegration complex of HIV-l in human cultured cells (Guilzia et al., 
1994; Stevenson, 1994), adenovirus EIA protein in cultured monkey cells (van Zee et 
al., 1993), and Xenopus U6 snRNA (Michaud & Goldfarb, 1992). However, this 
signal does not compete the import of Xenopus Ul to U5 snRNAs, indicating that 
these RNAs are imported into the nucleus via an alternative pathway that involves 
association with different factors (Michaud & Goldfarb, 1991, 1992). 
The saturable factors involved in the nucleocytoplasmic transport of RNAs/RNPs 
appear to be varied and specialised for particular RNA types. The import of U3 and 
U6 snRNAsIRNPs differ from Ul, U2, U4 and U5 snRNAsIRNPs (Michaud & 
Goldfarb, 1992). Ul, U2, U4 and U5 snRNA/RNP nuclear import can be competed 
by a free trimethylguanosine cap nucleotide, but not the SV 40 T antigen NLS. U3 
Table 4.1 Comparison of nuclear transport pathways by competition 
Competitor Competes the transport of: Direction Reference 
of 
SV40 T antigen Xenopus nucleoplasmin 
NLS and 'most' Xenopus 
nuclear proteins 
m3GpppN 
capping 
nucleotide 
tRNA 
m7GpppG 
capping 
nucleotide 
HIV-l Rev 
activation 
domain 
Xenopus V6 snRNP 
HIV-l preintegration 
complex 
adenovirus EIA 
. Xenopus VI, V2, V4 and 
V5 snRNPs (in oocytes) 
mRNA 
Xenopus VI, V2 and V5 
snRNAs 
mRNA 
5S rRNA 
V snRNAs 
transport 
import 
import 
export 
export 
export 
Michaud & Goldfarb, 1993 
Michaud & Goldfarb, 1991 
Stevenson, 1994 
van Zee et al., 1993 
Fischer et al., 1991 
Michaud & Goldfarb, 1992 
Dargemont & Kuhn, 1992 
Jarmolowski et al., 1994 
Pokrywka & Goldfarb, 1995 
Jarmolowski et al., 1994 
Dargemont & Kuhn, 1992 
Fischer et al., 1995 
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small nucleolar RNA (snoRNA) nuclear import is competed by neither the capping 
nucleotide nor the SV40 NLS, while the RNA polymerase III-transcribed V6 snRNA 
differs from the RNA polymerase II-transcribed VI to VS snRNAs in that its import is 
saturable in the presence of the protein NLS. Therefore, three distinct targeting 
pathways exist for the nuclear import of VI to V6 snRNA. 
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Comparative analysis has also been perfonned for the nuclear export of tRNA, 
mRNA, U snRNA and rRNA (Dargemont & Kuhn, 1992; Jarmolowski et al., 1994; 
Pokrywka & Goldfarb, 1995). The export of mRNA, U snRNAs and 40S ribosomal 
subunits is mediated by specific factors; in that their transport processes are self-
inhibited at saturating levels, but are not competed by the other RNAs (Jarmolowski et 
al., 1994; Pokrywka & Goldfarb, 1995). However, tRNA appears to have general 
competitive effects on the nuclear export of all RNAs, suggesting that it shares some 
common steps in RNA export (Dargemont & Kuhn, 1992; Jarmolowski et al., 1994; 
Pokrywka & Goldfarb, 1995). In contrast, saturating levels of 40S ribosomal subunits 
are able to stimulate tRNA export (Pokrywka & Goldfarb, 1995). This result implies 
the existence of intranuclear RNA binding sites which can be exhausted by the 
binding of ribosomal subunits, thereby releasing tRNA for nuclear export. 
The Rev protein of the HIV-l virus, which is responsible for the nuclear export 
of viral pre-mRNAs and RNAs containing the Rev binding site, also possesses a 
domain that interacts with factors involved in nuclear export (Fischer et al., 1995). 
Furthennore, the presence of this activation domain conjugated to the non-nuclear 
protein bovine serum albumin (BSA), strongly inhibited the export of both U snRNAs 
and 5S rRNA (Fischer et al., 1995), which have previously been found to exit the 
nucleus via independent pathways (Jarmolowski et al., 1994). The interpretation of 
these results is that both U snRNAs and 5S rRNA bind proteins that are functionally 
equivalent to Rev, that subsequently interact with the same nuclear export factor 
(Fischer et al., 1995). It should also be noted that Jarmolowski et al. (1994) were 
unable to saturate the 5S rRNA export pathway in their experiments, and therefore the 
common factor(s) between U snRNA and 5S rRNA export may not have been 
detectable. Interestingly, TFIIIA, the protein likely to be involved in 5S rRNA export 
(Guddat et al., 1990), possesses a sequence with high homology to the Rev activation 
domain which may be responsible for the interaction with the factor saturated by Rev 
(Fischer et al., 1995). 
4.1.3 Comparison of the pathway for SS rRNA nuclear import with other 
molecules 
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The coordinated nuclear transport of different molecules required for the same or 
related processes, such as the proteins and RNAs that comprise ribosomes, could be 
achieved via the utilisation of the same pathway of molecular interactions for all the 
transported molecules. In terms of the present study, it was interesting to determine 
whether nuclear import of 58 rRNA/RNP, a nucleolar-targeted ribosomal component, 
utilises any of the previously identified pathways of nuclear transport: that in common 
with most nuclear proteins, or those more specific mechanisms of U1 snRNA or U3 
snoRNA. The process of 58 RNP import could be via a protein-like mechanism, with 
L5 providing the dominant signal, or it could be imported by some type of small 
RNA/RNP mechanism, with the RNA potentially playing a role in the process. 
One of the 'competitor' RNAs used in this study was U3 snoRNA, a nucleolar 
RNA which has a role in 188-5.88-288 rRNA processing (for review see: Maxwell & 
Fournier, 1995). In most cells, U3 snoRNA is synthesised in the nucleus by RNA 
polymerase II and moves to the nucleolus without any journey into the cytoplasm 
(Terns & Dahlberg, 1994; Terns et ai., 1995). However, U3 snoRNA does possess the 
means to enter the nucleus in oocytes; the NL8 of U3 snoRNA is dictated largely by a 
structural motif at the 3' terminal stem, and does not require cap trimethylation or 
binding of 8m proteins (Baserga et al., 1992; Michaud & Goldfarb, 1992). These 
requirements for U3 snoRNA import suggest that a specific nuclear transport pathway 
has evolved for this molecule, that may be utilised at different stages of cell 
development when U3 snoRNA undergoes a journey into the cytoplasm with 
subsequent import back into the nucleus. For example, during the differentiation of 
rat myoblasts to myotubules, there is a shift in the cellular distribution of U3 snoRNA 
from exclusively nuclear to accumulation in the cytoplasm (Glibetic et al., 1992), 
suggesting that U3 snoRNA may possess a means to re-enter the nucleus if required at 
a later stage of differentiation. 
Because of the nucleolar nature of U3 snoRNA, and its association with 188-
5.88-288 rRNA, it was of interest to determine whether the pathway of nuclear import 
for U3 snoRNA utilises saturable factors in common with 58 rRNA. Localisation of 
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proteins to the nucleolus is a process that does not appear to be dependent on specific 
nucleolar targeting sequences, but is related to nuclear import and subsequent binding 
to rRNA or rDNA at the nucleolus (Dang & Lee, 1989; MeBmer & Dreyer, 1993; 
Schmidt-Zachmann & Nigg, 1993). Therefore, it is possible that the nucleolar 
localisation of U3 snoRNA and 5S rRNN5S RNPs may occur via the utilisation of 
the same nuclear transport pathway. Alternatively, 5S rRNN5S RNP import may be 
coordinated with other ribosomal proteins by using the same karyophilic protein-type 
nuclear import factors or may involve interactions with the same intermediates as Ul 
snRNA, as has been demonstrated for its export from the nucleus (Fischer et al., 
1995). 
4.2 Materials and Methods 
4.2.1 Plasmids and proteins used in this study 
The Ul snRNA gene template (Hamm et al., 1987) was provided by Dr D.S. 
Goldfarb (University of Rochester, Rochester, New York, USA). For transcription, it 
was linearlsed with Bam HI (Boehringer Mannheim). The U3 snoRNA gene template 
(pXIU3A'; Savino et al., 1992) was provided by Dr S. Gerbi (Brown University, 
Providence, Rhode Island, USA). The template used for transcription of U3 snoRNA 
was produced by M. Ezrokhi (Brown University), using PCR as described in Terns 
and Dahlberg (1994). The template contains the T7 promoter, and produces U3 
snoRNA with five extra nucleotides at the 3' end (3'-UUUUA), which enhances the in 
vivo stability of the transcript. P(lys)-BSA made from RNase-free BSA was prepared 
by K. Reynolds (University of Rochester), as described in Michaud and Goldfarb 
(1991). 
4.2.2 High-yield synthesis of RNA 
Synthesis of unlabelled 5S, Ul and U3 templates was performed in vitro using 
the Ampliscribe reaction kit (Epic entre Technologies, Madison, WI, USA) according 
to the manufacturer's instructions. Each reaction contained 1 pg DNA template, and 
was incubated for 2 h at 37°C. For the production of m7G-capped RNA transcripts, 
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necessary for the stability of U1 snRNA and U3 snoRNA in the oocyte, 
m7G(5')ppp(5')G capping nucleotide (New England Biolabs, Beverly, MA, USA) was 
added to 3 mM, with a ten-fold reduction in the amount of GTP (0.75 mM). The 
monomethylguanosine cap on in vitro-synthesised Ul snRNA has been found to be 
efficiently hypermethylated and assembled into nuclear import-competent U1 snRNPs 
after microinjection into oocytes (Fischer & Liihrmann, 1990). 
RNAs were purified as described in Chapter Two (Section 2.2.1) for 32P-Iabelled 
5S rRNA, and quantified by spectrophotometry at 260 nm. The typical yield was 180 
to 200 p,g of RNA per reaction. To ensure that the transcripts were of the correct size 
and undegraded prior to injection, samples were visualised by electrophoresis on 8% 
polyacrylamide/8M urea gels followed by ethidium bromide staining. The RNAs were 
dissolved in TE (10mM Tris-HCI, pH 7.6, 1mM EDTA) at a concentration of 10 to 20 
p,g/p,l and stored at -80°C. The RNAs were all soluble at such a high concentration 
due to their small size: 41 kD for 5S RNA (121 nt), 56 kD for U1 snRNA (165 nt), 
and 75 kD for U3 snoRNA (220 nt). 
32p_5S rRNA used in these assays was synthesised in vitro as described in 
Section 2.2. Capped 32p_U3 snoRNA was synthesised from the U3 snoRNA template 
in the same manner in the presence of 400 pM capping nucleotide. 
4.2.3 Preparation of RNA from oocytes and liquid scintillation counting 
Microinjections and incubation of oocytes was performed as described in Section 
2.2. Mter incubation for various times following co-injection of 32p_5S rRNA and 
'competitor', nuclei were manually dissected out of oocytes and RNA extracted from 
five pooled nuclear and cytoplasmic fractions as described in Section 2.2. To quantify 
sample radioactivity, the extracted RNA was dissolved in 50 p,l TE, pH 7.6 and added 
to 2 ml of Biodegradable Counting Scintillant (BCS!, Amersham) in 6 ml glass 
scintillation vials (Wheatman Scientific, Millville, NJ, USA) for liquid scintillation 
counting. Sample radioactivity was measured over 15 minutes in a Wallac 1410 
liquid scintillation counter (Pharmacia) on the 32p channel. Background was obtained 
by counting RNA extracted from uninjected oocytes or TE alone, with both giving the 
same measurements. 
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The fonnation of 32p_SS rRNA-containing RNPs within the oocyte was verified 
by non-denaturing gel electrophoresis of oocyte homogenates. Oocytes were injected 
with 20 nl 32P_SS rRNA. After incubation at 18°C for 18-26 h, five whole oocytes 
were homogenised in 30 pI RNP homogenisation buffer (see Section 3.2) using a 
Gilson pipette tip, and centrifuged at 10 000 x g for 10 min at 4°C. One tenth of the 
sample volume of glycerol dye loading buffer (see Section 3.2) was added to the clear 
supernatant, which was then loaded onto a 6% polyacrylamide gel containing 0.1 % 
Triton X-loo. The gel was run at room temperature in TBE with 0.1% Triton X-IOO 
for 1.S hours, dried for 2 h at 80°C under vacuum, and exposed to X-ray fIlm at 
-80°C. 
4.3 Results 
4.3.1 The saturability of SS rRNA nuclear transport 
To establish whether SS rRNA nuclear import is a saturable process that 
involves interactions with intermediates in the transport pathway, approximately 0.01 
to 0.02 pmoles of 32p_SS rRNA per oocyte was microinjected into the cytoplasm in the 
presence of 'excess' unlabelled SS rRNA. The presence of saturating levels of SS 
rRNA should reduce its rate of import, as detected by a reduction in 32p_SS rRNA 
present in the nucleus compared with that injected in the absence of competitor. 
Indeed, this was found to be the case. As shown in Fig. 4.1, the rate of nuclear 
accumulation of 32p_SS rRNA was markedly reduced in the presence of unlabelled SS 
rRNA (+ SS rRNA) at 7.S pmoles per oocyte, with 3% nuclear after 24 hours in the 
presence of unlabelled SS rRNA as opposed to approximately 8% with no competitor. 
Repetitions of this assay with variation in the amount of unlabelled SS rRNA added 
established that consistent import competition occurred only at concentrations of S 
pmole or more per oocyte (resulting in an approximately 2Soo-fold excess over the 
32P_SS rRNA; data not shown). The results of this assay demonstrate that SS rRNA 
nuclear transport is mediated by saturable transport intermediates. 
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Figure 4.1: The saturability of SS rRNA nuclear import. 
32p_SS rRNA was injected into the oocyte cytoplasm in the presence of unlabelled SS rRNA at a 
concentration of 7.S pmoles per oocyte (+ SS rRNA), or with no unlabelled SS rRNA (No Competitor). 
At various time points, oocytes were manually dissected and RNA was extracted from five pooled nuclear 
and cytoplasmic fractions for each sample. The percentage of radioactivity in the nucleus was quantified 
by liquid scintillation counting. Each point represents the mean from three sample replicates, with the bars 
indicating the standard error of the means. 
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Given this evidence for the presence of limiting factors in the 5S rRNA nuclear 
import pathway, it was of interest to detennine whether other karyophilic molecules 
utilise the same components. For studies using heterologous RNAs, 5S rRNA self-
competition was used as a positive control for the saturability of the transport process 
in all batches of oocytes, regardless of the rate and net extent of import. Note that 
32p-5S rRNA nuclear accumulation in the absence of competitor varied between 
batches, presumably due to slight differences in age and developmental stage (see also 
Fig. 2.1 for comparison). This variability has also been reported for the export of 5S 
rRNA after microinjection into oocyte nuclei (Fischer et al., 1995). 
4.3.2 The effect of U1 snRNA on 5S rRNA nuclear transport 
The nuclear import of Ul snRNA/RNPs has been found to occur via a saturable 
process (Fischer et al., 1991; Michaud & Goldfarb, 1991; 1992). To test whether 5S 
rRNN5S RNPs utilise the same limiting component(s) during nuclear import as Ul 
snRNPs, Ul snRNA was microinjected with 32P_5S rRNA at the same concentration 
(7.5 pmoles per oocyte) as that used for the self-competition experiments. The 
presence of 'excess' unlabelled Ul snRNA had no effect on the rate of nuclear 
accumulation of 32P_5S rRNA, as shown in Fig. 4.2 (+ Ul RNA), demonstrating that 
Ul snRNA and 5S rRNN5S RNPs are imported into the nucleus via different 
transport pathways. 
4.3.3 The effect of U3 snoRNA on 5S rRNA nuclear transport 
Although U3 snoRNA moves into the oocyte nucleus after cytoplasmic 
microinjection (Baserga et al., 1992), it does not 'naturally' appear to undergo nuclear 
import in oocytes (Terns & Dahlberg, 1994; Terns, 1995). Therefore, it was important 
in these assays to assess whether cytoplasmically microinjected U3 snoRNA was being 
imported by a mediated process that would indicate a specific nuclear transport 
pathway. That is, U3 snoRNA must be able to compete its own import for the 32P-5S 
rRNA competition assay to be valid. 32P_U3 snoRNA was microinjected into oocytes 
in the presence and absence of 'competitor' unlabelled U3 snoRNA (at 7.5 pmoles per 
oocyte) and nuclear accumulation was measured over time. As shown in Fig. 4.3A, 
32P_U3 snoRNA nuclear transport was reduced in the presence of U3 snoRNA, with 
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Figure 4.2: SS rRNA import in the presence of Ui snRNA. 
32p-SS rRNA was injected into the oocyte cytoplasm with unlabelled Ul snRNA at a concentration of 7.S 
pmoles per oocyte (+ Ul snRNA), with unlabelled SS rRNA (+ SS rRNA) or no competing RNA (No 
Competitor) as controls. The assay for nuclear import was perfonned as described in the legend to Fig. 
4.1. The bars indicate the standard error of the means for three sample replicates. 
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6% nuclear after 27 hours (+ U3 snoRNA) as opposed to 11 % in the absence of 
competitor (No Competitor). Therefore, the nuclear import of U3 snoRNA occurs via 
a saturable, mediated process. 
To test whether 5S rRNA nuclear import utilises the same limiting factors in its 
nuclear transport pathway as U3 snoRNA, 32P_5S rRNA import was assayed in the 
presence and absence of U3 snoRNA. The presence of U3 snoRNA at 7.5 pmoles per 
oocyte had no effect on the nuclear accumulation of 32p_5S rRNA, as shown in Fig. 
4.3B. Therefore, 5S rRNN5S RNP nuclear import does not proceed via the same 
saturable factors as this other nucleolar molecule. 
4.3.4 The effect of the SV 40 large T antigen nuclear localisation signal on 
5S rRNA nuclear transport 
The final treatment used in this comparative study of nuclear import was P(1ys)-
BSA. P(lys)-BSA is a synthetic protein formed by the conjugation of multiple copies 
of the minimal SV40 T antigen NLS to BSA (Michaud & Goldfarb, 1991). The use 
of this molecule enabled a comparison to be made between the pathway of nuclear 
import used by most nuclear proteins, and that of 5S rRNA. In contrast to the results 
with Ul snRNA and U3 snoRNA, the rate of nuclear import of 32P-5S rRNA in the 
presence of 15 pM P(lys)-BSA was significantly reduced when compared with import 
in the presence of BSA to the same concentration (Fig. 4.4A). 5S rRNA nuclear 
accumulation was reduced from 16% when coinjected with BSA only, to 2% in the 
presence of P(lys)-BSA. P(lys)-BSA has the potential to alter RNA-protein 
interactions, thus inhibiting RNP formation (Michaud & Goldfarb, 1992). Inhibition 
of 5S rRNA binding to L5 could account for a reduction in import, by preventing the 
formation of the putative transport competent form of 5S rRNA. Therefore, the effect 
of P(lys)-BSA on the formation of 5S RNPs within the oocyte was tested. As shown 
in Fig. 4.4B, the extent of 5S RNP (and 7S RNP) formation was the same regardless 
of the concentration of P(lys)-BSA within the oocyte. 
Figure 4.3: SS rRNA impon in the presence of U3 snoRNA. 
(A) The satmability of 32p·U3 snoRNA nuclear impon. 32p·U3 snoRNA was microinjected into the 
oocyte cytoplasm in the presence of unlabelled U3 snoRNA to a fmal concentration of 7.S pmoles per 
oocyte (+ U3 snoRNA), or with no unlabelled (No Competitor). At various time points as indicated, 
RNA was extracted from five pooled nuclear and cytoplasmic fractions, and the percentage of 
radioactivity in the nucleus quantified by liquid scintillation counting. The bars indicate the standard 
error of the means from three replicate samples. 
(B) Quantitation of nuclear accumulation of SS rRNA in the presence of U3 snoRNA. 32p·SS rRNA 
was microinjected into the oocyte cytoplasm in the presence of unlabelled U3 snoRNA to a final 
concentration of 7.5 pmole per oocyte (+ U3 snoRNA). or with SS rRNA (+ SS rRNA) or no added 
unlabelled RNA (No Competitor) for comparison. Nuclear accumulation with time was analysed as 
described in (A). 
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Figure 4.4: 5S rRNA import in the presence of P(1ys)-BSA. 
(A) Quantitation of nuclear accumuJation in the presence of P(1ys)-BSA. 32p_5S rRNA was 
microinjected into the oocyte cytoplasm with P(lys)-BSA (the minimal SV40 T antigen NLS conpled 
to bovine serum albumin) to a final cellular concentration of 15 pM, or BSA (at the same 
concentration) as a control. Samples were analysed as described in the legend to Fig. 4.3. 
(D) Formation of 32p-5S rRNA-containing RNPs in the presence of P(lys)-BSA. 32p-5S rRNA was 
injected into the oocyte cytoplasm in the presence of 15 pM BSA (lane 2) or P(lys)-BSA (lane 3). 
After incubation at 18°C for 18 h, oocytes were homogenised and run on a non-denatnring 6% 
polyacrylamide gel containing 0.1 % Triton X-l00. A marker of uninjected 32p_5S rRNA is shown in 
lane 1. The band migrating more slowly than 5S rRNA in lane 1 probably reflects an artifact of the 
transcription process, resulting in an RNA of different conformation· or length. This band is 
reproducibly present on non-denatnring gels (see Fig. 3.1 and Allison et a1., 1993). 
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4.4 Discussion 
The results presented in this chapter demonstrate that the pathway of nuclear 
import of 5S rRNN5S RNPs involves interactions with receptors that can also bind 
karyophilic proteins, but does not have saturable components in common with either 
Ul snRNA or U3 snoRNA. Therefore, unlike these other RNPs, 5S rRNN5S RNP 
nuclear transport follows a pathway similar to most nuclear proteins. The nuclear 
import of two other RNPs, the HIV -1 preintegration complex in growth-arrested cells 
(Stevenson, 1994), and U6 snRNP in Xenopus oocytes (Michaud & Goldfarb, 1992), is 
also competed by the SV40 T-antigen NLS. 
4.4.1 Requirements for saturation of the SS rRNA/SS RNP import pathway 
In these experiments, saturation of the 5S rRNA nuclear import pathway was 
only achieved with a high concentration of competitor 5S rRNA (7.5 pmoles per 
oocyte compared to approximately 0.002 pmoles of 32p-5S rRNA). In a previous 
study, the process of 5S rRNA nuclear export was not able to be inhibited by up to 5 
pmole of competitor 5S rRNA per oocyte, whereas microinjection of 2.5 pmole of 
unlabelled Ul snRNA per oocyte was sufficient to completely suppress the export of 
labelled Ul snRNA (Jarmolowski et al. 1994). The nuclear export of labelled mRNA 
and tRNA is also self-inhibited in the presence of competitor at 5 pmole or less 
(Jarmolowski et al., 1994). The difficulty in saturating 5S rRNA nuclear transport can 
be explained by the potential of microinjected oocyte-type 5S rRNA to form 
associations with either TFIIIA or L5. which signal either nuclear or cytoplasmic 
localisation. 
Oocyte-type 5S rRNA differs from the other RNAs for which nuclear transport 
pathways have been studied, in that its distribution between nucleus and cytoplasm is 
the result of two processes: cytoplasmic storage and nuclear accumulation for 
ribosome assembly. Thus, 5S rRNA microinjected into either the nuclear or 
cytoplasmic compartments of oocytes can be involved in interactions leading to either 
of these two situations. It is possible in the case of nuclear import that most of the 5S 
rRNA injected is forming storage 7S RNPs in the cytoplasm. and is consequently 
unable to undergo nuclear import (Allison et al .• 1995); therefore. a high amount of 
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competitor oocyte-type 58 rRNA is required to produce enough 58 RNPs to bind to 
nuclear transport receptors and reduce the rate of nuclear accumulation. This scenario 
can also be related to the export process, with a requirement for enough export-
competent RNPs (78 RNPs) to be formed before there can be any competition effect. 
Furthermore, some of the 58 rRNA in the nucleus is being assembled into 608 
. subunits at the nucleolus prior to export, and this would also reduce the potential for 
interaction with the nuclear export machinery. 
It is also possible that 58 rRNA import and export occur via pathways that are 
more general than those utilised by other RNAs. A general pathway would 
presumably have transport intermediates at a higher concentration within the cell. If 
this is the case, it would take a greater amount of 58 rRNA to saturate these binding 
sites than for the other, more specialised, RNA pathways which may have fewer 
transport factors available. This scenario is supported by the evidence presented here 
that 58 rRNA import is competed by a proto-typical protein NL8, which indicates that 
the import process may occur by the general protein pathway. This pathway is 
responsible for the nuclear accumulation of a large variety of nuclear proteins (see 
Table 4.1) and would therefore require many copies of the transport factors. It should 
be noted that the amount of competitor that has been used in this and other studies to 
saturate protein import is at a higher molar concentration (15 to 25 pM; Michaud & 
Goldfarb, 1991; 1992; 1993) than the competitor RNAs, which completely inhibited 
nuclear export at concentrations of less than 10 pM (assuming an oocyte volume of 
0.5 pI; Iarmolowski et ai., 1994). Furthermore, each molecule of P(lys)-BSA contains 
multiple copies of the NLS (Breeuwer & Goldfarb, 1990) and could possibly bind 
many transport factors. 
4.4.2 Signals and receptors required for 5S rRNAi5S RNP nuclear import 
Facilitated transport is mediated by nuclear localisation signals, therefore the 
question still remains as to the location of the NLS on the 58 RNP. The signal for 
the nuclear transport of RNPs could reside in the nucleotide sequence of the RNA, or 
it may be a component of the amino acid sequence of the bound protein (or proteins), 
or formed by a combination of sequences and conformation brought about by the 
RNA-protein interaction. Mutational analysis of 58 rRNA has shown that specific 
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structural elements of the 5S rRNA molecule are important for nuclear localisation, 
but no single region of 5S rRNA is solely responsible, suggesting that molecular 
shape, rather than specific sequence, plays a primary role in transport (Allison et al., 
1993; Allison & Romaniuk, in prep.). Therefore, the key to nuclear import may lie in 
the ability of the RNA to form a conformation that allows L5 to bind. As 5S 
rRNAJRNP nuclear transport was competed by a protein NLS, it is likely that the 5S 
RNP contains a similar targeting signal to this class of karyophiles. Since the 
sequence of L5 does possess a putative NLS (KKPKKFVKKK; Wormington, 1989), 
this signal probably resides on the protein "component of the 5S RNP. 
The inhibitory effect of P(lys)-BSA on 5S rRNAJRNP nuclear import may be 
due to competition for the same NLS receptor that targets both molecules to the NPC 
(reviewed by Simos & Hurt, 1995). This protein is likely to be the ex subunit of 
Xenopus importin (Gorlich et al., 1994; 1995a,b), which is homologous to the human 
NLS receptor hSRPlex (Gorlich et al., 1995a; Weis et al., 1995). Binding of a 
labelled SV40 T antigen NLS-protein conjugate to hSRPlex was found to be blocked 
in the presence of excess SV40 NLS (or the bipartite NLS of CBP80), demonstrating 
the saturability of this component of the nuclear transport machinery (Weis et al., 
1995). Failure of interaction of the NLS with its receptor would result in 5S RNPs 
being retained in the cytoplasm due to their inability to combine into the nuclear pore 
targeting complex and enter the nuclear import pathway (Gorlich et al., 1995a,b; 
Imamoto et al., 1995a,b,c). 
4.4.3 A role for shuttling proteins in SS rRNA/SS RNP import? 
The competition between P(lys)-BSA and 5S rRNAJRNP may also be for 
binding at an earlier stage in nuclear transport, to another molecule that subsequently 
interacts with the nuclear pore targeting complex. The nucleolar proteins nucleolin, 
N0381B23, and Noppl40 have been shown to shuttle across the nuclear membrane in 
both directions, suggesting the possibility that these proteins are involved in the 
ferrying of other karyophiles into the nucleus (Borer et al., 1989). Furthermore, NLS-
binding activity has been observed for some nucleolar proteins (Lee et al., 1991; 
Meier & Blobel, 1990; 1992; Xue et al., 1993), providing evidence for a role in 
nuclear transport. It is possible that 5S RNPs are imported into the nucleus, and 
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subsequently targeted to the nucleolus, bound with one of these nucleolar proteins. 
The fact that nucleolin is capable of binding the SV40 T-antigen NLS (Xue et al., 
1993), and that P(lys)-BSA is localised to the nucleolus after its nuclear import 
(Breeuwer & Goldfarb, 1990), suggests that P(lys)-BSA could associate with this 
shuttling protein in oocytes. This saturation of the NLS binding sites of the shuttling 
protein would prevent interaction with the NLS of 5S RNPs. Nucleolin has its own 
bipartite NLS (Schmidt-Zachmann & Nigg, 1993), which presumably must associate 
with the NLS receptor of the nuclear pore targeting complex prior to nuclear import. 
It is possible that the SV40 NLS on P(lys)-BSA is binding to both sets of NLS 
receptors, and doubly affecting 5S RNP nuclear import. 
Binding to shuttling proteins may be a general phenomenon in the nuclear 
import of ribosomal proteins. In the case of 5S RNP nuclear import, it appears that 
5S rRNA is simply being 'piggy-backed' by ribosomal protein L5, via a nuclear 
transport pathway that may be utilised by other ribosomal proteins, as well as L5 
when it is not bound with 5S rRNA (in somatic cells which do not possess a 
cytoplasmic pool of 5S rRNA). SV 40 T antigen or histone H2B NLSs alone 
conjugated with small, non-nuclear proteins were found to interact with the amino 
terminus NLS receptor domain of nucleolin (Xue et al., 1993). N0381B23 has also 
been found to bind simple peptides containing the SV40 or HIV-l Rev NLSs (Szebeni 
et al., 1995), and Nopp140 binds the SV40 NLS cross-linked with human serum 
albumin (Meier & Blobel, 1990). This suggests that the requirement for interaction of 
the transport substrate with the shuttling protein may be contained solely within the 
NLS. However, there may be moderators of NLS binding for nuclear proteins in vivo. 
It is possible that the nuclear import of proteins destined for the nucleolus is achieved 
by a 'default' pathway of binding to nucleolar shuttling proteins, and those karyophilic 
proteins that function in other areas of the nucleus must provide additional signals to 
prevent their interaction with shuttling proteins, and subsequent nucleolar targeting. 
This mechanism would potentially enable the efficient import of ribosomal proteins 
directly to their site of assembly into ribosomal subunits. 
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4.4.4 Implications for coordinated nuclear import 
5S rRNA, bound with ribosomal protein L5 as a 5S RNP complex, behaves like 
a protein in its pathway of import. This is in contrast to the nuclear import pathways 
of the two other small nuclear RNAs used in this study. U1 snRNA and U3 snoRNA 
both have an essential requirement for interaction between elements of RNA structure 
and the nuclear transport machinery, and do not utilise saturable components in 
common with karyophilic proteins (Michaud & Goldfarb, 1992), yet they are also 
complexed with proteins as RNPs during their import (Luhrmann et al., 1990, Baserga 
et al., 1992). So, why do 5S RNPs have protein-like targeting signals? The answer to 
this question may lie in the role of 5S rRNA as an integral component of ribosomes. 
The synthesis of ribosomes requires the coordinated assembly of proteins and 
ribosomal RNAs at the nucleolus (Hadjiolov, 1985). 5S rRNA is the only 
ribosomal. RNA that is stored in the cytoplasm in oocytes, and a separate mechanism 
of nuclear import than the ribosomal proteins with which it must combine would 
appear to be a waste of cellular resources. Several ribosomal proteins, such as yeast 
YL3 (Moreland et al., 1985) and L25 (Schaap et al., 1991), have been found to 
possess NLSs, suggesting that their nuclear import proceeds via the SV 40 T antigen-
saturable pathway. Employing the same pathway of import for all ribosomal 
components would also assist in the regulation of their concurrent nuclear (and 
nucleolar) localisation. 
The processes of nuclear export of U1 snRNA and 5S rRNA appear to involve 
common transport factors, as the presence of the mv -1 Rev protein inhibits the export 
of both RNAs (Fischer et al., 1995). However, the results presented here demonstrate 
that there are different saturable factors involved in the nuclear import of the two 
molecules. It is possible that a more general mechanism is utilised for the export of U 
snRNAs and 5S rRNA; whereas, import is regulated by more specialised interactions, 
to allow for differential timing of import and regulation with other components of 
spliceosomes and ribosomes, respectively. This may include the utilisation different 
members of the NLS receptor gene family for specific NLS-receptor interactions 
(Adam, 1995; Weis et al .• 1995). 
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Given the nucleolar nature of U3 snoRNA, it was thought that it might utilise a 
similar pathway of nuclear import to 58 rRNA, another nucleolar-targeted molecule. 
However, it appears that U3 snoRNA is normally retained in the nucleus, and is 
matured in that cellular compartment without a cytoplasmic journey (Terns et ai., 
1995). Therefore, the receptor-mediated import of U3 snoRNA into the nucleus may 
occur by a more obscure pathway, that does not require coordination with that of other 
nucleolar molecules. 
4.4.5 Summary 
The results presented here suggest that 58 rRNA is imported into the nucleus 
after cytoplasmic storage bound with ribosomal protein L5. It is possible that 58 
rRNA has a passive role in its own transport and L5 contributes the targeting signal to 
the complex~ In this scenario, 58 rRNA is imported by the same pathway as 
ribosomal proteins, which would aid in the coordination of the process of ribosome 
assembly. 
Chapter Five 
General Discussion 
The results of the study outlined in this thesis emphasise the importance of 
specific RNA-protein interactions in directing the nucleo-cytoplasmic localisation of 
oocyte-type 5S rRNA during oogenesis in Xenopus iaevis. Furthermore, the results of 
this investigation provide a model of 5S rRNA import which integrates its 
mobilisation to the nucleus with the pathway likely to be used by ribosomal proteins. 
5.1 The Pathway for 58 rRNA Nuclear Import 
Oocyte-type 5S rRNA moves between nuclear and cytoplasmic compartments 
throughout the stages of oogenesis, undergoing a period of storage in the cytoplasm 
prior to its assembly into ribosomal subunits. 5S rRNA is synthesised in the nucleus 
throughout oogenesis, but is transported to the cytoplasm to be stored as 42S RNPs 
and 7S RNPs in early stage oocytes (Honda & Roeder, 1980; Pelham & Brown, 1980; 
Picard et ai., 1980; Mattaj et ai., 1987; loho et ai., 1990). The synthesis of TFIIIA, 
the protein component of 7S RNPs, is greatly reduced in the later stages of oocyte 
development during vitellogenesis, and the accumulation of the protein components of 
the 42S RNPs ceases entirely (Dixon & Ford, 1982). In vitellogenic oocytes, 18S-
5.8S-28S ribosomal RNAs and proteins are synthesised and congregate in the 
nucleolus to take part in ribosome assembly (Mairy & Denis, 1971; Picard & Wegnez. 
1979; Picard et al., 1980; Dixon & Ford, 1982). Newly synthesised 5S rRNA 
accumulates in the nucleolus directly; however, stored 5S rRNA must be released 
from its retention in the cytoplasm to take part in the assembly of ribosomal subunits. 
The signal for nuclear accumulation appears to come from displacement of 
bound TFlIIA from 5S rRNA, and its replacement with ribosomal protein L5. The 
resulting 5S RNP is a precursor to ribosome assembly (Steitz et ai., 1988; Allison et 
al .• 1991), and remains as a stable complex which can be released intact from the 
fully assembled ribosome by EDTA treatment (Blobel. 1971). The results of studies 
presented in this thesis suggest that ribosomal protein L5 provides the signal for 
nuclear targeting of 5S RNPs. The yeast homologue of L5, YL3, possesses a 
sequence at its amino tenninus which is sufficient to localise the non-nuclear protein 
~-galactosidase to the nucleus (Moreland et al., 1985). Furthermore, sequence 
analysis of L5 reveals that it possesses a putative nuclear localisation signal between 
amino acid residues 255 and 264 (Wonnington, 1989). However, direct functional 
analysis of this sequence as an NLS has not been performed. 
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The presence of the NLS on L5 would allow the 5S RNP complex to interact 
with a karyophilic protein-type NLS receptor, and to enter the nuclear import pathway. 
This receptor could be the importin-o; part of the nuclear pore targeting complex 
(Gorlich et al., 1994; 1995a,b; Imamoto et al., 1995a,b,c). After interaction with the 
5S RNP, the nuclear pore targeting complex would dock at the nuclear pore complex, 
. and be translocated through the NPC channel. These docking andlor translocation 
processes must involve interacdon of the 5S RNP-nuclear pore targeting complex with 
N-acetylglucosamine-bearirig nucleoporins, as binding of wheat germ agglutinin to 
these sites inhibits 5S RNP nuclear accumulation. 5S RNPs are likely to remain 
associated with the targeting complex until their arrival at the nucleoplasmic side of 
the NPC, where the importin-~ component dissociates (Gorlich et al., 1995b). Prior to 
localisation to the nucleolus, or other potential retendon sites in the nucleus, 5S RNPs 
would be released from the rest of the complex, which could then be recycled for use 
in nuclear export or import of other molecules. 
The process of 5S RNP nuclear import is dependent on physiological 
temperatures and ATP. This temperature dependence probably reflects the many 
enzymes involved in the interactions between components along the nuclear transport 
pathway and in the mechanism promoting the diladon of the NPC channel to allow 
access to the 5S RNP. Similarly, the ATP requirements could be at any stage in the 
process leading to nuclear accumulation; from initial interaction with the NLS 
receptor, to interaction with a 5S RNP nuclear retention site such as at the nucleolus. 
The activation of the nuclear localisation sequence for 5S RNPs could require 
phosphorylation of the molecule by an ATP-dependent protein kinase (Rihs & Peters, 
1989; Rihs et al., 1991; MeSmer & Dreyer, 1993; Jans & Jans, 1994; Gauthier-
Rouviere et al., 1995; Vancurova et al., 1995). In addition, the 5S RNP may need to 
undergo an A TP-dependent conformational change to enter the NPC, as has been 
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visualised for Chironomus RNPs (Mehlin et al., 1992; 1995). Movement through the 
NPC channel also involves the use of metabolic energy. Recent studies have 
suggested that it is not necessarily A TP hydrolysis that is involved in the translocation 
mechanism, but GTP hydrolysis via the GTPase Ran and its associated proteins 
(Moore & Blobel, 1993; 1994a). However, is still possible that ATP is required for 
the regulation and activation of enzymes associated with the translocation process. 
Finally, the intranuclear movement of newly imported 5S RNPs from the NPC to the 
nucleolus may involve A TP. Although GTP is the nucleotide that has been implicated 
in the nucleolar localisation of U3 snoRNA (Cheng et al., 1995), there is evidence of 
an A TP requirement for movement of the nucleolar protein N038 within the nucleus 
(WU et al., 1995b). 
S.2 Shuttling 
Some nucleolar proteins possess NLS-binding domains and are able to move 
between the nucleus and cytoplasm, such as Nopp140 (Meier & Blobel, 1990; 1992), 
N038 and nucleolin (Borer et al., 1989). This has lead to the suggestion that these 
proteins could be involved in the nucleo-cytoplasmic trafficking of other nucleolar 
targeted molecules such as ribosomal proteins, although to date there has been no 
direct evidence of such a function (Borer et al., 1989; Meier & Blobel, 1992; Xue & 
M6lese, 1994). These so-called shuttling proteins would potentially collect protein or 
RNP cargo in the cytoplasm, move it through the import pathway to the nucleus, and 
subsequently deliver the transported molecule to the nucleolus, by the binding of the 
shuttling protein at this subnuclear compartment Nuclear transport mediated by 
shuttling proteins provides an elegant explanation for nucleolar targeting of proteins 
and RNAs/RNPs, eliminating a requisite for individual signals to establish localisation 
to the nucleolus. This could result in an efficient and more easily regulated mode of 
transport to this compartment, compared with a scenario where each molecule has to 
be transported individually. 
The inclusion of a nucleolar-based shuttling protein in the 5S RNP nuclear 
import pathway could explain both its nuclear and subsequent nucleolar localisation. 
Figure 5.1 illustrates two models for the pathway of 5S rRNA nuclear import; a direct 
Figure 5.1: Models for the pathway of nuclear impon of 5S rRNA in Xenopus oocytes. 
(A) Direct nuclear import of 5S rRNA/5S RNPs. 5S rRNA is released from storage bound with the 
protein TFIIIA as 7S RNPs by the replacement of TFIIIA with ribosomal protein L5. forming 5S 
RNPs. The 5S RNP NLS, supplied by L5, binds to the NLS receptor component, probably importin-a 
(OOrlich et a1., 1995a), of the nuclear pore targeting complex. The entire complex then undertakes the 
docking and translocation steps of transpon through the NPC, a process involving sequential interaction 
with different regions of the NPC including N-acetylglucosamine-bearing nucleoporins. Once at the 
nucleoplasmic face of the NPC, the nuclear pore targeting complex dissociates, leaving at least the 
importin-~ component in close proximity to the NPC (GOrlich et a1., 1995b). The NLS-receptor is 
likely to be released from the transported 5S RNP prior to nucleolar localisation of the pre-ribosomal 
particle. The NLS receptor is then able to be recycled for use in nuclear expon and/or import of new 
cargo molecules or complexes. 
(8) Shuttling protein-mediated nuclear import of 5S rRNA/5S RNPs. This model involves the same 
interactions as described in (A), with the addition of a shuttling protein adaptor between the 5S RNP 
and the NLS-receptor of the nuclear pore targeting complex. The shuttling protein, which could be 
one of the three nucleolar proteins found to recycle between nucleus and cytoplasm (see text), binds 
to the NLS on L5. The shuttling protein-5S RNP complex could then interact with the nuclear pore 
targeting complex, via the NLS contained within the shuttling protein, and pass through the NPC. 
Once in the nucleus, the NLS receptor dissociates, and the shuttling protein aids in localisation of the 
shuttling protein-5S RNP complex to the nucleolus by its interaction with nucleolar components. 5S 
RNPs would next be released and bind to a specific site at the nucleolus to take pan in ribosome 
assembly. The shuttling protein could potentially be recycled for use in nuclear export, possibly for 
ribosomal subunits. 
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(A) and a shuttling (B) scenario. The fIrst step in the shuttling model of 5S RNP 
nuclear import involves cytoplasmic 5S RNPs binding the NLS-binding portion of the 
shuttling protein. The Xenopus homologue of rat Nopp 140 has recently been isolated 
and cloned (Cairns & McStay, 1995), and nucleolin (MeSmer & Dreyer, 1993) and 
N038 (Schmidt-Zachmann et al., 1987) have previously been isolated from Xenopus, 
providing three options for potential shuttling proteins in oocytes. In the next step of 
the shuttling model, after binding in the cytoplasm, the 5S RNP-shuttling protein 
complex subsequently interacts with the nuclear pore targeting complex by the binding 
of the shuttling protein NLS with the importin-a type NLS receptor. The entire 
complex then undergoes the docking and translocation steps of nuclear import. Once 
in the nucleus, the 5S RNP-shuttling protein complex moves through the nucleoplasm 
to bind to components of the nucleolus. The initial nucleolar interaction is likely to 
be achieved via the interaction of the shuttling protein with molecules in the 
nucleolus, such as rRNA. 5S RNPs would then be in proximity to nucleolar 
components to which they can bind to contribute to the assembly of 60S ribosomal 
subunits. 
Phosphorylation of the putative shuttling protein B23/N038 has been shown to 
enhance its ability to bind NLSs (Szebeni et al., 1995). Therefore, the ATP 
requirement of the 5S RNP nuclear transport process could be due in part to the ATP-
dependent phosphorylation of the shuttling protein. In the absence of ATP, the 5S 
RNP NLS may be unable to interact with the NLS receptor on the shuttling protein, 
and would therefore be unable to be transported. 
5.3 Coordination of Ribosome Assembly 
Oocyte-type 5S rRNA is separated from the other ribosomal RNAs in Xenopus 
oocytes both temporally and spatially, in that it is synthesised from an earlier stage in 
oogenesis, and it resides in the cytoplasm until required. It would appear to be an 
ineffIcient use of cellular resources to establish an independent pathway for the 
nuclear import of 5S rRNA, especially as this RNA is able to form a complex with a 
ribosomal protein that is imported concurrently, and with which 5S rRNA remains 
bound within the functioning ribosome. Furthermore, a general mechanism is likely to 
exist for the nuclear import of ribosomal proteins, as most nuclear proteins are 
imported by a pathway that can be saturated by a prototypical NL5 (Michaud & 
Goldfarb, 1993). This 'general' mechanism would aid in the efficient simultaneous 
import of the many different proteins that are essential for ribosome assembly. It 
appears that 55 rRNA is 'piggy-backed' into the nucleus via this pathway by L5 . 
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. This enables it to be mobilised at vitellogenesis during the maximal synthesis of other 
ribosomal components, which in the cytoplasm are the ribosomal proteins. It is 
possible that other processes requiring coordination of nuclear transport, such as 
elements of the splicing machinery for pre-mRNA and transcription factors for a 
group of genes that need to be expressed simultaneously, utilise common transport 
pathways in a similar manner. 
5.4 Prospects and Conclusions 
Further definition of the 55 rRNAl55 RNP nuclear import pathway is required to 
unequivocally establish the role of ribosomal protein L5 in this process. Mutational 
analyses of L5 would be invaluable in the verification of a direct role for this protein 
in 55 rRNA nuclear import. Through microinjection assays of in vitro produced L5 
mutants lacking the putative NL5 and which are still able to bind oocyte-type 55 
rRNA, the targeting signal for the 55 RNP could be established. It would also be 
possible to test the ability of the 55 RNP to bind isolated NL5-receptors, including 
importin and putative shuttling proteins, to establish the molecular interactions 
involved in the transport pathway. Furthermore, it would be interesting to establish 
whether retention by non-diffusible elements plays a role in the nuclear accumulation 
of 55 RNPs. There is evidence that 55 RNPs are retained in the nucleus at sites apart 
from the nucleolus (M. North, pers. comm.); however, the nature of the retention 
complexes is unknown. This non-nucleolar pool of 55 RNPs in the nucleus may be a 
reserve ensuring that there is a constant supply of this essential ribosomal component 
during the rapid synthesis of ribosomes that accompanies oocyte development. 
The nucleo-cytoplasmic transport of 55 rRNA in Xenopus oocytes throughout 
oogenesis is a highly regulated process resulting from differential association of the 
RNA with specific proteins. This mechanism underscores the importance of RNA-
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protein interactions in creating the diversity of signals that coordinate nucleo-
cytoplasmic transport with other cellular processes throughout development. 
Furthermore, the discovery that 5S rRNA utilises the same pathway of nuclear import 
as karyophilic proteins reinforces the connection between the transport processes of 
RNAs and proteins. Through interaction with nuclear transport factors and adaptor 
. molecules such as shuttling proteins, the nucleo-cytoplasmic transport of RNA 
becomes a phenomenon of protein transport. Additionally, after initial interaction 
between NLSs and NLS receptors, many different types of RNAs and proteins may 
bind the same nuclear transport factors. It is possible that the many different 
molecules and complexes that move between the nucleus and cytoplasm converge on a 
limited number of nuclear transport pathways, due to interaction with these common 
transport intermediates. Therefore, a definitive model for nucleo-cytoplasmic transport 
of proteins and RNAs may turn out to be much simpler than might be imagined from 
the differences between these multifarious molecules. 
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Appendix 
This reprint from Molecular and Cellular Biology contains results from part of 
the work presented in this thesis. My contribution to this publication consisted of the 
studies investigating the nuclear import of oocyte-type and the two mutant 5S rRNAs, 
41-44 nt and 96-101 nt, with respect to temperature-dependence, ATP requirement and 
the effect of wheat germ agglutinin. 
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Structural requirements of 5S rRNA for nuclear transport and RNA-protein interactions have been studied 
by analyzing the behavior of oocyte-type 5S rRNA and of 31 different in vitro-generated mutant transcripts 
after microinjection into the cytoplasm of Xenopus oocytes. Experiments reveal that the sequence and 
secondary and/or tertiary structure requirements of 5S rRNA for nuclear transport, storage in the cytoplasm 
as 7S ribonucleoprotein particles, and assembly into 60S ribosomal subunits are complex and nonidentical. 
Elements of loops A, C, and E, helices II and V, and bulged and hinge nucleotides in the central domain of 5S 
rRNA carry the essential information for these functional activities. Assembly of microinjected 5S rRNA into 
60S ribosomal subunits was shown to occur in the nucleus; thus, the first requirement for subunit assembly is 
nuclear targeting. The inhibitory effects of ATP depletion, wheat germ agglutinin, and chilling on the nuclear 
import of 5S rRNA indicate that it crosses the nuclear envelope throngh the nuclear pore complex by a pathway 
similar to that used by karyophllic proteins. 
The orchestration of ribosome biogenesis in eukaryotic 
cells is a process that requires transfer of macromolecules 
into and out of the nucleus. InXenopus oocytes, SS rRNA is 
shuttled between the nuclear and cytoplasmic compartments 
of the oocyte during different stages of oogenesis in a 
complex pathway involving different protein associations. In 
previtellogenic oocytes, SS rRNA is synthesized before 
other components of ribosomes are available, is exported 
from the nucleus, and stored in the cytoplasm as 7S ribonu-
cleoprotein particles (RNPs) (SS rRNA complexed with 
transcription factor IlIA [TFIIIAD or as 42S RNPs (SS 
rRNA complexed with other nonribosomal proteins and 
tRNA). During vitellogenesis, the SS rRNA is released from 
storage and a SS rRNA-ribosomal protein LS complex, 
which is a precursor to assembly into the 60S large ribosomal 
subunit, forms (reference 3 and references therein). We are 
interested in the mechanisms that govern the subcellular 
trafficking of SS rRNA within the oocyte, particularly the 
requirements for the mobilization of stored SS rRNA during 
ribosome assembly. 
There is ample evidence that transit of RNA and RNPs 
into and out ofthe nucleus occurs exclusively via the nuclear 
pores (20, 4S; for a review, see reference 30). Although 
nuclear localization of proteins has been well characterized 
(1, 10, 21, 49; for a review, see reference 61), the factors 
governing nuclear export and import of RNA and RNPs 
remain enigmatic. Nuclear export cif tRNA (7S), pre-small 
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nuclear RNAs (SO), mRNA (16), 40S and 60S ribosomal 
subunits (6, 38), and SS rRNA (24) occurs in a manner 
consistent with a mediated process. Analysis of the nuclear 
transport of U small nuclear RNAs has multiple defined, 
kinetically distinct targeting pathways (27, 47, 48). Nuclear 
transport of different classes of RNA may thus involve 
targeting to the pore complex by different cytoplasmic 
receptors and then translocation into the nucleus by the 
same pore complex-mediated mechanism. Specific RNA 
structures have been implicated as requirements for both 
nuclear import and export (S, 22, 32, 33, 67, 7S). Transloca-
tion of RNA molecules across the nuclear envelope may also 
require interaction with specific proteins (28, 31, 33, 43, 62). 
RNA-protein interactions are important for many regula-
tory processes. There is growing evidence that RNA struc-
tures, such as helices, loops, bulges, mismatches, and 
pseudoknots, are key elements in protein recognition (for a 
review, see reference 19). The sequence and structural 
requirements for binding of TFIIIA to SS rRNA have been 
the subjects of extensive research (7, 8, S6, 66, 74). In 
comparison, the structural elements of the SS rRNA mole-
cule required for assembly into ribosomes and for its func-
tional activity within the ribosome remain to be elucidated 
(34, 37, 69). 
We report here the results of a structural analysis of 31 
different SS rRNA mutants by nuclear transport and RNP 
assembly assays in Xenopus oocytes. The results are dis-
cussed in relation to the abilities of these same SS rRNA 
mutants to bind TFIIIA in vitro (7, 8, S6, 74). We show that 
determinants of nuclear transport, TFIIIA binding, and 
ribosome incorporation within the SS rRNA molecule are 
complex and nonidentical. The results suggest that TFIIIA 
binding is not a prerequisite for nuclear targeting of 5S 
rRNA, consistent with earlier studies indicating that 7S 
RNPs are not imported (3, 44). We show that microinjected 
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5S rRNA is incorporated into 60S ribosomal subunits in the 
nucleus; thus, the first requirement for assembly is nuclear 
import. Finally, we demonstrate that nuclear import of 5S 
rRNA is sensitive to general inhibitors of nuclear pore-
mediated translocation. 
MATERIALS AND MEmODS 
Synthesis of mutant 5S rRNAs. The 5S rRNAgenes used in 
these experiments were eonstructed from a series of syn-
thetic oligonucleotides that were subsequently introduced 
into pUC18 as previously described (56, 58). Internally 
labelled 5S rRNAs were produced by in vitro transcrip-
tion from these gene templates with T7 RNA polymerase 
(Boehringer Mannheim N.Z. Ltd., Auckland, New Zealand) 
and 50 to 100 j.Lei of [cr_32p]GTP (3,000 Ci/mmol; Amersham 
Australia pty Ltd., Auckland, New Zealand). The mixture 
was incubated for 1.5 h at 37°C and then treated with 
RNase-free DNase (Boehringer Mannheim). The sample was 
extracted with phenol and chloroform, and the RNA tran-
scripts were precipitated twice with 2.5 M ammonium ace-
tate and ethanol. The RNA pellet was resuspended in 1E (10 
mM Tris-HCl, 1 mM EDTA), pH 7.6, and stored at -80Q C. 
RNA eoncentration was quantified by DNA Dipstick (Invit-
rogen Corp., San Diego, Calif.), according to the manufac-
turer's instructions. 
Microinjection and analysis of nuclear transport. An ovary 
lobe was surgically removed from an adult Xenopus laevis 
(reared at the University of Canterbury on a diet of cock-
roaches), and the oocytes were separated by brief collage-
nase treatment as previously described (3). Stage 5-6 oocytes 
were microinjected with 40 to 80 nl of RNA (0.2 to 0.5 ng of 
RNA per oocyte) into the oocyte cytoplasm with a PV 830 
PicoPurnp (World Precision Instruments, Inc., New Haven, 
Conn.) by previously published procedures (3). After over-
night incubation (18 h) in O-R2 medium (3), nuclei were 
manually dissected from oocytes in 1 % trichloroacetic acid 
and collected for analysis (3). RNA was extracted from 
nuclear and cytoplasmic fractions as described by Allison et 
al. (3). RNA was analyzed by 8% polyacrylamide-8 M urea 
gel electrophoresis as described previously (3). Dried gels 
were autoradiographed on Amersham Hyperfilm-MP at 
-80°C. A Kontron Uvikon 860 spectrophotometer equipped 
with a gel scan accessory was used to measure the intensity 
of bands on suitable exposures of autoradiograms (within the 
linear range of signal intensity of the film); data were 
quantified with software package 8543. The system has high 
resolution, and the software accommodates background 
levels and irregularly shaped bands. Only mutants that 
showed less than 50% nuclear transport relative to oocyte-
type 5S rRNA were considered to be significantly impaired. 
For ATP depletion assays, oocytes were preinjected with 
50 nl of 1-U/j.Ll apyrase (grade VIII; Sigma Chemical Co., St. 
Louis, Mo.) in phosphate-buffered saline (PBS) (3) to give a 
final intracellular concentration of 100 U/ml. Alternatively, 
50 nl of PBS was preinjected as a eontrol. After 30-min 
incubation at 18°C, oocytes were injected with labelled 
RNA. After an additional 6-h incubation, oocytes were 
analyzed for nuclear import as described above. ATP deple-
tion was verified with a CLS A TP bioluminescence kit 
(Boehringer Mannheim). Single oocytes were homogenized 
in boiling 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid), pH 7.5, and incubated for 5 min at 
100°C, and samples were then diluted 1:500 in double-
distilled water. A 500-j.Ll sample was added to an equal 
volume of luciferase extract immediately prior to measure-
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ment of luminescence with an SAl ATP photometer (model 
2000). 
Wheat germ agglutinin (WGA) (Sigma Chemical Co.) was 
dissolved in PBS at concentrations ranging from 0.25 to 2 
mg/m!. WGA (50 nl) or PBS (as a control) was injected into 
the oocyte cytoplasm. After incubation for 3 h, oocytes were 
injected with labelled RNA and analyzed for nuclear import 
as described above. As a control for the specificity of 
preinjection of 50 nl of 1-mg/rnl WGA, 50 nl of 1-mg/rnl WGA 
and 500 mM N-acetylglucosamine (Sigma Chemical Co.) 
were coinjected into oocytes prior to injection of labelled 5S 
rRNA. As a control for nonselective diffusion, oocytes were 
injected with 50 nl of 100-mg/ml fluorescein isothiocyanate-
dextran (molecular weight, 10,000 or 150,000; Sigma Chem-
ical Co.). After overnight incubation, nuclei were dissected 
out in nucleus isolation buffer (3) and viewed by fluorescence 
microscopy for diffusion of the dextran into the nucleus. 
Since there can be variability in synthetic activity between 
different batches of oocytes, experiments were repeated a 
minimum of two times with oocytes from different animals. 
Antisera. The antibodies raised against TFIIIA have been 
shown to react with the relevant protein; no cross-reaction 
with any other protein was noted by immunoblotting (70). 
Preparation of the antibodies raised against Xenopus 60S 
ribosomal subunits is described by Viel et a!. (70); however, 
there is a slight difference in the reaction of the anti-60S 
ribosomal subunit antiserum used in this study (anti-serum 
number 2679; sampling date, 7 November 1985) and of the 
antiserum described by Viel et aL (70). Immunoblot analysis 
was performed on total protein from ribosomal subunits 
purified from mature Xenopus ovaries by ultracentrifugation 
techniques (70) or from 7S fractions obtained after sucrose 
density centrifugation of cell homogenates of Xenopus ova-
ries (41). The proteins were fractionated by polyacrylamide 
gel electrophoresis and either stained with Coomassie blue 
or transferred to Immobilon-P polyvinylidene difluoride 
membranes (Millipore S.A., Saint-Quentin Yvelines, 
France). Membranes were incubated with diluted antiserum 
(1:287) in a solution of 10 mM sodium phosphate (pH 7.4), 
150 mM NaCl, and 1% bovine serum albumin, washed in the 
same buffer, treated with 35S-labelled-protein A in order to 
label the antigen-antibody complexes, washed again, and 
exposed to X-ray films at -800C by previously published 
procedures (70). 
To further ensure that the anti-60S antiserum did not 
cross-react with 7S RNPs, immunoprecipitation analyses 
were performed on 7S RNPs purified from immature Xeno-
pus ovaries as previously described (3). Immunoprecipita-
tion assays were performed as described by Allison et a!. (3), 
using approximately 10 j.Lg of 7S RNPs and 10 j.Ll of anti-
serum bound to protein A-Sepharose (Pharmacia LKB Bio-
technology, Auckland, New Zealand). Immunoprecipitates 
were vortexed briefly in sample buffer (2% sodium dodecyl 
sulfate, 100 mM dithiothreitol, 60 mM Tris [PH 6.8], 0.01% 
bromophenol blue), heated at 100·C for 5 min, and then 
centrifuged for 30 s. Proteins from the supernatant were 
resolved by polyacrylamide gel electrophoresis and silver 
stained with a Bio-Rad silver stain kit (Bio-Rad Laboratories 
Pty Ltd., Auckland, New Zealand), according to the manu-
facturer's instructions. 
Immunoprecipitation assays. Microinjected oocytes were 
incubated for 48 h at 18°C. Immunoprecipitation assays were 
performed as described by Allison et al. (3), using homoge-
nates of 20 microinjected oocytes and 10 j.LI of antiserum 
bound to protein A-Sepharose. For nuclear immunoprecipi-
tations, 20 nuclei were isolated in nucleus isolation buffer 
VOL. 13, 1993 
(3). RNA was recovered from the immunoprecipitates and 
immunosupernatants and resolved on 8% polyacrylamide-8 
M urea gels, and then autoradiography was performed. 
Results were interpreted qualitatively by comparing the 
amounts of the different mutants immunoprecipitated with 
the amount of oocyte-type 5S rRNA immunoprecipitated 
and by comparing the relative specific activities of the RNA 
mutants and the amounts of RNA injected, using the super-
natant fractions. 
Electrophoretic mobility shift assays. After a 48-h incuba-
tion at 18°C, five microinjected oocytes were homogenized 
in 20 fLl of RNP homogenization buffer (20 mM Tris [pH 7.6],. 
100 mM KCl, 1.5 mM MgClz, 2 mM dithiothreitol, 0.1 mM 
phenylmethylsulfonyl fluoride, 10 U of RN asin per ml; 
Promega:Pacific Diagnostics Pty. Ltd., Auckland, New 
Zealand). A crude cellular lysate was prepared by disrupting 
oocytes with a Gilson tip, spinning down the cellular debris 
(yolk and pigment) by centrifugation at 9,000 x g for 10 min 
at 4°C, and removing the supernatant, taking care not to 
disturb the lipid pellicle floating on the surface. Glycerol-dye 
loading buffer was added to the supernatant, and samples 
were loaded directly onto a 6% polyacrylamide-O.l % Triton 
X-I00 gel in Tris-borate-EDTA buffer plus 0.1% Triton 
X-I00. Samples were electrophoresed at 300 V; gels were 
dried at 80°C for 30 min, and then autoradiography was 
performed. A sample of unlabelled, native 7S RNPs were 
included as a marker. The marker lane was stained with 
ethidium bromide and viewed by UV illumination. 
RESULTS 
Sequence and structural requirements for nuclear transport 
of 5S rRNA. The sequence and structural requirements of 5S 
rRNA for nuclear transport in Xenopus oocytes were inves-
tigated by analyzing 31 mutant 5S rRNA molecules gener-
ated by in vitro transcription. Figure 1 shows the secondary 
structure of oocyte-type 5S rRNA and the locations of the 
mutations analyzed. With the exception of seven mutants, 
substitutions were located between nucleotides 11 and 108 in 
the region of the RNA molecule shown to provide the 
necessary sequence and conformational information re-
quired for nuclear transport (3). In our previous study, 
however, we did not investigate quantitative differences in 
nuclear transport. 
All mutant 5S rRNAs were stable 24 h after cytoplasmic 
microinjection (data not shown). Analysis of oocyte-type 5S 
rRNA revealed that on average, 14% of the microinjected 
RNA was found in the nucleus after 18 h (Fig. 2, lanes 1 and 
2). These results were consistent with a previous study, 
which demonstrated that the total amount of labelled 5S 
rRNA found in the nucleus increases for up to 18 to 21 hand 
then remains constant (3). Presumably, this constant amount 
reflects steady-state levels of 5S rRNA molecules which 
have migrated into the nucleus and are being assembled into 
ribosomes. Nuclear transport of 5S rRNA thus represents a 
state of flux between the cytoplasm and nucleus, as opposed 
to a measure of nuclear import alone. The 31 mutant 5S 
rRNAs showed a variety of transport phenotypes. The 
intracellular distribution of five mutant RNAs is presented in 
Fig. 2. The most defective mutant, 16-21, showed a 75% 
reduction in nuclear transport relative to that of oocyte-type 
5S rRNA (lanes 3 and 4). Mutants 41-44 and 105-108 were 
less defective in nuclear transport, showing reductions of 67 
and 54%, respectively (compare lanes 5 and 6 and lanes 11 
and 12). In contrast, mutants .:163 and 67-70 had transport 
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characteristics similar to those for oocyte-type 5S rRNA 
(lanes 7 to 10). The data are summarized in Table 1. 
Mutations within predicted helices II and V tend to have 
lower nuclear transport values if the mutations are helix 
breaking (HB in Table 1), than if the mutations are helix 
maintaining (HM). Nucleotide substitutions that alter either 
the 5' sequence of helix II or the sequence and structure of 
helix V resulted in a significant reduction (;::50%) in nuclear 
transport. The loop mutants tested have block sequence 
substitutions in one loop which alter the sequence but 
maintain the single-stranded secondary structure (56). Nu-
cleotide substitutions that alter the 3' sequence of loop C or 
the noncanonical base pairing in loop E (57, 72) resulted in a 
significant reduction in nuclear transport. The deletion of 
bulged nucleotides did not impair transport. In contrast, 
alteration of the hinge nucleotide at position 66 resulted in a 
57% reduction in nuclear transport, suggesting this nucle-
otide is located in a key region of the 5S rRNA. This is in line 
with a previous study showing that nucleotides in the hinge 
region of the 5S rRNA, the junction of the three helical 
domains, play a central role in determining the coaxial 
stacking interactions and tertiary structure of the RNA and 
are critical for TFIIIA recognition (8). In summary, specific 
structural elements of the 5S rRNA molecule have been 
shown to be important for nuclear transport, but no single 
region of 5S rRNA is solely responsible. 
TFIIIA has been implicated in mediating 5S rRNA nuclear 
export (31), but indirect evidence suggests that 7S RNPs are 
not import competent (3, 44). In order to determine whether 
there is a correlation between wild-type TFIIIA binding 
affinity and wild-type nuclear transport, results on nuclear 
transport of the mutants are compared with data on their 
ability to bind TFIIIA in vitro from previous studies (7, 8, 56, 
74). In general, the two sets of data are comparable (Table 
1); there are, however, important exceptions. For example, 
mutants 10-13, 57-62, and GI09 possess low binding affini-
ties for TFIIIA (17 to 40% of oocyte-type 5S rRNA), yet the 
measure of nuclear transport is closer to that of oocyte-type 
5S rRNA (63 to 77%). Furthermore, other mutants (e.g., 
96-101 and 14-15) with higher TFIIIA binding affinities (59 to 
85%) exhibit defective nuclear transport (36 to 49%). Since 
some of the structural requirements of 5S rRNA for nuclear 
transport and 7S RNP assembly differ, this suggests that 
TFIIIA binding is not a prerequisite for nuclear targeting. 
Nuclear import of 5S rRNA and mutant RNA molecules 
occurs by a mediated process. One possible explanation for 
oocyte-type and mutant 5S rRNAs entering the nucleus is 
that their small size allows for unrestricted entry. 5S rRNA 
is a 121-nucleotide molecule of approximately 41 kDa. The 
nuclear pore complex contains an aqueous channel of 9- to 
11-nm diameter which acts like a molecular sieve; this 
channel allows rapid, nonselective diffusion of molecules of 
approximately 20 to 40 kDa, while excluding larger cytoplas-
mic proteins (52). A truncated, 98-nucleotide 5S rRNA does 
not enter the nucleus (Fig. 2) (3), however, which implies 
that nuclear uptake of full-length 5S rRNA occurs by a 
mechanism other than unrestricted entry. Further, compar-
ing 5S rRNA and a globular protein may not be a valid 
comparison; the frictional ratio of naked 5S rRNA has been 
shown to be higher than that of 7S RNPs, suggesting that 5S 
rRNA is more elongated (17). 
Translocation across the nuclear envelope occurs by an 
energy-dependent process (2, 51, 55). Thus, sensitivity to 
ATP depletion is one criterion for distinguishing active 
transport from diffusion. We therefore tested the effect of 
cytoplasmic ATP depletion on 5S rRNA nuclear import. 
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FIG. 2. Intracellular distribution of 32P-labelled oocyte-type or 
mutant 5S rRNA species following microinjection in X laevis 
oocytes. 32P-labelled oocyte-type or mutant 5S rRNA was microin-
jected into the cytoplasm of fully grown oocytes. After overnight 
(18-h) incubation, RNA was extracted from five pooled nuclear (N) 
and cytoplasmic (C) fractions and separated electrophoretic ally on 
denaturing 8% polyacrylamide gels containing 8 M urea. The num-
bers refer to those nucleotides in the oocyte-type 5S rRNA (oocyte) 
which have been substituted or deleted (Fig. 1). A truncated 5S 
rRNA molecule consisting of nucleotides 1 to 98 (control) which 
does not enter the nucleus was included as a control for isolation of 
nuclei free of cytoplasmic contamination. 
Mter injection of the ATP-hydrolyzing enzYme apyrase, 
ATP depletion was verified by a luciferase assay. At a final 
intracellular concentration of 100 Vlml, there was a rapid 
decline in ATP levels from 2 mM to 10 to 40 f.LM. This 
decrease occurred within 30 min and remained low after 25 h 
of incubation (data not shown). As shown in Fig. 3, ATP 
depletion significantly inhibited nuclear import of oocyte-
type 5S rRNA (lane 4). The autoradiogram was deliberately 
overexposed to demonstrate the absence of detectable levels 
of labelled 5S rRNA in the nuclear fraction. 
Another criterion for signal-mediated import via the nu-
clear pore complex is sensitivity to the lectin WGA. WGA is 
known to inhibit active transport by binding to N-acetylglu-
cosamine (GlcNAc)-containing proteins present in the nu-
clear pore complex (25, 26, 65). Preinjection of WGA signif-
icantly inhibited nuclear import of oocyte-type 5S rRNA 
(Fig. 4A, lane 4). To verify that inhibition of import resulted 
from WGA interacting with GlcNAc-containing glycopro-
teins, WGA was coinjected with GlcNAc. Figure 4A (lane 6) 
shows that the presence of 50 mM GlcNAc abolished WGA-
induced inhibition of import. The inhibitory effect of prein-
jected WGA on oocyte-type 5S rRNA was dose dependent 
(Fig. 4B), with 86% inhibition occurring at a concentration of 
0.1 mg/ml. To ensure that WGA was not acting by physically 
occluding the nuclear pores, small fluorescently labelled 
dextrans (10 kDa) were microinjected into the oocyte cyto-
plasm. Mter overnight incubation, oocytes were dissected, 
and the nuclei were viewed by fluorescence microscopy. 
Preinjection of WGA had no effect on nonselective diffusion 
of small dextrans, and large fluorescently labelled dextrans 
(150 kDa) were excluded from the nucleus (data not shown). 
Similar results have been obtained in cultured somatic cells 
(15, 25). 
An additional criterion for mediated transport is exclusion 
of nuclear proteins from the nucleus in chilled cells. Nuclear 
accumulation of large and small karyophilic proteins is 
inhibited by chilling, which slows enzyme-mediated reac-
tions, whereas small proteins lacking nuclear localization 
signals may diffuse freely across the nuclear envelope, 
regardless of the temperature (10). Thus, 5S rRNA nuclear 
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import was tested for temperature dependence. Figure 5 
shows that the nuclear import of oocyte-type 5S rRNA was 
inhibited in chilled oocytes (lane 4). Chilling did not inhibit 
nonselective diffusion of a small fluorescent dextran into the 
nucleus (data not shown). 
To determine whether nuclear import of mutant 5S rRNAs 
occurs by a mediated process or by nonselective diffusion, 
loop C mutant 41--44 and loop E mutant 96-101 were tested, 
since these RNAs have reduced abilities to enter the nucleus 
relative to that of oocyte-type 5S rRNA (Table 1). Preinjec-
tion of WGA significantly inhibited nuclear import of both 
mutant 5S rRNAs, although mutant 41--44 was less sensitive. 
Data are summarized in Table 2. Nuclear import of mutants 
41--44 and 96-101 was also inhibited in chilled oocytes (Table 
2), although both mutants were less sensitive than oocyte-
type 5S rRNA. The possibility remains that nuclear entry of 
these mutants is partly diffusional; binding to an import 
receptor protein may be of low affinity or weakly tempera-
ture sensitive. Not all RNA-protein interactions, however, 
are temperature sensitive, because assembly of microin-
jected 5S rRNA into 7S RNPs (storage particles) does occur 
in chilled oocytes (data not shown). 
In summary, nuclear import of 5S rRNA is sensitive to 
general inhibitors of nuclear pore-mediated translocation, so 
import is likely accomplished by a pathway similar to that 
used by karyophilic proteins. 
5S rRNA is assembled into 60S ribosomal subunits in the 
nucleus_ Although indirect evidence to date suggests that 
cytoplasmic 5S rRNA returns to the nucleus for ribosome 
incorporation (3, 18), a nuclear assembly site has not yet 
been demonstrated. To deduce the site of 5S rRNA assembly 
into 60S ribosomal subunits, labelled 5S rRNA was micro-
injected into the cytoplasm and subsequently immunopre-
cipitated from the nuclear versus cytoplasmic compartment. 
The anti-60S ribosomal subunit serum detects two major 
bands in extracts of 60S ribosomal subunits (Fig. 6A and B, 
lanes 3); one band is approximately 37 kDa, and the other is 
approximately 14 to 15 kDa. The 37-kDa band corresponds 
to ribosomal protein L2; the 14- to 15-kDa band is not as 
easily identified but migrates similarly to ribosomal proteins 
in the range of L17 to L20 (53). This antiserum also reacts 
slightly with an approximately 18-kDa band in extracts of 
40S ribosomal subunits (Fig. 6A and B, lanes 4). In the 7S 
fraction from a sucrose gradient, apart from the high-molec-
ular-mass bands which probably represent polysaccharides, 
there is no cross-reaction (Fig. 6A and B, lanes 2). This 
antiserum does not immunoprecipitate 7S RNPs (Fig. 6C, 
lane 2). Intact ribosomes are immunoprecipitated by the 
anti-60S serum; the immunoprecipitates contain proteins 
that react with anti-40S ribosomal subunit serum as revealed 
by immunoblotting and contain both 28S and 18S rRNA as 
revealed by Northern blot (RNA) analysis (data not shown). 
60S subunits containing labelled 5S rRNA were first 
faintly detectable in the nuclear fraction after 18 h but were 
not detectable in the cytoplasm (data not shown). Mter 48 h, 
labelled 5S rRNA was immunoprecipitated as 60S subunits 
from both the cytoplasmic fraction (Fig. 7, lane 2) and the 
nuclear fraction (lane 4), thus indicating a nuclear site of 
assembly, followed by export to the cytoplasm. 
In a previous study, 7S RNPs were detected only in the 
oocyte cytoplasm after microinjection of labelled 5S rRNA 
and immunoprecipitation with anti-TFIIIA antibodies (3). 
Since TFIIIA has been shown to bind nuclear 5S rRNA (31), 
we repeated these assays with a different antibody prepara-
tion to determine whether a small nuclear pool of 7S RNPs 
was present. The antibodies raised against TFIIIA react with 
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Mutant 
designation" 
Oocyte type 
Helix II 
14-15 (HB) 
64-65 (HB) 
14-15/64-65 (HM) 
16-21 (HB) 
57-62 (HB) 
16-21157-62 (HM) 
Helix III 
27-32 (HB) 
45-52 (HB) 
Helix IV 
78-81 (HB) 
95-98 (HB) 
78-81/95-98 (HM) 
82-86 (HB) 
91-94 (HB) 
82--86/91-94 (HM) 
Helix V 
67-70 (HB) 
105-108 (HB) 
67-70/105-108 (HM) 
71-72 (HB) 
103-104 (HB) 
71'-72/103-104 (HM) 
Loop A 
10-13 (SEQ) 
LoopB 
22-26 (SEQ) 
LoopC 
33-39 (SEQ) 
41-44 (SEQ) 
Loop D 
87-90 (SEQ) 
Loop E 
73-76 (SEQ) 
96-101 (SEQ) 
Bulged nucIeotides 
M9,50 (DEL) 
1163 (DEL) 
Hinge nucIeotides 
C66 (SEQ) 
G109 (SEQ) 
TABLE 1. Summary of mutant phenotypes 
Nuclear TFIIIAKa in transport relative 
to oocytes type' vitro
c 
1.00 1.00 
0.49 ± 0.03 (3) 0.85 ± 0.22 
0.97 (1) 0.74 ± 0.24 
1.04 ± 0.16 (3) 1.11 ± 0.32 
0.25 ± 0.05 (2) 0.32 ± 0.15 
0.73 (1) 0.40 ± 0.15 
1.88 (1) 1.09 ± 0.48 
0.70 ± 0.23 (2) 0.75 ± 0.10 
1.45 ± 0.34 (3) 0.76 ± 0.12 
0.99 (1) 0.88 ± 0.01 
0.86 (1) 0.78 ± 0.02 
1.19 ± 0.46 (3) 0.86 ± 0.01 
1.75 ± 0.02 (2) 0.81 ± 0.30 
0.85 ± 0.31 (4) 0.96 ± 0.18 
1.38 ± 0.19 (2) 1.21 ± 0.35 
1.18 ± 0.44 (2) 0.75 ± 0.12 
0.46 ± 0.15 (4) 0.39 ± 0.06 
1.07 0.34 (2) 0.71 ± 0.01 
0.44 0.12 (3) 0.35 ± 0.21 
0.48 ± 0.18 (3) 0.50 ± 0.23 
1.37 ± 0.43 (3) 1.18 ± 0.32 
0.63 ± 0.00 (2) 0.30 ± 0.01 
1.18 (1) 1.00 0.02 
0.97 ± 0.25 (3) 1.00 ± 0.D2 
0.33 ± 0.06 (3) 0.40 ± 0.10 
1.26 (1) 0.71 ± 0.10 
1.60 ± 0.20 (2) 0.57 ± 0.02 
0.36 ± 0.04 (3) 0.59 ± 0.01 
0.76 ± 0.38 (2) 1.00 ± 0.D2 
1.04 ± 0.40 (4) 1.00 ± 0.02 
0.43 ± 0.05 (2) 0.12 ± 0.01 
0.77 ± 0.02 (2) 0.17 ±0.05 
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a The numbers in the designations refer to those nucleotides in 5S rRNA which have been substituted or deleted (Fig. 1). RB, helix breaking; HM, helix 
maintaining; SEQ, sequence mutation; DEL, deletion. 
b Assays were performed as described in the legend to Fig. 2; nuclear transport was quantified by densitometry of suitable exposures of autoradiograms (within 
the linear range of signal intensity of the film), relative to the steady-state levels of oocyte-type 5S rRNA localized to the nucleus during each experiment. 
Experimental values are presented (mean ± standard deviation from the mean). Numbers in parentheses indicate the number of independent experiments 
performed. 
C In vitro binding data is summarized from references 8, 56, 58, and 74. 
d Assays were performed as described in the legend to SA. Protein binding was quantified by qualitative estimation of relative amounts of bound and free 
RNA. IR, inconclusive results caused by RNA with low specific activity . 
• Electrophoretic mobility shift assays (EMSAs) were performed as described in the legend to Fig. 8e. ND, not determined. 
the relevant protein (Fig. 6C, lane 1); no cross-reaction was 
noted with any other protein by immunoblotting (70). Under 
similar conditions, in this present study 7S RNPs containing 
labelled 5S rRNA were detectable only in the cytoplasmic 
fraction from 10 oocytes incubated for 21 h after microinjec-
tion (data not shown). However, a small nuclear pool of 7S 
RNPs was revealed by increasing the incubation time aiter 
microinjection to 48 h, increasing the specific activity of the 
labelled 5S rRNA, and increasing the sample size to 20 
oocytes (Fig. 7, lane 3). 
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FIG. 3. Nuclear import of oocyte-type 5S rRNA is ATP depen-
dent. OOL"Ytes were preinjected with a final intracellular concentra-
tion of 100 U of apyrase per ml (-ATP), or PBS as a control 
(+ATP). After incubation for 30 min at 18°C, 32P-labelled oocyte-
type 5S rRNA was injected into the cytoplasm, and the oocytes 
were incubated for a further 6 h. The analysis for nuclear import was 
then performed as described in Fig. 2. C, cytoplasm; N, nucleus. 
Sequence and structural requirements of 5S rRNA for 60S 
ribosomal subunit assembly and 7S RNP assembly in vivo. 
Since the results above demonstrated that the first require-
ment for subunit assembly is nuclear targeting, it was of 
interest to ascertain which sequence and structural elements 
of 5S rRNA are required for incorporation into 60S riboso-
mal subunits. Immunoprecipitation assays were thus per-
formed on microinjected oocytes with antibodies against 60S 
subunits. . 
The results of several representative experiments are 
shown in Fig. 8A, and the complete data are presented in 
Table 1. Of 31 mutants, only 4 were completely defective in 
ribosome incorporation. Of these four mutants, two had 
mutations in single-strand loop regions, mutants 96-101 (Fig. 
SA, lane 14) and 10-13 (lane 16), indicating that these regions 
of the molecule are important in recognition or binding of 5S 
rRNA with other ribosomal components. Comparable 
amounts of oocyte-type and mutant 5S rRNAs were detect-
able in the immunosupernatant fractions, demonstrating that 
the mutants were not degraded during the 48-h incubation 
(Fig. 8B). The simplest explanation for mutant 96-101 not 
being detected in ribosomes is that this results from impaired 
nuclear transport (Table 1). However, mutant 41-44 is 
equally defective in nuclear transport, yet it is found incor-
porated into 60S ribosomal subunits (lane 12). The other two 
defective mutants were A49,50 (lane 18) and 8.63 (lane 20), 
indicating that these bulged nucleotides are important for 5S 
rRNA incorporation into the 60S subunit. Results were 
inconclusive for six mutants (Table 1). The possibility that 
the absence of these labelled RNAs in 60S ribosomal sub-
units was due to the low specific activity of the RNA could 
not be ruled out. Despite repeated attempts to increase the 
specific activity, these particular mutant 5S rRNA gene 
constructs continued to provide poor templates for tran-
scription. 
In addition to assaying different mutant 5S rRNA mole-
cules for their incorporation into 60S subunits, immunopre-
cipitation of 7S RNPs was also performed with anti-TFIIIA 
antibodies. This qualitative analysis provided a comparison 
with the in vitro data previously obtained for TFIIIA binding 
to the mutant 5S rRNA molecules (summarized in Table 1). 
All but six mutant 5S rRNAs were found to be able to bind 
TFIIIA in the oocyte in an immunodetectable complex. One 
of these defective mutants, 10-13 (Fig. 8A, lane 15), corre-
sponds with the in vitro data; mutant 10-13 has a Ka of 0.30 
and is 20 times less effective in inhibiting TFIIIA binding 
than oocyte-type 5S rRNA is (56). Negative results with 
other mutants, however, were contradictory. For example, 
5S rRNA STRUCTURE-FUNCTION RELATIONSHIPS 
A 
B 
100 
90 
80 
70 
:g 80 
,3 50 
'" 40 
30 
20 
10 
0.00 0.01 0.02 0.03 0.04 0.05 0.06 0.07 0.06 0.09 0.10 
Cellular WGA Concentration (mg/ml) 
6825 
FIG. 4. Nuclear import of oocyte-type 5S rRNA is inhibited by 
WGA. (A) Oocytes were preinjected with WGA at a final intracel-
lular concentration of 0.1 mg/mt or with WGA (0.1 mg/ml) and 50 
mM N-acetylglucosamine (WGA + GlcNAc). PBS was preinjected 
as a control. After incubation for 3 h, 32P-Iabelled oocyte-type 58 
rRNA was injected into the cytoplasm and the oocytes were 
incubated for a further 18 h. The analysis for nuclear import was 
then performed as described in the legend to Fig. 2. C, LytopJasm; 
N, nucleus. (B) Dose-dependent inhibition of 5S rRNA nuclear 
import. Oocytes were preinjected with 50 nl of WGA at various 
concentrations. The final intracellular concentration of WGA is 
denoted on the x axis. The nuclear import of 32p-tabelled 5S rRNA 
was assayed 18 h after injection. Import in the presence of WGA is 
expressed as a percentage of the import of 5S rRNA in control 
oocytes preinjected with PBS only (% Control). 
mutant 67-70 (Fig. 8A, lane 7) was not immunoprecipitated 
with anti-TFIIIA yet has an in vitro binding affinity of 0.75 
(74). To clarify these results, homogenates of microinjected 
oOcytes were analyzed by electrophoretic mobility shift 
assays. As shown in Fig. 8C, mutant 67-70 (lane 5) clearly 
showed a band shift present at a position corresponding to 
that of 7S RNPs. Similarly, mutants 64-65, 73-76, 96-101, 
and GI09 which were not immunodetectable by anti-TFIIIA 
showed band shifts corresponding to 7S RNPs (Fig. 8A and 
C and Table 1). In contrast, consistent with the in vitro 
binding data and immunoprecipitation data, no band shift 
corresponding to 7S RNPs was detected with mutant 10-13 
(Fig. 8C, lane 8). The data are summarized in Table 1. 
The inconsistent anti-TFIIIA immunoprecipitation assay 
and electrophoretic mobility shift assay results described 
above can be explained by reasoning that for these mutant 
5S rRNA molecules, the 5S rRNA-TFIlIA complexes that 
are formed have different conformations which are not 
recognized by the anti-TFIIIA antibody or that the com-
plexes formed are not stable under the assay conditions. 
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FIG. 5. Effect of chilling on the nuclear import of oocyte-type 5S 
rRNA. 32P-Iabelled oocyte-type 5S rRNA was injected into the 
oocyte cytoplasm. After incubation for 18 h at either 18°C as a 
control or on ice (O°C), the analysis for nuclear import was per-
formed as described in the legend to Fig. 2. C, cytoplasm; N, 
nucleus. 
These observations raise a cautionary note toward relying 
solely on antigen-antibody interactions for the analysis of 
RNA-protein interactions. 
The potential formation of an RNA-protein complex not 
recognized by an antibody is not a likely consideration with 
the anti-60S ribosomal subunit antibody. 5S rRNA-is thought 
to be buried in the 60S subunit (42), within the peptidyl 
transferase center, whereas the ribosomal proteins recog-
nized by this antibody (L2 and another in the range of L17 to 
L20) are not detected in this region (23, 63, 68). Given the 
apparent lack of direct cross-links between 5S rRNA and the 
ribosomal proteins recognized by the anti-60S antibody, it is 
unlikely that any conformational change resulting from in-
corporation of a mutant 5S rRNA molecule into the 60S 
subunit would be transmitted to these ribosomal proteins; 
A B 
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TABLE 2. Summary of effects of WGA and chilling on nuclear 
import of oocyte-type and mutant 5S rRNA 
RNA 
Oocyte type 
41-44 
96-101 
WGA 
14.6 (±0.4) 
42.0 (±3.4) 
17.0 (±1.6) 
% Control" 
O'C 
4.1 (±2.1) 
43.0 (±3.0) 
22.0 
a Nuclear import of the designated 32P-labelled RNA (Fig. 1) was assayed in 
samples of five ooeytcs as described in the legend to Fig. 4A for WGA (final 
intracellular concentration of 0.2 mg/ml) and in the legend to Fig. 5 for 
chilling. Import was quantified by densitometry and expressed as a percentage 
(± standard deviation from the mean) of the amount of import in control 
oocytes (% Control). Tabulated results are from two samples, except for 
mutant 96-101 (O°C) for which one sample was used. 
thus, the recognition or binding of the anti-60S antibody to 
these epitopes would not be affected. 
In summary, specific structural elements of the 58 rRNA 
molecule have been shown to be critical for ribosome 
incorporation. Deletion of bulged nucleotides and nucleotide 
substitutions that alter the sequence of loop A or the 
noncanonical base pairing in loop E (57, 72) abolish ribo-
some incorporation. 80me of the structural elements of 58 
rRNA required for ribosome incorporation differ from those 
elements required for nuclear transport. Further, some of 
the structural requirements of 58 rRNA for 78 RNP assem-
bly and for 608 ribosomal subunit assembly differ. 
DISCUSSION 
From the 5S rRNA mutants studied in this report, a 
picture emerges of complex and nonidentical structural 
features within the central domain of the RNA molecule that 
C 
FIG. 6. Control of antiserum specificity by immunoblotting and immunoprecipitation assays. Total protein from 7S fractions and from 
ribosomal subunits purified from Xenopus ovaries was fractionated by electrophoresis in 15% polyacrylamide gels containing 0.1 % sodium 
dodecyl sulfate (SDS) and either stained with Coomassie blue (A) or transferred to Immobilon-P polyvinylidene difluoride membranes and 
probed with anti-60S ribosomal subunit antiserum (B). The antigen-antibody complexes were revealed by treatment with 35S-labelled protein 
A and then autoradiography (48 h). The high-molecular-mass bands in lane 2 of panel B are probably polysaccharides. Lanes: MW, protein 
molecular mass markers (in kilodaltons); 7S, approximately 10 fLg of protein purified from the 7S region of a sucrose gradient; 60S, 
approximately 3 fLg of protein from 60S ribosomal subunits purified by sucrose gradient centrifugation; 40S, approximately 1 fLg of protein 
from 40S ribosomal subunits purified by sucrose gradient centrifugation. (C) 7S RNPs purified from immature Xenopus ovaries were incubated 
with protein A-Sepharose-antibody complexes in an immunoprecipitation assay. Proteins were recovered and separated electrophoretically 
on 12% polyacrylamide gels containing 0.1% SDS and then silver stained. Lanes: anti-7S, immunoprecipitation with anti-TFIIIA; anti-60S, 
immunoprecipitation with anti-60S ribosomal subunit; control, mock immunoprecipitation with anti-60S antiserum, but without 7S RNPs; 
TFIIIA, TFIIIA protein from 7S RNPs. 
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FIG. 7. Intracellular localization of microinjected 5S rRNA in 
60S ribosomal subunits and 7S RNPs. Labelled 5S rRNA was 
microinjected into the cytoplasm of oocytes. After incubation for 48 
h, 20 oocytes were manually fractionated into cytoplasmic (C) and 
nuclear (N) compartments. Homogenates from each compartment 
were incubated with protein A-Sepharose-antibody complexes in an 
immunoprecipitation assay. Labelled RNAs were recovered and 
separated electrophoretically on 8% polyacrylamide gels containing 
8 M urea. Lanes: 7S, immunoprecipitation with anti-TFIIIA; 60S, 
immunoprecipitation with anti-60S ribosomal subunit. 
are required for nuclear transport, aSSembly into 7S RNPs 
(storage particles) and assembly into 60S ribosomal subunits 
(Fig. 9). 5S rRNA is assembled into 60S ribosomal subunits 
in the nucleus; thus, the first requirement for subunit assem-
bly is nuclear targeting. However, some of the structural 
elements of 5S rRNA required for ribosome incorporation 
differ from those elements required for nuclear transport 
(Fig. 9). Differences in the requirements for nuclear trans-
port and lFIllA binding suggest that TFliIA binding is not 
a prerequisite for nuclear targeting of 5S rRNA. 
Subcellular tramcking of 5S rRNA. Since 5S rRNA can be 
easily and specifically dissociated from intact ribosomes or 
subunits as a 5S rRNA-LS complex (3), it was thought that 
the 5S rRNA might be added as a surface component to 
partially assembled subunits, hence a cytoplasmic site of 
integration of stored 5S rRNA seemed plausible. However, 
results presented here indicate that cytoplasmically stored 
5S rRNA returns to the nucleus for assembly into the large 
60S subunit. This conclusion is consistent with a recent 
study in Saccharomyces cerevisiae, which suggests that 5S 
rRNA is crucial to an early step in subunit assembly (69). 
Thus, analysis of intracellular distribution reflects the 
steady-state levels of 5S rRNA molecules reached after 
overnight incubation (3); 5S rRNA is released from storage, 
migrates into the nucleus, is assembled into ribosomes, and 
then is exported to the cytoplasm. Since ribosome assembly 
continues for a protracted period of time in Xenopus 
oocytes, only a small fraction of microinjected 5S rRNA 
would be expected to appear in the nucleus at any given time 
or be incorporated into nascent ribosomes. The latter is 
reflected in the small fraction of labelled 5S rRNA found in 
60S subunits compared with 7S RNPs (storage particles). 
Interestingly, a number of mutants accumulated in the 
nucleus to a greater degree than oocyte-type 5S rRNA, for 
example, nuclear accumulation of mutant 16-21/57-62 was 
nearly twice that of oocyte-type 5S rRNA. It is not clear 
whether this distribution represents enhanced nuclear im-
port or whether the increased nuclear accumulation of some 
mutants is due to a defect in another function, such as 
nuclear export. 
Mediated nuclear import of 5S rRNA. Nuclear import of 5S 
rRNAis inhibited by cytoplasmicATP depletion, WGA, and 
chilling. Similarly, nuclear protein import (2, 51, 55), export 
of ribosomal subunits (6), and mRNA export (16) require 
metabolic energy in vivo. The concentration of WGA re-
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FIG. 8. AssembJy of mutant 5S rRNAs into 60S ribosomal sub-
units and 7S RNPs. (A) 32P-Iabelled oocy1e-type or mutant 5S rRNA 
was microinjected into the oocyte cytoplasm. After 48 h, homoge-
nates of whole oocytes were analyzed by immunoprecipitation assay 
as described in the legend to Fig. 7. Labelled RNAs were recovered 
and separated electrophoretically on 8% polyacrylamide gels con-
taining 8 M urea. The numbers in the mutant designations refer to 
those nucleotides in oocyte-type 5S rRNA ( oocyte) which have been 
substituted or deleted (Fig. 1). Lanes: 7S, immunoprecipitation.with 
anti-TFIIIA; 60S, immunoprecipitation with anti-60S nbosomal 
subunit. (B) Labelled RNA~ recovered from inlmunosnpernatant 
fractions, from the anti-60S immunoprecipitation assays in paneJ A. 
Lane 1, oOcy1e-type RNA; lane 2, mutant 67-70; lane 3, mutant 
96-101; lane 4, mutant 10-13; lane 5, mutant .6.49,50; lane 6, mutant 
.6.63. (C) Electrophoretic gel mobility shift assays of mutant 5S 
rRNAs. Labelled oocyte-type or mutant 5S rRNA was injected into 
the oocyte cytoplasm. After 48 h, homogenates were electrophore-
sed on nondenaturing 6% polyacrylamide gels containing 0.1% 
Triton X-lOO. The location of 7S RNPs was determined by running 
an additional lane of unlabelled, purified 7S RNPs; this lane was 
stained with ethidium bromide and visualized by UV illumination 
(not shown). The arrows indicate a band shift that may represent the 
5S rRNA-ribosomal grotein L5 complex, but this has yet to be 
confirmed. Marker, 3 P-Iabelled 5S rRNA. Lanes 1 to 4 and lanes 5 
to 8 represent experiments in which samples were electrophoresed 
for different lengths of time. 
quired to inhibit 5S rRNA nuclear import is comparable to 
the concentration of WGA shown to inhibit the nuclear 
import of U6 small nuclear RNA, but 20 times less than the 
concentration required to inhibit nuclear import of U1 small 
nuclear RNA to a similar degree (see Fig. 3 in reference 48). 
These results correlate with studies on nuclear export of 5S 
rRNA and 5S rRNA-containing RNPs. Approximately 60% 
inhibition of ribosomal subunit export can be achieved when 
WGA is injected into the nucleus at a final concentration of 
0.5 mg/ml (6), and export of 5S rRNA newly synthesized 
from microinjected cloned genes is significantly inhibited by 
preinjection of RL1, an antinucleoporin monoclonal anti-
body (24). The sensitivity of 5S rRNA to general inhibitors of 
nuclear transport suggests that 5S rRNA is targeted to 
oocyte nuclei by a receptor-mediated process. 
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FIG. 9. Complex, nonidentical regions of 5S rRNA required for different functions. Shaded boxes indicate regions in which nucleotide 
substitution results in at least a 50% reduction in nuclear transport of 5S rRNA. Boxes outlined in bold indicate regions in which nucleo-
tide substitution results in at least a 50% reduction in TFIIIA binding affinity. Boxes outlined in dashed lines indicate regions in which 
nucleotide substitution abolishes incorporation of 5S rRNA into the 60S ribosomal subunit. 
Given the specificity of receptor-mediated processes, it 
seemed surprising that all mutants were capable of at least 
some degree of nuclear import. However, the results pre-
sented here are similar to an analysis of the nuclear export 
phenotypes of 30 different point mutants of human tRNA; Met 
which revealed variable defects in transport; the percentage 
of microinjected tRNA exported to the cytoplasm ranged 
from 85 (wild type) to 34% (D stem mutant) (67). Glyceral-
dehyde-3-phosphate dehydrogenase binds two defective mu-
tants with lower affinity than that of wild-type tRNA, sug-
gesting that this protein may be involved in tRNA export 
(62). This comparison with tRNA export and a model for the 
tertiary structure of 5S rRNA provide some insight into 5S 
rRNA import. 5S rRNA has been proposed to adopt a 
Y-shaped structure in which the three helical domains are 
independent (13, 71), that is, the effect that a mutation has on 
the RNA structure is primarily restricted to the mutated loop 
(12, 40). If a protein involved in nuclear targeting makes 
numerous contacts with 5S rRNA, disruption of one small 
region may not disrupt binding in other regions, therefore 
potentially providing a stable complex that is still recognized 
by the transport machinery. Relatively small changes in 
complex stability may be masked at the saturating levels of 
RNA used in these experiments. 
Guddat et al. (31) proposed that 5S rRNA nuclear export 
is mediated by either TFIIIA or L5 on the basis of studies 
showing that mutant RNA molecules that do not form 
immunodetectable complexes with these proteins are re-
tained in the nucleus. Results of this present study suggest 
that TFIIIA binding is not a prerequisite for nuclear import 
of 58 rRNA, consistent with earlier work suggesting that 78 
RNP transport is unidirectional (3, 44). A small nuclear pool 
of 78 RNPs containing labelled 58 rRNA was detected after 
microinjection of labelled 58 rRNA into the oocyte cyto-
plasm, but it is likely that these 7S RNPs were assembled 
after nuclear entry. If 58 rRNA enters the nucleus in excess 
of the amount required for assembly into nascent 60s 
ribosomal subunits, it may become associated with TFIIIA. 
Along these lines, it has been proposed that excess 58 rRNA 
may be targeted to the cytoplasm of mammalian somatic 
cells for degradation bound to a TFIIIA-like protein (39). 
Ribosomal protein L5 and 58 rRNA form a stable complex 
prior to assembly of ribosomal subunits (3, 11, 64, 73). 
Cytoplasmic exchange between TFIIIA and L5 for binding 
of 58 rRNA correlates with the mobilization of 58 rRNA 
from storage within the Xenopus oocyte cytoplasm (3), 
suggesting that L5 may mediate 5S rRNA nuclear targeting. 
Little is known about the sequence and structural require-
ments for L5 binding to 58 rRNA, although chemical pro-
tection assays (35) and immunoprecipitation assays (3) indi-
cate a binding domain similar to that of TFIIIA. Delineation 
of the sequence and structural requirements of 58 rRNA for 
L5 binding and correlation with data on subcellular localiza-
tion should provide further insight into the role of L5 in 
nuclear import and nucleolar targeting of 5S rRNA. The 
possibility remains that other proteins, such as carriers that 
shuttle between the cytoplasm and the nucleus (9, 36, 46, 
60), are involved in the subcellular trafficking of 58 rRNA. 
5S rRNA structural elements required for ribosome assem-
bly. Loop structures, bulged nucleotides, and non-Watson-
VOL. 13, 1993 
Crick base pairs of RNA have been shown to be of impor-
tance for specific protein recognition (4, 14, 54). Similarly, 
results presented here show that incorporation of 5S rRNA 
into ribosomes is abolished by deletion of bulged nucle-
otides, A at nucleotides 49 and 50 or C at nucleotide 63, and 
by nucleotide substitutions that alter the sequence of loop A 
or the noncanonical base pairing in loop E. These results 
correlate with results from other workers investigating pro-
karyotic 5S rRNA-protein interactions. Escherichia coli 5S 
rRNA has a structure similar to that of eukaryotic 5S rRNA, 
but E. coli 5S rRNA binds to three ribosomal proteins, 1.5, 
L18, and L25, rather than to one protein as in eukaryotes. A 
bulged nucleotide at position 65 in E. coli 5S rRNA, corre-
sponding to position 63 in eukaryotic 5S rRNA, is necessary 
for binding of L18 to the 5S rRNA (reviewed in reference 
29). 
Various regions of 5S rRNA have been postulated to be of 
importance for ribosome assembly and function (69; for a 
review, see reference 29). Complementary base pairing 
between nucleotide sequences at the 5' and 3' ends of mouse 
18S rRNA contained in the 40S ribosomal subunit and 
nucleotides 9 to 26 and 90 to 107 of 5S rRNA occurs in vitro 
(59). The functional significance of this stable interaction has 
yet to be determined. Interestingly, mutant 96-101 which has 
increased Watson-Crick base pairing in the loop E-helix IV 
region of 5S rRNA and mutant 10-13 which has an altered 
sequence in loop A were shown here to be defective in 
ribosome incorporation. These results indicate a correlation 
between the structural elements of the 5S rRNA molecule 
required for 60S ribosomal subunit assembly and the struc-
tural elements previously proposed to aid in formation of the 
80S ribosome by 5S rRNA-nucleic acid interactions. Protein 
recognition of the noncanonical base pairing in loop E 
encompassing nucleotides 96 to 101 of the 5S rRNA mole-
cule (57, 72) may be of importance for 60S ribosomal subunit 
assembly, as well as RNA-RNA hybridization. 
5S rRNA represents an important model system for study 
of the regulated subcellular trafficking of RNA, because it 
involves many different components: shuttling of the 5S 
rRNA molecule across the nuclear envelope, a variety of 
RNA-protein interactions and exchanges, cytoplasmic local-
ization of the 5S rRNA in RNPs (storage particles), and 
nucleolar targeting. Continued study of the effects of muta-
tions by an in vitro binding assay (7, 8, 56, 74) and by the in 
vivo functional assays described here should help to further 
identify and clarify those sequence and structural elements 
of 5S rRNA required for some of its biological activities. 
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